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SUMMARY
Twenty one monoclonal antibody-secreting hybridoma cell lines were 
produced from fusions between mouse myeloma cells and spleen cells 
from mice immunised with axenically-cultivated Entamoeba histolytica. 
These monoclonal antibodies (Mabs) were used in the subsequent study 
of the antigens for which they were specific.
The subcellular locations of these antigens within E. histolytica 
trophozoites were visualised by use of the Mabs in indirect 
fluorescent antibody tests (IFAT). Three of the Mabs recognised 
antigens located on the surface of the amoebae; confirmed by positive 
results in IFAT experiments using live E. histolytica. These Mabs 
recognised only a percentage of cells (the percentage was different 
for each Mab) present in cultures. This heterogeneity of antigen 
expression within a culture was not a stable property of the cells, 
since cloned lines were also heterogeneous when tested. The 
phenomenon, which occurred in all isolates recognised by these Mabs, 
may be related to the cell cycle or, more likely, be due to 
subpopulations of cells arising in the cultures. Two of the Mabs 
were specific for antigens related to the vacuolar system of the 
amoeba while the remainder recognised other internal components of 
the amoeba.
The Mabs were tested for their ability to recognise antigens in IFAT 
tests using other protozoan cell types, including other members of 
the genus Entamoeba. Two of the Mabs recognised all cell types 
tested, including a mammalian cultured cell line. Eight Mabs failed 
to cross-react with any of the cells tested, while a further nine 
reacted with either Entamoeba invadens (a reptile pathogen) or 
Entamoeba moshkovskii (free-living in sewage) or both. These 
experiments demonstrated a high degree of antigenic relatedness 
between some members of the quadrinucleate cyst group of the genus
Entamoeba; E. histolytica, E. invadens and E. moshkovskii, but not
E. hartmanni. The identical pattern of Mab cross-reaction obtained 
with Entamoeba coli (from man) and Entamoeba muris (from mice) 
reflected the morphological indistinguishability of these two members 
of the octonucleate cyst group of Entamoebae.
Fifteen isolates of E. histolytica, other than strain 200:NIH 
(against which these Mabs were raised), were tested in IFAT 
experiments using the Mabs. In general, very little antigenic 
heterogeneity was observed. The failure of the three 
surface-staining Mabs to recognise some strains may have been due to 
an undetectably low number of positive cells. Apart from these, only 
three other Mabs failed to recognise all isolates. In subsequent 
IFAT experiments involving a larger sample of E. histolytica 
isolates, two of these Mabs, 22.3 and 22.5, were shown to react 
specifically with amoebae belonging to pathogenic zymodemes. The 
nature of the pathogen-specific antigens recognised by these Mabs, is 
not known.
Approximate molecular weights of some of the antigens recognised by 
these Mabs, were determined using the Mabs as probes in electro­
immunotransfer blotting of amoebic lysates previously subjected to 
polyacrylamide gel electrophoresis. Values were obtained using 
thirteen of the Mabs and ranged from 12 kD to over 300 kD with the 
majority between 95 and 130 kD.
Mabs found not to cross-react with other tested human protozoan 
parasites (selected on the basis of previous IFAT experiments) were 
tested for their ability to detect E. histolytica antigen as primary 
capture reagents in a double sandwich enzyme-linked immunosorbent 
assay (ELISA). Two Mabs, 24.7 and 29.3, consistently detected 
antigen (amoebic lysate) down to a concentration of 0.1 pg total 
protein per ml of sample, indicating their potential usefulness in an 
immunodiagnostic test for amoebiasis.
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CHAPTER 1 INTRODUCTION
1.1 GENERAL INTRODUCTION
It is estimated, based on published reports, that there are nearly 
500 million human infections with Entamoeba histolytica worldwide 
(Walsh, 1986b). Of these infections, which occur mainly in the 
developing world, only 8-10% cause clinical disease, the remainder 
being asymptomatic. With an estimated mortality of between 40,000 
and 110,000 (Walsh, 1986a), amoebiasis has been ranked third among 
parasitic causes of death, behind only malaria and schistosomiasis 
(Walsh, 1986a).
Amoebiasis can be defined as infection with the protozoan parasite 
Entamoeba histolytica Schaudinn, 1903, with or without overt clinical 
symptoms (W.H.O., 1969). Dysentery (of which amoebiasis is one 
cause) and its potentially infectious nature, was recognised as long 
ago as the 4th century B.C. and was discussed by Hippocrates (Adams, 
1939). Losch (1875) found the parasite in the stools of a patient 
(from Arkhangel'sk in N. Russia) suffering from chronic dysentery and 
although colitis could be reproduced in dogs given the patient's 
stool orally or rectally, he did not believe that the amoebae were 
the causative agent. Invasion of tissues by amoebae was described by 
Koch in 1887 and detailed clinical and pathological descriptions of 
amoebic dysentery and amoebic liver abscesses were provided four 
years later by Councilman and Lafleur (1891). Cysts of the parasite 
were first recognised by Quincke and Roos (1893) and in 1903 the 
organism was named Entamoeba histolytica by Schaudinn (1903) because 
of its apparent ability to lyse tissue. The organism was first 
cultured in vitro by Boeck and Drbohlav (1925) and the perseverance 
of Diamond (1961, 1968, 1978) resulted in the successful axenic 
culture of E. histolytica.
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1.2 TAXONOMIC CLASSIFICATION
E. histolytica belongs to the subkingdom and phylum Protozoa; the 
subphylum Sarcodina (motility dependent on pseudopodia); the 
superclass Rhizopoda (class Lobosea); and the order Amoebida (Levine 
et al.. 1980). Separated from the free-living amoebae, family 
Valkampfidae - genus Naegleria and family Acanthamoebidae - genus 
Acanthamoeba. the family Entamoebidae contains the genera Endolimax 
and Iodamoeba as well as the genus Entamoeba, which includes the 
species E_;_ histolytica and others further discussed in Chapter 3.
1.3 MORPHOLOGY AND GENERAL BIOLOGY OF E. HISTOLYTICA
E. histolytica can exist in two basic forms; the trophozoite and the 
cyst. The trophozoites, or feeding stages, show extreme pleomorphism 
when viewed under the light or electron microscope (when preservation 
is adequate) and can vary considerably in size. When the diameters 
of fixed rounded trophozoites are measured, amoebae obtained directly 
from liver or intestinal lesions are generally large (20-40 pm) while 
those found in non-dysenteric stools or in culture are smaller 
(7-30 pm). The diameters of living trophozoites are larger than 
their fixed counterparts.
Active living cultured trophozoites, and indeed carefully fixed 
amoebae, are elongated with protruding lobopodia and a trailing 
uroid. Under the scanning electron microscope most of the cell 
surface has a wrinkled appearance, with circular endocytotic stomata 
and filopodia more frequently observed in axenically-grown amoebae 
(Martinez-Palomo, 1976). The circular stomata are of two types; 
0.2-0.4 pm diameter openings corresponding to micropinocytotic 
vesicles and 2-6 pm diameter openings corresponding to 
macropinocytotic vesicles. Filopodia are thin filamentous surface 
projections about 0.1 pm in diameter and several microns in length. 
They can occur at any site on the cell surface but are more common at 
the basal surface, particularly around the uroid (Lushbaugh and
Pittman, 1979), an area at the posterior of actively progressing 
trophozoites consisting of irregular folds of membrane. Foreign 
particles, cells and bacteria have been observed attached to this 
region but it is not definitely known whether the uroid participates 
in endocytotic or exocytotic processes (Lushbaugh and Pittman, 1979).
The plasma membrane of E. histolytica trophozoites is approximately 
10 nm thick and has a classic trilaminar unit membrane appearance in 
thin section transmission electron microscopy (Martinez-Palomo et 
al., 1976). This membrane is covered by a surface coat, composed of 
short filaments, 6-10 nm in length, detectable by either ruthenium 
red or alcian blue staining used together with osmium tetroxide in 
electron microscopy (Pinto da Silva et al., 1975). The actual 
thickness of the coat seems to be dependent on the origin of the 
amoebae, appearing thicker in amoebae isolated from intestinal 
lesions and grown monoxenically than in amoebae grown under axenic 
conditions (Lushbaugh and Miller, 1974). However, the loosely-bound 
nature of the coat components and the adsorption of serum and other 
components to the surface make such differences difficult to 
interpret (Martinez-Palomo et al 1980). The plasma membrane and 
surface coat will be mentioned in more detail in Chapter 2.
The bulk of the cytoplasm, when viewed in thin sections, appears to 
consist of vacuoles of variable size, ranging from 0.5-9.0 fim in 
diameter within a cytoplasmic matrix (Martinez-Palomo, 1982). A 
system of tubules and vesicles, approximately 20 nm in diameter, 
superficially resembling the smooth endoplasmic reticulum of 
mammalian cells can also be found in the cytoplasm. Although it is 
likely that the vacuoles represent components of the phagolysosomal 
system (since some contain ingested food particles) and the vesicles, 
components of the intracellular synthetic apparatus, the exact 
functional significances of these organelles have not been elucidated 
(Martinez-Palomo, 1982).
Other cytoplasmic inclusions encountered in electron microscopic 
studies include ribosomes, both free and in ordered helical arrays.
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The significance of such arrays remains unclear. In cysts and 
resting cultured trophozoites such helices may aggregate into large 
crystalline inclusions (constituting the "chromatoid body" visible 
under the light microscope) which may represent ribosomal precursors 
(Barker and Swales, 1975) or may be related to storage of ribosomes 
during periods of reduced metabolic activity (Kusamrarn, 1975).
Dense cylindrical bodies, often arranged in rosettes, have frequently 
been described in the cytoplasm of both cultured trophozoites and 
amoebae obtained directly from lesions (Feria-Velasco and Trevino, 
1972; Bird and McCaul, 1976). These bodies are up to 250 nm in 
length and 90 nm in diameter, are surrounded by a thin incomplete 
membrane and their morphological characteristics have led to the 
suggestion that they may be rhabdoviruses (Bird and McCaul, 1976). 
Various filamentous and polyhedral DNAviruses have been described in 
cultured amoebae (Mattern et al., 1972), although such particles are 
not observed in healthy axenic cultures (Diamond and Mattern, 1976). 
No evidence of a relationship between virus presence and amoebic 
virulence has so far been obtained (Mattern et al., 1979; Hickman 
(pers. comm.), 1987).
In contrast to free-living amoebae, whose cytoskeleton has been 
extensively studied, very little is known about the structural 
organisation of the cytoskeleton of E. histolytica. Short 
microfilaments, 7 nm in diameter, have been identified with the 
electron microscope, located immediately below the plasma membrane 
(Martinez-Palomo, 1974). In phagocytic channels, a fibrogranular 
material can be observed but few definite fibrillar structures can be 
identified even when specimens are fixed under conditions known to 
minimise depolarisation of actin filaments during fixation 
(Martinez-Palomo et al., 1976). Immunofluorescence studies using 
anti-actin antibodies have failed to show structured microfilaments 
in Entamoeba (Aust-Kettis et al., 1977) which can be identified in 
similar experiments using vertebrate fibroblasts. Microtubules have 
only been identified in the nuclei of dividing trophozoites 
(Martinez-Palomo, 1982). Several authors have found occasional
microtubule-like structures in the cytoplasm of E. histolytica 
(Rosenbaum and Wittner, 1970; Michel and Schupp, 1975) but their 
diameter (36 nm), general ultrastructure and rare occurence suggests 
the possibility that they may be filamentous viruses.
The nuclear morphology of iron haematoxylin-stained amoebae has been 
used in the identification of E. histolytica in clinical laboratories 
for many years (Dobell, 1919). Although a number of these 
morphological characteristics are known to be artefacts, the majority 
have been corroborated by electron microscopic studies. The nucleus 
of the trophozoite is 4-7 |jun in diameter with uniformly sized 
chromatin clumps usually evenly distributed on the inside of the 
nuclear membrane. The endosome is a 0.5 pm diameter, spherical mass 
located in the central part of the nucleus and generally appears less 
dense than the peripheral material. Albach et al. (1980), using 
radiolabelled nucleotides, showed that the "peripheral chromatin" is 
rich in RNA, and may be the counterpart of the nucleolus in other 
eukaryotes, while the endosome is a site of DNA condensation. 
Intranuclear bodies in Entamoeba are a common occurrence (Zaman,
1973) though their function is not known.
The mechanism of nuclear division is not understood but it is known 
that it occurs without dissolution of the nuclear membrane (Cervantes 
and Martinez-Palomo, 1980) and that intranuclear microtubular 
spindles occur in dividing cells (Martinez-Palomo, 1982).
All published electron microscopic studies confirm that E. 
histolytica possesses no mitochrodria, rough endoplasmic reticulum 
and no centrioles. The existence of a golgi apparatus is disputed. 
While two groups of workers describe such a structure (Eaton et al., 
1970; Proctor and Gregory, 1972) most workers have found no evidence 
for golgi membranes (reviewed by Martinez-Palomo, 1982).
The exact life cycle of E. histolytica in the human is not known and 
the most detailed knowledge has come from the work of Dobell (1928) 
on cultures of a strain obtained from a monkey. He describes four
consecutive stages: trophozoite, precyst, cyst and metacyst. It is
thought that under adverse conditions in the lower colon,
trophozoites develop into precystic and cystic stages, which are
followed by two nuclear divisions producing two to four nuclei within
the cyst. Asymptomatic carriers, convalescent patients and
dysenteric patients between periods of active disease, are capable of
6shedding up to 15 x 10 cysts per day in their faeces (Feachem, et 
al., 1983). Mature quadrinucleate cysts may survive outside the host 
for several weeks in a moist environment and are responsible for 
faecal-oral transmission of the infection via food, water, fomites or 
direct person-person contact (Feachem, 1984).
After ingestion, the quadrinucleate cysts reach the large intestine 
where excystation occurs and a quadrinucleate metacystic amoeba is 
thought to emerge from the cyst and undergo a further nuclear 
division to produce eight uninucleate trophozoites (Dobell, 1928).
The investigation of the biochemical requirements for encystation 
have been hampered by the fact that E. histolytica in culture only 
encysts in xenic media. A reliable axenic medium for the encystation 
of Entamoeba invadens (a species pathogenic in reptiles) has been 
developed (Rengpien and Bailey, 1975) and it appears that the 
depletion of carbohydrate sources and a decrease in osmolarity of the 
medium are essential triggers (Balamuth, 1962; Rengpien and Bailey, 
1975).
Cysts of E. histolytica are round or slightly oval in shape and are 
8-20 pm in diameter. The cyst wall is 125-150 pm thick and, when 
viewed under the electron microscope, appears to be composed of 
2-3 run diameter fibrils in a tight mesh (Chavez et al., 1976). It is 
known to contain chitin (Arroyo-Begovich et al., 1978). One to four 
nuclei and chromatoid bodies can be seen within a cytoplasm similar 
in structural organisation to that described for trophozoites.
Since the large intestine provides an essentially anaerobic 
environment for the trophozoite and since a low redox potential is 
required for in vitro growth, E. histolytica has previously been 
considered to be an obligate anaerobe. However amoebae are able to 
consume oxygen and will grow in an atmosphere containing up to 5% 
oxygen (Weinbach and Diamond, 1974) and could be better described as 
"micro-aerophilic". The biological significance of this oxygen 
utilisation is not known; since the organism possesses no 
mitochondria or tricarboxylic acid cycle. Electrons are thought to 
be transferred from reduced substrates to oxygen via a series of 
carriers including flavins, iron-sulphur proteins and ubiquinone 
(Weinbach, 1981).
Carbohydrates provide the main source of energy for E. histolytica; 
glucose or glucose-containing polymers being essential (Charoenlarp 
et al., 1968). Glucose uptake occurs via a specific transport 
mechanism, which is the rate limiting step in the utilisation of 
glucose, while pinocytosis plays a relatively insignificant role 
(Serrano and Reeves, 1975). Glucose is metabolised to pyruvate via 
the Embden-Meyerhoff pathway with ethanol and CO^ being the principal 
end products (Lo and Reeves, 1978). The glycolytic process differs 
most noticably from other eukaryotes in the use of inorganic 
pyrophosphate as a high energy substrate (ATP, in most other 
eukaryotes) in several reactions (Reeves, 1968; Reeves et al., 1974). 
This peculiarity, shared by a number of other organisms, mostly 
bacteria (Klemme, 1976), and the absence of glutathione metabolism 
(Fahey et al., 1984) demonstrate the primitive nature of this 
organism which in terms of metabolism resembles anaerobic and 
microaerophilic bacteria more closely than other eukaryotes.
1.4 HOST SPECIFICITY
Although man is the major host and reservoir of infection of E. 
histolytica, a few other mammalian species have been reported to be 
naturally or experimentally infected with this organism.
Asymptomatic natural infections have been recorded in Macaque monkeys 
and pigs, and those in dogs and rats may be symptomatic (Hoare,
1962). Among non-human primates, only Macaque monkeys have been 
shown to spontaneously harbour E. histolytica in nature (Dobell,
1931) but zoo infections have occurred in a number of other species 
(Fremming et al., 1955; Frank, 1982). Although the normal intestinal 
site of infection in most hosts is the colon, in leaf-eating monkeys, 
gastric amoebic ulcers occur due to the neutral pH of the anterior 
regions of the stomach (Frank, 1982; Loomis et al., 1983).
Both infection with colonic or hepatic involvement and asymptomatic 
cyst excretion have been described in dogs (Ganapathy and Alwar, 
1957). Natural infections have been reported in North Africa, India, 
South East Asia, China and the United States (Hoare, 1962). Although 
the potential exists for transmission from dogs to humans, it is not 
widely recognised. The source of these canine infections is not 
known, but it is likely to be human faeces. It has also been 
postulated that natural infections in rats play a role in the 
transmission of human amoebiasis (Neal, 1951).
Experimental infections have been reported in a number of hosts, 
however rodents, particularly young rats (Neal and Harris, 1977), 
guinea-pigs (Rees et al., 1954) and hamsters (Jarumilinta and 
Maegraith, 1961) have been the most widely used models. Attempts to 
develop a model naturally infected via the oral route have been 
hampered by the inability to produce large quantities of amoebic 
cysts in culture. Some progress has been made however, using 
trophozoites in conjunction with cimetidine, a gastric acid secretion 
inhibitor (Owen, 1984).
1.5 VIRULENCE OF E- HISTOLYTICA
Despite the worldwide distribution of amoebic infections, invasive 
disease seems to be more frequent in certain geographical areas 
(Elsdon-Dew, 1971), although epidemic outbreaks may occur anywhere
(Deschiens, 1965). This observation and the finding that in 90% of 
individuals (on global average), E. histolytica exists as a 
commensal, (Walsh, 1986) has led to years of discussion concerning 
the underlying biology.
Dobell in 1919 stated that ME. histolytica is always a destroyer of 
tissue, but by no means always a producer of disease", and regarded 
all apparently healthy carriers to suffer some form of intestinal 
ulceration. He later suggested that the amoeba could, in fact, be a 
commensal (Dobell, 1931) although some later authors still favoured 
this hypothesis (Faust et al., 1970). However asymptomatic carriers 
frequently show negative serology and show no evidence of intestinal 
invasion as demonstrated by rectosigmoidoscopic examination (Meza et 
al., 1986).
Brumpt (1925) suggested that two species of morphologically similar 
Entamoebae infected man. One species (E. dysenteriae) was restricted 
to warm climates and was responsible for invasive amoebiasis, while 
another (E. dispar) had a cosmopolitan distribution and caused 
asymptomatic luminal amoebiasis (Brumpt, 1949). This hypothesis has 
received renewed interest in the light of Sargeaunt's recent studies 
(see below).
A third, widely supported hypothesis, proposes that the species E. 
histolytica is composed of an unknown number of different strains 
with varying degrees of virulence (Neal, 1966; Elsdon-Dew, 1968; 
W.H.O., 1969). Crowding, poor hygiene and thus repeated faecal-oral 
transmission is believed to increase the virulence of E. histolytica 
in areas with a high incidence of invasive disease (Swellengrebel, 
1961).
Virulent strains are generally defined as those isolated from 
patients with active amoebiasis while avirulent strains are those 
isolated from proven asymptomatic carriers (Sepulveda, 1982).
Although no morphological differences could be determined in light
and electron microscopic studies (Kazuko-Kawashima et al., 1973; 
Trevino-Garcia Manzo et al. , 1973) several biological differences 
have been found and since used as virulence markers:
1) Trophozoites of pathogenic strains have a higher susceptibility 
to agglutinate in the presence of concanavalin A than trophozoites of 
carrier strains (Martinez-Palomo et al., 1973; Trissl et al., 1977).
2) Pathogenic trophozoites also show a greater erythrophagocytic 
capability (both in terms of rate and maximum number of red cells 
ingested) than those of carrier strains (Trissl et al., 1978).
3) Trophozoites from asymptomatic carriers have been shown to be 
non-pathogenic when inoculated into the livers of adult and new-born 
hamsters while inoculation with pathogenic strains produces amoebic 
abscesses (Tanimoto-Weki et al., 1974).
4) Strains from invasive cases of amoebiasis and strains from 
carriers can be differentiated on the basis of the electrophoretic 
mobilities of certain enzymes (Sargeaunt et al., 1978; Sargeaunt and 
Williams, 1979). (This will be further discussed below). It should 
be noted that variations in virulence and virulence-related 
properties can occur between trophozoites within one cultured isolate 
of E. histolytica due to the genetic heterogeneity of subpopulations 
(Orozco et al., 1986).
Sargeaunt et al (1980a; 1982; 1984) have carried out an extensive 
survey of isolates of E. histolytica from several continents using 
starch gel electrophoresis of amoebic enzymes. More than twenty 
different mobility patterns have been identified and isolates 
displaying identical patterns, grouped into zymodemes. Amoebae 
cultured from well characterised cases (showing clinical signs and 
positive serology) of invasive amoebiasis can be grouped into 8 
different zymodemes. These show a (3 band with absence of an a band 
in the enzyme phosphoglucomutase, and "fast-running" bands in 
hexokinase, except for zymodeme XIII which has slow hexokinase bands.
Isolates from probable carriers, showing no clinical signs and 
negative serology, produce other patterns without the features 
described above. Amoebae belonging to pathogenic zymodemes have been 
isolated from asymptomatic, cyst-passing individuals showing both 
positive and negative serology (Meza et al., 1986; Sargeaunt, 1987). 
However no amoebae belonging to "non-pathogenic zymodemes" have ever 
been isolated from cases of invasive amoebiasis (Sargeaunt, 1987).
Axenically-grown trophozoites of isolates, originally from sympomatic 
cases and belonging to the same pathogenic zymodeme, have been shown 
to differ considerably in their virulence, assayed by various 
methods. For example strain HK-9 in comparison to strain HM1:IMSS 
has been found to possess a reduced capibility to (a) induce hepatic 
abscesses in hamsters (Diamond et al., 1974; Mattern et al., 1982)
(b) destroy tissue culture monolayers (Mirelman et al., 1983) (c)
demonstrate erythrophagocytosis (Mirelman et al., 1983) and (d) 
produce soluble toxic substances (Bos, 1979; Kobiler et al., 1981).
It has also been found that the virulence of axenically-grown strains 
of E. histolytica can be increased by a variety of procedures: (1)
extensive subculturing and repeated hamster liver passage (Bos, 1979; 
Mattern et al., 1982) (2) the addition of cholesterol to the culture
medium (Bos and van de Griend, 1977) (3) association with living
bacteria (Wittner and Rosenbaum, 1970).
For many years it was thought that cultured E. histolytica 
trophozoites were unable to produce a pathogenic effect unless grown 
in association with bacteria, in spite of the frequent observation 
that liver abscesses produced in man usually contained no other 
microorganisms. This belief was further supported by the work of 
Phillips et al. (1972) who reported the failure of axenically-grown 
strains to produce intestinal lesions in germ-free guinea pigs. 
Virulence was regained after co-culture with bacteria. However other 
work showed that axenic amoebae were capable of producing both 
intestinal and hepatic lesions in hamsters (Ghadirian and Meerovitch, 
1979; Tanimoto et al., 1971).
The role of bacteria in the augmentation of amoebic virulence is 
unclear but it is known that living bacteria are necessary (Wittner 
and Rosenbaum, 1970) and that even short term associations (one hour) 
of axenically-grown amoebae with certain types of bacteria markedly 
enhance their virulence (Bracha and Mirelman, 1984). It has been 
suggested that ingested bacteria may protect the amoebae from the 
toxic effects of hydrogen peroxide and also help to lower the redox 
potential within the cell (Bracha and Mirelman, 1984). Mirelman et 
al. (1984) showed that although association with bacteria was capable 
of increasing the virulence of a particular E. histolytica strain, as 
determined by tissue culture cell monolayer destruction and hepatic 
abscess formation in hamsters, the isoenzyme electrophoretic pattern 
of the amoebae remained unchanged. Experiments involving the 
long-term association of amoebae belonging to non-pathogenic 
zymodemes with bacteria isolated with pathogenic amoebae also 
produced no change in isoenzyme electrophoretic pattern (Sargeaunt, 
1987). Based on these studies and others by Sargeaunt and 
colleagues (Sargeaunt and Williams, 1978; Sargeaunt et al., 1980b) it 
has been proposed that zymodemic analysis would suffice as the basis 
for deciding whether drug treatment is necessary in infected 
individuals (Nanda et al., 1984; Editorial, 1985; Allason-Jones et 
al., 1986; Goldmeier et al., 1986).
This philosophy has recently been challenged by the work of Mirelman 
et al. (1986a, 1986b). For many years, the study of virulence of E. 
histolytica has been hampered by the fact that no amoebae belonging 
to non-pathogenic zymodemes can be grown in the absence of bacterial 
flora. The first successful axenization of such an isolate was 
achieved (Mirelman et al., 1986b) using antibiotic suppression of 
bacterial growth and X ray-irradiated bacteria as a temporary 
supplement for growth in Diamond's axenic medium (Diamond, 1978). A 
gradual increase in virulence, assayed by in vitro mammalian cell 
monolayer destruction and liver abscess formation in hamsters, was 
observed after transfer to this medium without viable bacteria. Such 
changes were accompanied by an alteration in isoenzyme electro­
phoretic pattern from one characteristic of a non-pathogenic zymodeme 
(Z I) to one characteristic of a pathogenic zymodeme (Z II).
In order to exclude the possibilty that such a result was due to 
culture conditions selecting for the growth of a subpopulation within 
the original culture, the same experiment was performed using a 
cloned culture of a non-pathogenic strain (Mirelman et al., 1986b). 
The same concomitant change in zymodeme and increase in virulence 
were observed. A reverse conversion to a non-pathogenic zymodeme was 
also accomplished by subculturing the newly converted pathogenic 
clone reassociated with the original bacterial flora. These results 
and similar ones in other laboratories (B. Andrews, pers. comm.) 
suggest that isoenzyme electrophoretic patterns of E. histolytica may 
not be a constant and stable property of the organism, as has been 
previously found in other protozoa such as Paramecium (Rowe et al., 
1970) and Tetrahymena (Allen, 1968). Whether such changes in E. 
histolytica, achieved in these experiments by quite considerable 
artificial manipulation, can actually occur in vivo is not known.
The subject is currently an area of debate but most epidemiological 
features, including Sargeaunt's extensive studies, seem to point to 
the relative stability of zymodeme and virulence.
Recent work by Burchard and Mirelman (1988) has further suggested 
that virulence does not necessarily correlate with a pathogenic 
zymodeme. These authors found that two out of four strains of 
amoebae from asymptomatic carriers and belonging to non-pathogenic 
zymodemes were as virulent as known pathogenic strains. Virulence 
was assayed both in vitro, by measuring rates of destruction of 
monolayers of baby hamster kidney cells, and in vivo, by assessing 
their capacity to form hepatic abscesses in hamsters, and caecal 
ulcerations in rats. Such results demonstrate the difficulty of 
using experimental assays for virulence to obtain clear information 
on the pathogenicity of E. histolytica in man. An animal model that 
more closely approximates the natural conditions of growth and 
infectivity in the human intestine would help to dispel much of the 
uncertainty of current studies.
A number of other amoebic properties are likely to be important 
virulence factors since they aid in the survival of trophozoites in 
the host by evading or surviving the host's immune response. Reed et 
al. (1983) found that isolates belonging to non-pathogenic zymodemes 
from asymptomatic carriers were all susceptible to complement- 
mediated lysis (alternative pathway). Nine of eleven pathogenic 
strains were resistant to lysis under identical conditions while two 
were susceptible. Although correlation with virulence was not 
complete it is interesting to note that all five of the strains 
isolated from liver abscesses were resistant to lysis indicating that 
such a property may indeed by a necessary factor in extraintestinal 
spread of the disease. Other factors suggested, include resistance 
to destruction by neutrophils (Guerrant et al., 1981) and the removal 
of bound host antibodies by capping (Aust-Kettis and Sundqvist, 1978; 
Calderon et al., 1980). Attempts to correlate these two factors with 
zymodeme have not been made.
Clearly a variety of variable host factors may possibly affect the 
outcome of the host-parasite relationship and thus the apparent 
virulence of the amoeba. Proposed factors include sex (Alvarez-Alva 
and de la Loza-Saldivar, 1971), age (Fuchs et al., 1988), nutritional 
status (Gutierrez et al., 1970) and immunosuppression (Ghadirian and 
Meerovitch, 1981). A definite genetic component of host 
susceptibility has been identified in mice (Ghadirian and Kongshavn,
1984), while in man, it has been noticed that expression of certain 
HLA antigens was significantly higher in amoebiasis patients than in 
a control population (Kretschmer et al., 1985). In summary, it seems 
likely that all isolates of E. histolytica possess some pathogenic 
capability, the expression of which depends on a complex interaction 
between host, parasite and bacterial flora.
1.6 PATHOGENESIS
The pathogenesis of invasive amoebiasis requires four basic events:
(1) Adherence of E. histolytica trophozoites to the colonic mucus 
layer; multiplication at this site resulting in intestinal 
colonisation.
(2) Disruption of the mucus layer and intestinal barrier by the 
secretion of enzymes or toxins.
(3) Lysis of intestinal epithelial cells and other cell types, 
resulting in colonic ulceration and possibly distant organ invasion 
(eg. liver).
(4) Resistance to host immune responses.
In asymptomatic carriers of E. histolytica where the amoebae exist as 
commensals within the lumen of the colon, trophozoites adhere to the 
mucus layer and multiply, but further pathogenic processes do not 
occur.
Lectin-like molecules have been identified in E. histolytica and are 
known to be necessary for (a) phagocytosis of bacteria in the 
luminal phase of the parasite (Bracha et al., 1982), (b) adhesion to
the colonic mucus layer and the surface of intestinal epithelial 
cells (Ravdin et al., 1985a) and (c) adhesion prior to 
contact-dependent killing of target cells (Ravdin et al., 1980). 
Galactose-inhibitable adherence of E. histolytica to bacteria (Bracha 
and Mirelman, 1983) and a variety of mammalian cells including 
erythrocytes, mononuclear cells and cultured epithelial lines (Ravdin 
et al., 1980; Salata et al., 1982) has been demonstrated. The 
activity of this recently purified 260 kD lectin (Petri et al.,
1987b) is also inhibited by N-acetyl-D-galactosamine (GalNAc) (Ravdin 
et al., 1980) and more effectively by galactose (Gal) terminal 
glycoproteins such as asialofetuin (Petri et al., 1987b). Chadee et 
al. (1987) found that human colonic mucins, rich in such sugars, are
high-affinity ligands for the E. histolytica Gal/GalNAc adherence 
lectin. Although colonic mucins probably facilitate intestinal 
colonisation by E. histolytica, it is thought that they may be an 
important defence mechanism, preventing the amoebae from attaching to 
and lysing intestinal epithelial cells (Ravdin, 1989). Infected 
individuals are known to mount an antibody response against this 
lectin (Petri et al 1987a) and both monoclonal antibodies and 
polyclonal antisera raised against it inhibit adherence of the 
amoebae to cultured mammalian cells (Petri et al., 1987b; 1989).
Other amoebic adherence proteins are known to exist. A 220 kD lectin 
whose activity is inhibitable by N-Acetyl-D-glucosamine (GluNAc) 
(Kobiler and Mirelman, 1980) has recently been isolated 
(Rosales-Encina et al., 1987). However unlike the situation with the 
260 kD lectin described above, monoclonal and polyclonal antibodies, 
raised against this protein, and the specific monosaccharide (free 
GluNAc) only partially inhibited amoebic adherence to tissue culture 
cells (Leitch et al., 1988; Ravdin and Guerrant, 1981). Arroyo and 
Orozco (1987) have produced monoclonal antibodies which inhibit 
erythrophagocytosis by E. histolytica and recognise a 112 kD protein 
in electroimmunotransfer blotting experiments.
Experiments with animal models of colonic amoebiasis suggest that, 
prior to mucosal invasion by E. histolytica trophozoites, there is a 
depletion of intestinal mucus, diffuse inflammation and disruption of 
the epithelial barrier (Chadee and Meerovitch, 1985). Although this 
depletion of mucus may provide the potentially invasive amoeba with 
more direct access to the epithelium, this may not be sufficient.
E. histolytica lysates do contain enzymes capable of degrading 
protein in hog gastric mucin-impregnated agarose gels (Spice, W., 
pers. comm.) but whether or not they possess a specific mucinase 
complex similar to that found in Vibrio cholerae (Stewart-Tull et 
al., 1986) is not known.
A variety of enzymes and toxins have been implicated as possible 
mediators of the tissue-invasive activity of E. histolytica. No one 
component has been shown to be necessary and sufficient for the 
virulent capacity of the amoeba but it is likely that if one of these 
factors is impaired, virulence may be affected. These factors are 
also likely to be important, after the initial invasion, in the 
formation of both intestinal and extraintestinal pathological 
lesions.
A neutral protease described by Keene et al. (1986) was shown to 
degrade fibronectin, laminin and type I collagen suggesting a 
possible role for this enzyme in disrupting cell-cell adhesion and 
extracellular matrix integrity during initial invasion. A 
(3-N-acetylglucosaminidase purified by Lundblad et al. (1981) is 
secreted by E. histolytica trophozoites and may also have a role in 
degrading glycoprotein bonds between adjacent epithelial cells.
Other enzymic activities of the amoeba which may help to effect 
extracellular tissue matrix breakdown include hyaluronidase 
(Jarumilinta and Maegraith, 1969) and collagenase activity (Munoz et 
al., 1982), the latter requiring direct contact between the amoeba 
and substrate. A serum-sensitive protease, initially postulated as a 
cytotoxin by Lushbaugh et al. (1979) is not cytolethal, but has a 
reversible cell-releasing effect on tissue culture cells (Lushbaugh 
et al., 1984; 1985). The protease described by Keene et al. (1986) 
has a similar effect in such in vitro studies.
Amoebic secretion of an enterotoxin or cytotoxin has been postulated
(Pittman et al., 1973), although animal studies and human pathology 
show that damage to the mucosa only occurs in areas in direct contact 
with amoebae (Prathap and Gilman, 1970; Proctor and Gregory, 1972). 
Using indomethacin to impair prostaglandin-mediated mucosal 
protection, Udezulu et al. (1981) demonstrated enterotoxic activity 
in soluble fractions of sonicated amoebae. This heat-labile
enterotoxin activity caused no other noticeable pathological changes
and interestingly was not detectable in the non-pathogenic 
"E. histolytica-like" Laredo strain. A 30 kD amoebic protein with 
heat-labile enterotoxin activity in indomethacin pretreated rats, has 
been partially purified by Feingold et al. (1985). Whether living 
amoebae secrete such enterotoxic substances during invasion is not 
known.
Lynch et al. (1982) and Young et al. (1982) have reported the 
existence of an ion channel-forming protein ("amoebapore") that is 
present within E. histolytica, and can be secreted into the 
extracellular medium. The protein can spontaneously incorporate into 
mammalian cell membranes causing depolarization and in experiments 
using lipid vesicle membranes and artificial bilayers, it appears to 
induce rapid cation permeability. The release of amoebapore from 
cultured trophozoites can be stimulated by exposure to calcium 
ionophore, concanavalin A or Escherichia coli lipopolysaccharide. It 
is not known if amoebapore actually participates in the cytolytic 
activity of E. histolytica but it is interesting to note that in E. 
invadens, a species highly pathogenic in reptiles (with similar 
lesion pathology to human amoebiasis), the pore forming activity was 
much lower than that of E. histolytica, similar to that of the 
non-pathogens, "E. histolytica-like1 Laredo strain and Entamoeba 
moshkovskii (Keller et al., 1988).
Ravdin et al. (1980) demonstrated that E. histolytica exerts a rapid 
contact-dependent cytolytic effect on target cells in vitro which is 
followed by phagocytosis of the dead target cell. It is believed 
that this activity is essential to penetration of the mucosa and the 
formation of tissue lesions characteristic of amoebiasis 
(Martinez-Palomo, 1982). Most of the work investigating this 
phenomenon has been performed using established tissue culture cell 
lines of epithelial origin (Ravdin and Guerrant, 1981;
Martinez-Palomo et al., 1985) although fibroblasts (Ravdin and 
Guerrant, 1981) and leucocytes (Guerrant et al., 1981) have been 
used. The contact-dependent cytolytic mechanism requires 
lectin-mediated adherence between the amoeba and the target cell, is
temperature-dependent, 37 °C being optimal, and requires amoebic 
microfilament function (Ravdin and Guerrant, 1981).
The exact cytotoxic factor or factors involved are not known but a 
number of possible candidates exist. Morphological observations 
initially suggested that a "surface-active lysosome" was released on 
contact with host cells, liberating lytic enzymes (Eaton et al., 
1970). However the fusion of such organelles with the plasma 
membrane during interaction with target cells has not been confirmed 
in other studies (Martinez-Palomo, 1982; Martinez-Palomo et al.,
1985).
Phospholipase A (PLA) enzymes may be involved, since pharmacological
inhibitors of these enzymes inhibit parasite cytolysis of Chinese
hamster ovary cells (Ravdin et al., 1985b). E. histolytica is known
2+to contain two PLA enzymes: a Ca -dependent enzyme with optimal
24-
activity at pH 7.5, and a Ca -independent enzyme optimal at pH 4.5
2+
(Long-Krug, 1985). The Ca -dependent enzyme is highly associated 
with the surface plasma membrane and its in vitro enzymic activity is 
inhibited by known pharmacological inhibitors of PLA enzymes. This 
enzyme and the free-fatty acids released from membrane phospholipids 
via its action, and been proposed as major factors in the 
cytopathogenic activity of E. histolytica (Said-Fernandez and 
Lopez-Revilla, 1988).
2 +Free intracellular Ca concentrations in target cells show a marked
irreversible increase within 30-300 s after contact with an amoeba
(Ravdin et al., 1988) followed by death of the cell. Interestingly,
immunoaffinity-purified Gal/GalNAc adherence lectin produced a
2+similar rise in target cell intracellular Ca concentration.
Although plant lectins are capable of causing transient increases 
(Hesketh et al., 1983; 1985) the magnitude and irreversibility of the 
increase in this case has led Ravdin et al. (1988) to suggest that 
the lectin involved has a cytotoxic activity. The 13 kD ionophore 
described by Lynch et al. (1982) and Young et al. (1982) is a
possible mediator of this calcium flux and the possibility that the 
lectin contains amoebapore as a subunit cannot be ruled out (Ravdin 
et al., 1988).
Amoebic phagocytosis of target cells which can occur in the absence 
of lectin-mediated adhesion and cytolysis (Ravdin and Guerrant, 1981) 
is also important in the pathogenesis of amoebiasis. The level of 
phagocytic activity appears to correlate with in vivo virulence 
(Trissl et al., 1978) and it is thought that the mechanical 
activities of the amoeba are important in the separation and 
displacement of neighbouring cells during mucosal invasion and 
subsequent spread (Martinez-Palomo, 1987).
1.7 DISEASE SYNDROMES
The outcome of infection with E. histolytica can range from 
asymptomatic infection to fatal disease depending on the balance of 
the host-parasite relationship, due to factors discussed above 
(Section 1.5).
1.7.1 Asymptomatic infection
The majority of human infections with E. histolytica (~90%) are 
completely asymptomatic (Walsh, 1986b). Trophozoites live as 
commensals on the wall, and in the lumen, of the colon and up to 15 
million cysts per day can be shed in the faeces (Feachem et al.,
1983). It is these patients that represent the main source of human 
infection. The ratio of asymptomatic to symptomatic cases varies 
between different populations. In endemic areas, such as Mexico, it 
has been estimated that there are four or five asymptomatic carriers 
to every one case of invasive amoebiasis (Sepulveda, 1982). In more 
temperate zones, where the overall prevalence is low, the proportion 
of carriers is much higher. The higher concentration of invasive 
amoebiasis in certain geographical areas, in particular South East 
Asia, the Indian subcontinent, South East Africa and Central America, 
has been attributed to the distribution of certain pathogenic strains 
of E. histolytica (Sargeaunt et al., 1984). High population density, 
poor hygiene and sanitation, and consequently high transmission rates 
in such areas, have also been implicated (Swellengrebel, 1961). Most 
asymptomatic carriers are believed to eliminate the parasite from the 
gut within twelve months (Nanda et al., 1984).
1.7.2 Symptomatic intestinal infection
Intestinal amoebiasis occurs when virulent trophozoites breach the 
mucosal barrier and cause lesions in the intestinal wall. The form 
of the disease depends on the site and severity of the lesions. The 
most frequent sites of primary lesions are the caecal and 
rectosigmoidal regions, where intestinal flow is slowest. Less 
frequent sites include the ascending colon, the rectum and appendix
(Brown and Neva, 1983). Lesions can occur in other sites in the 
colon as the infection progresses.
The mildest form is characterised by moderate malaise, abdominal 
discomfort with irregular colicky pain and weakness. Constipation 
may alternate with mild diarrhoea. Acute intestinal amoebiasis has 
been observed one to four weeks after the ingestion of cysts 
(Bundesen et al., 1936) but incubation periods of up to one year have 
been recorded (Craig, 1917). The onset may be insidious and preceded 
by the symptoms described above, or overt, with severe dysentery. 
Numerous small stools are passed containing blood, mucus and shreds 
of necrotic mucosa and these symptoms are usually accompanied by 
acute abdominal pain and tenderness and sometimes fever (Adams and 
MacLeod, 1977a). Trophozoites of E. histolytica, rather than cysts 
are found in the stools.
Initially the ulceration is superficial with minimal necrosis and 
cell infiltration at the site of invasion. The ulcerations may 
extend laterally and downwards to form the classic "flask-shaped" 
ulcer which extends through the mucosa and muscularis mucosae into 
the submucosa. Such lesions appear to occur in only a minority of 
cases (Prathap and Gilman, 1970). An amorphous, granular material 
surrounds trophozoites in tissue lesions (whether intestinal or 
extraintestinal) and consistent with the fact that E. histolytica can 
exert a cytolytic effect on leucocytes (Guerrant et al., 1981), 
intact inflammatory cells are found only at the periphery of lesions 
(Prathap and Gilman, 1970; Griffin and Juniper, 1971). Evidence in 
animal models suggests that lysis of inflammatory cells and the 
consequent release of their contents may be involved in the 
production of focal necrosis of the mucosa (Chadee and Meerovitch,
1985). Complications of acute intestinal amoebiasis include amoebic 
appendicitis, fulminating colitis, intestinal perforation and 
haemorrhage. Secondary bacterial infections of lesions are common.
Chronic intestinal amoebiasis is characterised by recurrent attacks 
of dysentery with intervening periods of mild to moderate 
gastrointestinal disturbances with constipation. Liver enlargement 
and localized abdominal tenderness may be present (Haider and Rasul, 
1975).
Chronic ulceration of the intestinal mucosa can cause the formation 
of a non-fibrotic proliferation, termed amoeboma (Brandt and 
Perez-Tamayo, 1970; Prathap and Gilman, 1970). These psuedotumoural 
lesions occur predominantly in the caecum, sigmoid colon and rectum 
and are often mistaken for malignant growths (Brown and Neva, 1983). 
These lesions are infrequent, occuring in an estimated 0.5-1.5% of 
all patients presenting with amoebic colitis, and respond well to 
anti-amoebic therapy (Ravdin, 1988).
1.7.3 Extraintestinal infection
Extraintestinal amoebiasis may develop within days of the onset of 
symptomatic intestinal amoebiasis, or follow up to several years 
afterwards. Indeed in up to 50% of cases it may occur in the absence 
of any history of intestinal infection (Adams and MacLeod, 1977b).
The liver is the commonest site of spread of intestinal amoebiasis 
and dissemination from the primary focus appears to occur most 
frequently via the hepatic portal system (Carrera, 1950; Aikat et 
al., 1979). Hepatic amoebiasis is characterised by an enlarged, 
tender liver with pain ranging from vague right upper-quadrant 
discomfort to localized tenderness between the ribs, on palpation. 
Elevation and immobility of the right side of the diaphragm and 
severe pain referred to the right shoulder frequently occurs. Fever 
is common and may be either low grade or acute. A leucocytosis with 
increased neutrophils helps to distinguish the disease from viral 
hepatitis. Mortality from amoebic liver abscess is estimated at 
approximately 20% (Sepulveda and Martinez-Palomo, 1982) where 
adequate diagnosis and treatment is not available but with modern
hospital facilities the mortality rate can be as low as 2% even in 
endemic areas (Martinez-Palomo, 1987).
In a hamster model of liver abscess formation, early lesions 
consist of a small rounded mass of necrosed hepatocytes and 
E. histolytica trophozoites surrounded by a neutrophil infiltrate 
(Martinez-Palomo, 1987). As the lesions enlarge, macrophages and 
epithelioid cells replace other leucocytes and granulomata develop, 
with subsequent fusion to form large lesions. In human patients, 
although granulomatous lesions can occur, they were not reported in a 
large study performed by Aikat et al. (1979). Amoebic abscesses 
contain proteinaceous debris, rather than the pus of true bacterial 
abscesses and it has been proposed (as for intestinal lesions) that 
the products released from lysed polymorphoneclear cells contribute 
to the necrosis (Ravdin and Guerrant, 1982).
Pulmonary amoebiasis, although infrequent is the second commonest 
extraintestinal site of amoebiasis. Lesions usually occur from 
direct extension of a liver abscess through the diaphragm and pleura 
(Adams and MacLeod, 1977b). Haematogenous spread of amoeba is 
responsible for the rare occurrence of abscesses in brain and spleen. 
Other rare complications include fistular and perineal cutaneous 
lesions, ulcerative vaginitis, cervicitis and balanitis.
An interesting feature of most amoebic lesions, is the lack of 
proliferation of connective tissue and their ability to heal without 
scar formation. This is particularly noticeable in liver and 
cutaneous lesions in which treatment can result in remarkable 
anatomical and functional recovery (Perez-Tamayo, 1986). No adequate 
explanation exists, although it has been postulated (Dennis and 
Chadee, 1988) that the lack of macrophages in amoebic lesions may be 
significant, since macrophages are involved in the stimulation of 
collagen deposition in wound healing (Freundlich et al., 1970).
1.8 IMMUNE AND NON-IMMUNE MECHANISMS DIRECTED AGAINST E. HISTOLYTICA
The characterisation of amoebic antigens responsible for stimulating 
host immune responses against the parasite, will be dealt with in 
subsequent chapters.
1.8.1 Non-immine mechanisms
Colonic mucins are thought to be a major host defence against 
intestinal invasion by E. histolytica (Dennis and Chadee, 1988; 
Ravdin, 1989). Not only are they high-affinity receptors for the 
Gal/GalNAc lectin (Chadee et al., 1987), but they also appear to bind 
released parasite toxins (McGowan et al., 1982; Lushbaugh et al., 
1979). Physical trapping of E. histolytica trophozoites by mucus 
also occurs (Leitch et al., 1988).
Normal human milk has been shown to have an amoebicidal effect in 
vitro that is not due to the presence of secretory immunoglobulin A 
(s-Ig A) (Gillin et al., 1983). The active component, which had a 
similar effect on Giardia lamblia (another intestinal protozoan 
parasite) is believed to be bile salt-stimulated lipase.
1.8.2 Evidence for protective immunity in amoebiasis
In most cases, non-invasive asymptomatic infections are apparently 
spontaneously cleared within twelve months (Nanda et al., 1984). It 
is not known, however, whether this clearance is due to a specific 
antiamoebic response and followed by resistance to further challenge. 
Indeed epidemiological studies demonstrating an increasing prevalence 
of asymptomatic infections with age suggest a lack of such resistance 
(Oyerinde et al., 1977).
Some resistance to intrarectal reinfection following cure has been 
documented in dogs (Thompson and Lilligren, 1949; Swartzwelder and 
Avant, 1952) and similar results have been obtained using 
intrahepatically-inoculated hamsters following drug treatment 
(Vazquez-Saavedra et al., 1973). However the relevance of such
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results to the human situation is doubtful, since hamsters and dogs 
are far from being perfect animal models.
Studies in humans have been based on epidemiological data. In one 
uncontrolled study, performed in Mexico City in a population at high 
risk of reinfection, a 0.29% recurrence of hepatic abscess was 
demonstrated over a period of five years (de Leon, 1970). This rate 
is well below the expected rate in the total population (Kagan, 1974; 
Gutierrez et al., 1976). Further evidence of the role of the immune 
system in resistance to infection has come from the observation that 
there is an increased severity of invasive amoebiasis when it is 
associated with immunosuppression. Several authors have reported the 
activation of previously undiagnosed amoebiasis and the exacerbation 
of existing hepatic lesions following corticosteriod treatment (Mody, 
1959; El-Hennawy and Abd-Rabbo, 1978; Stuiver and Goud, 1978). 
Amoebiasis is known to be more severe and frequently fatal in 
pregnant women (Abioye, 1973; Constantine et al., 1989) in whom 
depression of cell-mediated immunity is known to occur (Weinberg,
1984).
1.8.3 Humoral immunity
Patients with invasive amoebiasis normally develop a high titre of 
circulating antibodies specific for E. histolytica within one to two 
weeks of the onset of symptoms (Kotcher et al., 1970; Krupp, 1970; 
Patterson et al., 1980). These antibodies are predominantly of the 
IgG class (Lee et al., 1970). Individuals with asymptomatic 
infection less frequently develop a systemic antibody response 
(Kotcher et al., 1970) although frequencies of up to 78% have been 
recorded (Savanat et al., 1974). Although this may be due to a 
response to luminal amoebic antigens, it has been suggested that 
positive serological results in asymptomatic carriers are due to 
subclinical invasion by the parasite (Trissl, 1982). This is 
supported by the studies of Sargeaunt, who reports that while 
asymptomatic patients harbouring E. histolytica belonging to 
pathogenic zymodemes may or may not be serologically positive,
patients with non-pathogenic amoebae are always serologically 
negative (Sargeaunt, 1988).
In general, positive results in serological tests are regarded as an 
indication of current or prior invasive disease (Elsdon-Dew, 1970; 
Trissl, 1982). There is no evidence that antibody titre correlates 
with clinical status of the patient or with severity of lesions 
(Krupp and Powell, 1971; Trissl, 1982), but higher serum titres are 
generally associated with a recent onset of invasive disease (Krupp, 
1970). Antibody levels are known to decrease after recovery but can 
persist at detectable levels for up to 11 years (Healy et al., 1974; 
Patterson et al., 1980). The relevance of the systemic humoral 
response to E. histolytica is questionable since invasive amoebiasis 
is known to recur even in the presence of high antibody titres 
(Krupp, 1970; Krupp and Powell, 1971).
Several studies have demonstrated the presence of locally secreted 
copro-antibodies in patients with invasive intestinal amoebiasis 
(Shaalan and Baker, 1970; Mahajan et al., 1972; Martinez-Cairo et 
al., 1979). In contrast to circulating antibodies, these antibodies, 
predominantly of the IgA class (Martinez-Cairo et al., 1979), persist 
only for a short time. It has been suggested that secretory IgA 
antibody to the Gal/GalNAc amoebic adherence lectin could be a 
potential defence mechanism against intestinal colonisation by 
preventing parasite adhesion to the colonic mucus blanket (Ravdin, 
1989).
Several authors have reported the ability of E. histolytica 
trophozoites in vitro to rapidly aggregrate and shed or ingest human 
antiamoebic antibodies that have bound to the cell surface 
(Aust-Kettis and Sundqvist, 1978; Calderon et al., 1980; Aust-Kettis 
et al., 1981). These results suggest a possible mechanism by which 
the amoeba may evade the humoral immune response.
E. histolytica trophozoites incubated in vitro with human sera have 
been shown to be vulnerable to complement-mediated lysis via both the 
classical and alternative pathways (Sepulveda et al., 1973; 
Ortiz-Ortiz et al., 1978). Depletion of complement in hamsters using 
cobra venom factor caused an increased susceptibility to the 
formation of hepatic abscesses (Ghadirian and Meerovitch, 1982c).
The studies of Reed et al. (1983) suggest that amoebic resistance to 
complement-mediated lysis may be an important prerequisite for 
invasion. All tested isolates belonging to non-pathogenic zymodemes 
were uniformly susceptible to lysis while nine out of eleven 
pathogenic isolates (including all five isolates obtained from liver 
abscesses) were resistant.
1.8.4 Cellular Immunity
1.8.4.1 Polymorphonuclear neutrophils
E. histolytica trophozoites have been shown capable of lysing human 
neutrophils in vitro without loss of amoebic viability (Geurrant et 
al., 1981; Salata et al., 1982), although some axenic strains of low 
virulence (with a reduced ability to lyse cultured epithelial cells) 
were killed by the neutrophils. Apart from being a mechanism for 
avoiding one particular arm of the body's defence mechanism, lysis of 
neutrophils and the release of their contents may contribute to the 
tissue necrosis characteristic of amoebic lesions (as previously 
stated; 1.7.2) (Chadee and Meerovitch, 1985).
1.8.4.2 Cell-mediated immunity
Clinical observations in patients receiving corticosteroid treatment 
have indicated the importance of cell-mediated immune mechanisms in 
invasive amoebiasis (Section 1.8.2). Similarly, using a hamster 
model, it has been shown that procedures which depress cell-mediated 
immunity, such as corticosteroid treatment, neonatal thymectomy, 
ionising radiation treatment, and antimacrophage and antithymocyte 
globulin treatment, cause enhanced formation of hepatic abscesses 
(Ghadirian and Meerovitch, 1981; 1982b; Ghadirian et al., 1983).
Stimulation of the macrophage system, on the other hand, by 
immunisation with bacille Calmette-Guerin (BCG) had the opposite 
effect on such lesions (Ghadirian and Meerovitch, 1982b).
Peripheral blood lymphocytes and peritoneal mononuclear cells from 
hamsters immunised intradermally and intrahepatically with live 
amoebae, killed E. histolytica trophozoites vitro (Ghadirian and 
Meerovitch, 1982a). In humans, Guerrero et al. (1976) found that the 
in vitro interaction between E. histolytica trophozoites and 
lymphocytes obtained from patients recovering from treated liver 
abscess, resulted in lysis of the amoebae. However, lymphocytes 
obtained from patients with acute hepatic amoebiasis or from 
uninfected controls were themselves lysed by the amoebae. The 
importance of the macrophage and T-lymphocyte in the response against 
E. histolytica has been further indicated by the work of Salata and 
co-workers. While they found that T-lymphocytes from treated hepatic 
abscess patients did not display a spontaneous cytotoxic effect on 
cultured trophozoites (c.f. above), if the lymphocytes were 
stimulated for five days with a soluble amoebic protein preparation, 
the amoebae were killed (Salata et al., 1986). Exposure of 
T-lymphocytes from non-infected control patients to the amoebic 
antigen was ineffective in producing an amoebicidal response. This 
group has also shown that cured liver abscess patients show an in 
vitro T-lymphocyte proliferative response to E. histolytica antigen, 
producing lymphokines (including gamma-interferon) that can stimulate 
human monocyte-derived macrophages to kill trophozoites in vitro 
(Salata et al., 1986; Salata et al., 1987).
Several clinical studies have measured delayed type hypersensitivity 
reactions to intradermal amoebic antigen and demonstrated that 
patients with acute hepatic amoebiasis showed an absence or reduction 
in reactions while reactiveness returned after treatment (Kretschmer 
et al., 1972; Ortiz-Ortiz et al., 1975; Ganguly et al., 1979, 1981). 
In one study, a specific state of unresponsiveness to amoebic 
antigens was suggested, since skin reactions against unrelated
antigens were positive at all stages of the disease (Kretschmer et 
al., 1972). Confirmatory evidence for this state has been obtained 
in experiments studying the in vitro responses of lymphocytes from 
early hepatic amoebiasis patients (Ortiz-Ortiz et al., 1975). The 
reason for this suppression is not known. Recent evidence in an 
animal model shows that constituents of a crude extract of E. 
histolytica are capable of exerting an inhibitory effect on a variety 
of macrophage functions including responsiveness to lymphokines, 
oxidative metabolism and phagocytic ability (Denis and Chadee, 1988).
In summary, it seems that effective afferent and efferent 
cell-mediated immune responses that develop after invasive amoebiasis 
represent the major host defence against E. histolytica. Although 
antibody and complement may have a role in preventing invasion by 
certain strains of amoebae, and antibody levels can be used as an 
indicator of invasive disease, humoral immune systems do not appear 
to provide protective immunity.
1.9 TREATMENT
The drug of choice for severe intestinal and hepatic amoebiasis is 
Metronidazole, a 5-Nitroimidazole. If oral treatment with this drug 
fails, intramuscular or deep subcutaneous infections of emetine 
hydrochloride or dehydroemetine dihydrochloride are recommended 
(Brown and Neva, 1983). The choice of treatment of asymptomatic 
carriers, if it is performed (Editorial, 1985; Sargeaunt, 1987), 
varies from country to country. Drugs such as diloxanide furoate and 
diiodohydroxyquin (either alone or with tetracyclines) are active 
against amoebae in the lumen of the intestine. These drugs are 
effective in the treatment of carriers and are also frequently used 
in the treatment of invasive intestinal disease, in conjunction with 
those mentioned above, since emetine and dehydroemetine are only 
active against amoebae in the tissues and not against those in the 
intestinal lumen (Knight, 1980). The use of diiodohydroxyquin in 
conjunction with metronidazole treatment of such cases is also 
recommended (Brown and Neva, 1983) for the same reason.
Treatment of amoebiasis is not without risk; metronidazole and 
emetine, although effective, have numerous unpleasant side-effects 
and metronidazole has been shown to be mutagenic in bacteria (Voogd 
et al., 1974) and carcinogenic in rats (Roe, 1979) while emetine has 
a serious cardiotoxic effect (Klatskin and Friedman, 1948). Such 
information demonstrates the need for the development of less harmful 
antiamoebic agents.
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1.10 AIMS OF THE PROJECT
The aim of this project was to study some of the antigens of E. 
histolytica using monoclonal antibodies raised against whole 
trophozoites. Chapter 2 describes the production of the monoclonal 
antibodies using hybridoma technology (a technique pioneered by 
Kohler and Milstein (1975)). The subcellular locations of the 
antigens, for which these monoclonal antibodies are specific, are 
discussed. Chapter 3 examines the specificity of the antibodies for 
E. histolytica and discusses possible phylogenetic relationships 
between members of the genus Entamoeba. Chapter 4 examines the 
antigenic heterogeneity of different isolates of E. histolytica using 
the monoclonal antibodies as probes. In Chapter 5, preliminary 
attempts at immunochemical analysis of the antigens recognised by the 
monoclonal antibodies, are discussed. Chapter 6 describes efforts to 
investigate the suitability of the monoclonal antibodies as 
antigen-capture agents in an enzyme-linked immunosorbent assay for 
amoebic antigen. Chapter 7 describes work investigating the 
possibility that two of the monoclonal antibodies recognise, in 
indirect fluorescent antibody tests, antigens specific to isolates of 
E. histolytica belonging to pathogenic zymodemes. This work has been 
previously published as Strachan et al. (1988).
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CHAPTER 2 PRODUCTION OF MONOCLONAL ANTIBODIES
2.1 INTRODUCTION
The immunochemical characterisation of an individual parasite antigen 
requires, at some stage, the ability to distinguish that antigen from 
others that may be present in the organism. Previous study of 
Entamoeba histolytica antigens has involved the use of 
amoeba-specific antibodies. However antisera raised against whole 
cells contain antibodies against many of the constituent antigens. 
Hybridoma technology, pioneered by Kohler and Milstein (1975), 
provides a method of obtaining antibodies which are specific for a 
single antigenic determinant and such monoclonal antibodies (Mabs) 
are now routinely used to identify and purify single antigens from 
complex mixtures.
Monoclonal antibody-secreting hybridomas are produced by fusing 
antibody-producing spleen cells with myeloma cells. As spleen cells 
rapidly die in vitro, the myeloma cells, which are adapted to grow in 
culture, are required to confer immortality on the hybridoma.
Various methods have been used to induce fusion of these cells 
(reviewed by Goding, 1986) including treatment with Sendai virus, 
lysolecithin and polyethylene glycol (PEG). PEG treatment 
(Pontecorvo, 1976) has been the most widely used and this method 
appears to give the most reproducible results. When spleen cells are 
mixed with myeloma cells in the presence of PEG, fusion of the cells 
takes place in a random fashion. If the fusion products and unfused 
cells are allowed to grow, the unfused myeloma cells will overgrow 
other cells leading to the inability to select hybrids secreting the 
desired Mabs. To overcome this, mutant myeloma cells have been 
isolated which lack hypoxanthine guanine phosphoribosyl transferase 
(HGPRT), an enzyme involved in the salvage pathway of purine 
synthesis. If the de novo pathway of synthesis is blocked by 
aminopterin, these cells cannot synthesise DNA (Littlefield, 1964).
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Spleen cells, when fused with these mutant myeloma cells supply the 
resultant hybrids with HGPRT, and therefore using a medium containing 
aminopterin supplemented with thymidine and hypoxanthine (HAT medium) 
selection for growth of hybrid cells ("hybridomas") can be achieved. 
Myeloma cells which have further mutated and do not synthesise or 
secrete immunoglobulin chains of their own have now been isolated 
(Kearney et al., 1979). Fusion of spleen cells with these myeloma 
cells results in hybridomas which secrete biologically active Mabs 
containing no myeloma-derived immunoglobulin chains. Cloning of 
individual cells can be performed after initial screening for 
antibody in spent medium (supernatant) from hybridoma-containing 
wells. Theoretically Mabs can then be obtained in unlimited 
quantities from cell culture supernatants or from ascitic fluid from 
hybridoma-bearing mice.
In this work monoclonal antibodies were produced by hybrid cells from 
fusions between mouse myeloma cells and spleen cells from mice 
immunised with axenically-cultured Entamoeba histolytica 
trophozoites. The techniques described here for the production of 
hybridoma cells have been based on the method used by Crowe (1983) 
adapted and modified from protocols published by Norwood et al. 
(1976); Goding (1980) and Pearson et al. (1980).
The subcellular locations of the antigens against which the Mabs were 
directed were examined in experiments using the indirect fluorescent 
antibody test (IFAT) as a preliminary to further investigation of the 
antigens.
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2.2 MATERIALS AND METHODS
2.2.1 Axenic in vitro culture of Entamoeba histolytica
2.2.1.1 Medium
Amoebae were grown in TYI-S-33 medium developed by L.S. Diamond 
(Diamond et al., 1978). Complete medium was prepared in 100 ml 
volumes from:
87 ml TYI broth
10 ml Heat inactivated horse serum 
3 ml Vitamin-Tween 80 solution
TYI broth
Trypticase (Lab. Impex, Twickenham) 2 g
Yeast extract (Oxoid, Basingstoke) 1 g
Glucose (Sigma, Poole) i g
NaCl (Sigma, Poole) 200 mg
K-HPO (Sigma, Poole) 
& 4 100 mg
KH2P04 (Sigma, Poole) 60 mg
L-Cysteine HCl (Sigma, Poole) 100 mg
L-Ascorbic Acid (Sigma, Poole) 20 mg
Ferric Ammonium citrate (Mallinskrodt) 2.28 mg
Distilled H20 50 ml
The final volume was adjusted to 87 ml and the pH adjusted to 6.8 
with 1M NaOH.
It was then clarified by passage through one layer of Whatman No.l 
filter paper, autoclaved for 15 min at 121 °C, and stored at room 
temperature.
Vitamin-Tween 80 mixture
All chemicals were obtained from Sigma (Poole).
Four stock solutions, A, B, C and D were prepared.
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A - vitamin mixture 107 
B - vitamin B12 solution 
C - Thioctic Acid solution 
D - Tween 80 solution
A) Vitamin mixture 107
Five primary stock solutions (1-5) were prepared.
1) Water soluble B vitamins
Solution (i) 62.5 mg niacin
125 mg para-aminobenzoic acid 
dissolved in boiling distilled f^O and brought to a total volume 
of 150 ml.
Solution (ii) 62.5 mg niacinamide
62.5 mg pyridoxine HC1
62.5 mg pyrodoxal HC1 
25 mg thiamine HC1
25 mg calcium panthothenate 
125 mg i-inositol 
1.25 g choline chloride 
dissolved in distilled water and brought to a total volume of 
150 ml.
Solution (iii) 25 mg Riboflavin added to 75 ml of distilled H20 
and dissolved with the aid of 0.1M NaOH added dropwise. The 
total volume was then brought up to 100 ml.
Solutions (i), (ii) and (iii) were combined and brought to a 
total volume of 500 ml with distilled f^ O.
2) Biotin solution
30 mg D-Biotin was dissolved in 200 ml distilled H^O 
with the aid of 0. 1M NaOH and brought to a final volume 
of 300 ml with distilled H^ O.
3) Folic Acid solution
30 mg Folic Acid was dissolved in 200 ml of distilled 
H^O with the aid of 0.1 M NaOH and the final volume 
brought up to 300 ml with distilled H^ O.
4) Lipid soluble vitamins A, D and K
Solution (i) 300 mg vitamin D2 (calciferol) was
dissolved in 63 ml of 95% Ethyl alcohol. To this,
300 mg of vitamin A (retinol) were added and dissolved.
Solution (ii) 60 mg vitamin K (menadione sodium 
bisulphite) were dissolved in 300 ml of a 5% (v/v) 
aqueous solution of Tween-80.
Solution (i) was then combined with solution (ii) and 
the total volume brought up to 3 L with distilled H^ O.
5) Vitamin E solution
25 mg of vitamin E (alpha tocopherol acetate) were 
dissolved in 250 ml of distilled H20. A working mixture 
of vitamin mixture 107 was then prepared by combining 
the 5 primary stock solutions in the following 
proportions:
500 ml Solution 1
250 ml Solution 2
250 ml Solution 3
2500 ml Solution 4
250 ml Solution 5
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This mixture was stored at -22 ®C
B) Vitamin B12 solution
40 mg vitamin B12 was dissolved in 100 ml distilled H^ O.
C) Thioctic Acid solution
100 mg DL-6,8-Thioctic Acid in 100 ml of absolute 
ethanol.
D) Tween-80 solution
50 g Tween-80 was dissolved in 100 ml of absolute 
ethanol,
The final working solution of the vitamin-Tween-80 mixture was 
obtained by combining the 4 stock solutions (A - D) in the following 
proportions:
1000 ml A
12 ml B
4 ml C
4 ml D
180 ml distilled H20
The mixture was filtered through a 0.2 urn polycarbonate filter and 
stored as 3 ml aliquots at - 22 °C in the dark.
Horse serum
Batch tested, mycoplasma screened, sterile horse serum was obtained 
from Gibco (Paisley). It was heat inactivated at 56 °C for 30 min 
before use.
The complete TYI-S-33 medium was stored in the dark at 4 °C and used 
within 5 days after preparation.
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2.2.1.2 Culture
Stock cultures of E. histolytica, strain 200:NIH (ATCC:30458) (Tobie, 
1949) were maintained in Lux 16 x 125 mm plastic tissue culture tubes 
(Flow, Irvine) filled to within 5 mm of the top with TYI-S-33 medium. 
For bulk growth Lux 50 ml plastic tissue culture flasks (Flow,
Irvine) were used. Tubes and flasks containing amoebae were kept 
incubated at 35.5 °C and stock cultures were subcultured at 
approximately 48 h intervals. Subculturing was performed by chilling 
the tubes and fresh medium on ice for 3 minutes. The tubes were 
inverted several times to release attached amoebae and 1 ml of the 
resulting suspension, containing approximately 10^ cells, was 
transferred to tubes containing fresh (chilled) medium.
2.2.2 Production of monoclonal antibodies
2.2.2.1 Immunisation of mice
Tubes of amoebae in late log phase growth (36-48 h cultures) were
cooled in ice water for 3 min and gently inverted several times to
dislodge adherent amoebae. The tubes were centrifuged at 200 £ for
5 mins at room temperature, and the cells resuspended in 13 ml of
Phosphate-buffered saline (PBS) (pH 7.4) and a sample counted in a
haemocytometer. After a second wash, 10 amoebae were suspended in
0.2 ml of PBS. One 6-8 week old female Balb/c mouse was injected
intraperitoneally with 10 amoebae and the procedure repeated 4 weeks
£
later. After a further 2 weeks 10 amoebae were administered 
intravenously (via the caudal vein) and 3 days later the mouse was 
sacrificed and the spleen was removed for hybridoma production.
2.2.2.2 Culture of myeloma cells 
Media
RPMI incomplete medium
This was used as a stock solution for culture medium and, in various 
procedures for washing cells. It consisted of RPMI 1640
(Gibco-Europe, Paisley) with 25 |im HEPES (Sigma, Poole) at pH 7.2.
Ten litre batches of this medium were prepared from powder and filter 
sterilised (0.22 |im pore size). The prepared medium was stored for 
up to six months at 4 °C.
RPMI complete medium
This medium was used as the growth medium for myeloma and hybridoma 
cells. The following stock solutions were produced or purchased and 
stored as stated.
Gentamycin sulphate 
Sodium bicarbonate 
Fungizone (Amphotericin B)
L-Glutamine 
2-Mercaptoethanol 
Foetal Calf serum (FCS)
30 min, screened for the 
ability to support growth 
of myeloma cell line 
P3-X63-Ag8-653 
(Flow, Irvine), - 20 °C
10 mg/ml (Sigma, Poole), 4 °C
7% w/v (BDH, Poole), 4 °C
250 ng/ml (Flow, Irvine), - 20 °C
200 mM (Sigma, Poole), - 20 °C
0.1 M (Sigma, Poole), 4 °C
Heat inactivated, 56 °C,
To produce 100 ml of RPMI complete medium the following amounts of 
the stock solutions were mixed:
80 ml RPMI incomplete medium
2 ml Gentamycin sulphate
1 ml 7% Sodium Bicarbonate
0.8 ml Fungizone
1 ml L-Glutamine
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50 |il 2-Mercaptoethanol
15 ml Heat inactivated Foetal Calf serum
RPMI complete medium was stored at 4 °C for not more than 7 days.
Culture of myeloma cells
The P3-X63-Ag8-653 mouse myeloma cell line was used, (Flow, Irvine). 
The cells were grown at 37 °C in 5% CO^ in a humidified atmosphere in 
RPMI complete medium.
The cells were kept at log phase growth in Lux tissue culture flasks
(Flow, Irvine) at a density of approximately 1-5 x 10^ cells per ml
medium. Fresh RPMI complete medium was added to the flask daily.
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For fusion, 10 myeloma cells were required. Immediately prior to 
fusion the cells were harvested by gentle shaking of the flask to 
release the attached cells followed by centrifugation at 200 g for 
5 min (RT). The required myeloma cells were resuspended in 10 ml of 
RPMI incomplete medium.
2.2.2.3 Preparation of spleen cells from an immunised mouse
The mouse was killed by gentle cervical dislocation and briefly 
immersed in 70% alcohol. The spleen was removed under aseptic 
conditions and placed in 5 ml of RPMI incomplete medium at RT and 
teased apart using forceps. After disruption the remaining larger 
clumps were allowed to sediment for 1 minute. The cell- 
containing supernatant was passed through hypodermic needles of 
decreasing bore (21 G, 23 G, 26 G) in a 10 ml syringe. The spleen 
cell suspension was transferred to a 50 ml centrifuge tube filled 
with RPMI incomplete medium and centrifuged at 200 g for 5 min (RT). 
The pellet was washed in a further 50 ml of RPMI incomplete medium as 
above, and the final pellet resuspended in 10 ml RPMI incomplete 
medium. The spleen cells were counted in a haemocytometer and the 
viability assessed by phase-contrast microscopy (always > 90%).
2.2.2.4 Fusion of cells
Solutions
Polyethylene Glycol (PEG)
Solution A
10 g PEG (Molecular wt. 1540) (Sigma, Poole) was autoclaved at 
121 °C, for 20 min. After cooling to 60 °C, 11 ml of RPMI incomplete 
medium and 3 ml of Dimethyl sulphoxide (DMSO) (Sigma, Poole) were 
added. This gave 41.6% PEG/15% DMSO solution.
Solution B
5 g PEG 1540 was autoclaved at 121 °C for 20 min. After cooling to 
60 °C, 15 ml of RPMI incomplete medium were added. This gave 25% PEG 
solution.
These solutions were stored for up to 6 months at 4 °C.
HAT medium
Hypoxanthine Aminopterin Thymidine solution (x50) (Flow, Irvine) was 
stored at - 20 °C. 2 ml of 5Ox HAT were added to 73 ml of RPMI
complete medium to make 1.3x HAT medium.
All solutions and cell suspensions were pre-warmed to 37 °C.
8 71) 10 spleen cells and 10 myeloma cells were mixed in a 50 ml
conical plastic centrifuge tube and the volume made up to 50 ml with 
RPMI incomplete medium.
2) The mixture was centrifuged at 200 g for 5 min' at RT' and the 
supernatant completely removed.
3) 0.5 ml of PEG solution A was added using a 1 ml pipette over a
30 second period, the pellet being disrupted with the tip of the
pipette, and gently rocked for a further 30 seconds.
4) 0.5 ml of PEG solution B was added. The pellet was resuspended
in this solution for 2-3 min using the pipette tip.
5) 40 ml of RPMI complete medium was added dropwise over a 10 min
period with constant rocking of the tube, after which a further 60 ml
of the same medium was added. The resultant suspension was
distributed into wells of 5 Nunc flat-bottomed microtitre plates 
(Gibco, Paisley), 200 pl/well, an<^  incubated at 37 °C, 5% CO^ in a 
humidified atmosphere.
6) 24 hours after the fusion, 150 pi of supernatant from each well 
was removed and replaced with 150 pi of 1.3x HAT medium containing
4
10 freshly isolated Balb/c peritoneal exudate cells per ml. The
plates were then reincubated for 9 days without feeding.
7) On day 10 post fusion, the plates were observed using an inverted 
microscope. Wells containing plaques of hybridoma cells were 
recorded and 20 pi samples of supernatant were removed for screening 
(see below). Cells secreting Mabs against E. histolytica were 
removed using a pasteur pipette and transferred to wells in a 24-well 
Linbro plate (Flow, Irvine) containing 1 ml of RPMI complete medium 
and 104 Balb/c peritoneal exudate cells set up 24 hours previously to 
allow conditioning of the medium. The original microtitre plate 
wells were refilled with 200 pi of RPMI complete medium.
2.2.2.5 Cloning of Hybridoma cells
After 24-48 hours growth in 24-well plates the cells were removed for 
cloning by limiting dilution.
Cells were resuspended using a pasteur pipette and counted in a 
haemocytometer. Six columns of a microtitre plate were used to clone 
cells from one of the above wells. The microtitre plate was prepared
£5
24 hours prior to cloning by placing 150 \l1 of RPMI complete medium, 
. . 4containing 10 peritoneal exudate cells per ml, in each well. The 
following numbers of cells were placed in the microtitre plate:
Wells in column 1 - io2 hybridoma cells
Wells in column 2 - 10 hybridoma cells
Wells in column 3 + 4 1 hybridoma cells
Wells in column 5 - io"1 hybridoma cells
Wells in column 6 - io'2 hybridoma cells
Supernatants from wells in columns 3-6 showing growth of hybridomas 
by day 10 were screened by IFAT. Mab-secreting cells were 
transferred to 24-well plates and recloned by the same technique. 
Positive clones were then transferred from 24-well plates to 6-well 
Linbro plates (Flow, Irvine) for 2-7 days depending on growth rate,
g
and then into tissue culture flasks. When a total of 3 x 10 cells 
in log phase growth was reached the cells were harvested and 
centrifuged at 200 £ for 5 min (RT), resuspended in 90% foetal calf 
serum (Gibco, Paisley), 10% DMSO (Sigma, Poole) placed in 1.8 ml 
cryotubes (Gibco, Pailsey) and stored under liquid nitrogen.
2.2.2.6 Production of Ascitic fluids
Six to eight week old female Balb/c mice were injected 
intraperitoneally with 0.5 ml of pristane (2,6,10,14-tetramethyl- 
pentadecane) (Sigma, Poole). Seven to ten days after pristane 
treatment the cultured hybridomas were harvested by centrifugation 
(200 £, 5 min, RT) and resuspended in RPMI incomplete medium at a 
density of 2 x 10 cells/ml. Each mouse received 0.5 ml of the cell 
suspension intraperitoneally via a 23 G hypodermic needle. The 
animals were inspected daily for swelling of the abdomen (indicating 
fluid production) and ascitic fluid was removed using a 5 ml syringe 
and a 19 G hypodermic needle. Cells were removed by centrifugation 
at 500 £ for 10 min, RT, and aliquots stored frozen at -40 °C. Some 
samples of ascitic fluid were kept refrigerated at 4 °C with 0.02%
sodium azide and with 1 pi of 0.1 M Phenylmethylsulphonyl Fluoride 
(PMSF) in acetone added per ml of ascitic fluid.
2.2.2.7 Screening of supernatants by indirect fluorescent antibody 
test using fixed cells
Culture tubes containing amoebae in late log phase growth were cooled 
in ice water for 3 min, inverted several times and centrifuged at 
200 g: for 5 min (RT). The pellet was washed twice in PBS (pH 7.4) 
and centrifuged as above. The washed cells were resuspended in 0.2 
ml 10% horse serum in PBS (pH 7.4) and one drop placed in each well 
of a multispot microscope slide (Hendley, Essex). The slides were 
air dried, fixed in methanol (5 min) and could be stored with silica 
gel (Sigma, Poole) at - 22 °C. For screening, 5 (il quantities of 
supernatant were placed in reaction zones and the slides incubated 
for 30 min at room temperature in a humidified atmosphere. After two 
washes in PBS (pH 7.2) fluorescein isothiocyanate (FITC)-conjugated 
rabbit anti-mouse IgG (whole molecule) antiserum was applied at 1/100 
dilution in PBS containing Evans blue (1/10,000) and the slides 
incubated for a further 30 min. Control wells received 5 pi of 
complete RPMI medium in place of culture supernatant.
Finally the slides were washed twice in PBS and mounted in 50% w/v 
glycerol/PBS and reaction zones examined using a Leitz Ortholux II 
microscope with incident light fluorescence, an HB 50 high pressure 
mercury vapour lamp, a TK 510 dichroic mirror, 2 x KP 490 (exciting) 
and a K 515 (suppressing) filter. Photographs were taken on 
Fujichrome 1600 ASA film.
2.2.3 IFAT using live amoebae
In this protocol Phosphate Buffered Saline (pH 7.45) was used 
according to the method of Diamond (1968).
NaCl 6.5 g
K2HP04 2.8 g
KH PO 0.4 g2 4 ^
distilled H20 1 litre (pH 7.45)
All materials and solutions were maintained on ice at below 4 °C. 
Trophozoites in late log phase growth were harvested, washed twice in 
cold PBS (pH 7.45) and resuspended at a final concentration of 2 x
4
10 /ml in 500 (il of diluted ascitic fluid in TYI broth (1/100). 
(Ascitic fluids used in these experiments contained neither sodium 
azide nor proteinase inhibitors). After 30 min incubation on ice the 
cells were washed twice in 10 ml of PBS (centrifugation at 200 £ for 
5 min at 4 °C) then resuspended in 500 |il of TYI broth with 5 (il of 
FITC-conjugated rabbit anti-mouse IgG (whole molecule) antiserum.
The cells were incubated on ice for 30 min, washed twice in PBS, and 
samples placed on microscope slides for examination using incident 
light fluorescence as previously described.
2.2.4 Determination of Immunoglobulin subclasses
The immunoglobulin subclasses of the monoclonal antibodies produced 
were determined by IFAT experiments using methanol-fixed amoebae 
similar to those described above. In these experiments however the 
second antibody used was an FITC-conjugated rabbit antiserum raised 
against a particular murine immunoglobulin subclass (Nordic)
Anti-IgG^, ^<3^2a' IgG3' and IgM antisera were used-
2.2.5 Cloning of E. histolytica
Axenically-cultured E. histolytica (Strain 200:NIH), cooled to 4 °C, 
were diluted in TYI-S-33 medium to a concentration of 40/ml.
Aliquots of 25 pi of amoebic suspension were dispensed under aseptic 
conditions into sterile Benjamin glass haematocrit tubes (Harshaw, 
Daventry) and the tubes sealed in a Bunsen flame. The tubes were 
examined microscopically, by two observers, for the presence of 
single amoebae and such tubes incubated at 35.5 °C. After adequate 
growth the haematocrit tubes were immersed in 70% ethanol for 3 min,
subsequently opened under aseptic conditions and transferred to 16 x 
125 mm plastic tissue culture tubes containing 11 ml of TYI-S-33 
medium and incubated at 35.5 °C as described above.
2.2.6. Erythrophaqocytosis by E. histolytica
Two drops of fresh whole mouse blood obtained via tail bleed from a 
Balb/c mouse were added to a late log phase culture of E. histolytica 
(strain 200:NIH) in a plastic tissue culture tube. The tube was 
inverted 5 times to mix and incubated at 35.5 °C for 20 min. The 
cells were subsequently harvested as previously described and 
methanol-fixed antigen slides were prepared.
2.3 RESULTS
2.3.1. Hybridomas
In three fusions using whole E. histolytica (strain 200:NIH) as
antigen, 279 hybrid cultures were obtained, of which 61 secreted
anti-E. histolytica antibodies detectable by IFAT screening. A
number of indirect immunofluorescence assay reactivity patterns were
distinguished during the primary screening and 21 hybrids were
successfully cloned, maintained in culture and stored frozen. The
hybrids were assigned a figure code or GUPM number (Glasgow
University Protozoology Monoclonal), the first figure of which
corresponded to the number of the fusion from which it was produced
(ie. fusion 22, 24 or 29). Of the 21 monoclonal antibody secreting
hybridomas produced, 4 produced antibodies of the IgM class and 17
produced antibodies of the IgG class. Of these IgG secreting
hybridomas 15 produced IgG subclass antibodies, one produced IgG
X ids.
and one IgG^. (See Table 2.1).
2.3.2 Innninofluorescence patterns
Five basic types of staining pattern were observed in IFAT 
experiments using methanol-fixed amoebae. (See Table 2.1).
Surface; Monoclonals 22.1, 22.6 and 29.6 produced surface staining 
patterns confirmed by positive results in experiments using live 
amoebae (see below). Such patterns were characterised by a bright 
ring of fluorescence around the boundary of the cell, the remainder 
of the cell showing a less intense uniform fluorescence (Plate 2.1). 
Filopodia and other surface protrusions were clearly visible.
Mab 22.1 stained virtually all of the cells observed although 
occasionally negative cells were seen. Such cells were not 
considered fixation artefacts since, under normal light, they were 
morphologically identical to positive cells. Mabs 22.6 and 29.6
stained only a percentage of cells. Some cells showed no staining at 
all (red background staining only) while others showed an 
intermediate range of patterns involving small discrete areas of 
surface fluorescence (Plate 2.2). The pattern of fluorescence 
appeared to show no obvious correlation with particular morphology 
when observed under normal light, or with cell size, although no 
detailed counts were made (see Plates 2.3 and 2.4). While Mab 22.1 
consistently produced just less than 100% positive staining, the 
percentages obtained with 22.6 and 29.6 were found to vary during 
long term culture of strain 200:NIH when cells were tested after 
intervals of several months. With 22.6, the percentage of positive 
cells varied between 52% and 98%, while with 29.6 the percentage 
varied between 17% and 59%. Accurate time-sampling experiments were 
not performed.
Internal vacuolar: Monoclonal antibodies 22.5 and 22.7 produced
fluorescence of internal components which appeared to be internal 
vacuoles of variable size. With Mab 22.5 all cells observed were 
stained in this manner (Plate 2.5) but with 22.7, only a percentage 
of cells were stained with many of these showing a more generalised 
internal fluorescence as well (Plate 2.6). With both these Mabs the 
size of the apparent vacuoles varied considerably with the state of 
the cells. Some large cells, which appeared highly vacuolated when 
viewed under normal light, had large fluorescent vacuoles while 
others had more numerous smaller ones. Using both Mabs the vacuolar 
fluorescence obtained was rarely evenly distributed throughout the 
cytoplasm but frequently concentrated in certain areas leaving other 
parts of the cytoplasm free of fluorescent material (Plate 2.5). 
Occasionally in experiments using 22.7, cells were observed with a 
ring of fluorescence at the margin of the cell (centre cell, Plate 
2.6), similar to the surface fluorescence described above, but live 
amoebae-IFAT experiments did not confirm its surface nature (see 
below). Methanol-fixed slides of amoebae which had internalised 
(phagocytosed) erythrocytes were used in IFAT experiments using Mabs
22.5 and 22.7. It was observed that the vacuolar fluorescence did
not surround the internalised erythrocytes which were clearly 
visible, stained dark red by the background stain, but remained in 
other regions of the cytoplasm.
Internal granular: Ten Mabs (22.3, 22.4, 24.1, 24.3, 24.5, 24.7,
24.8, 29.9, 29.10 and 29.11) produced internal granular fluorescence 
patterns distributed evenly throughout the cell.
Using Mabs 24.5, 24.7 and 24.8 course granular fluorescence patterns 
were consistently produced (Plate 2.7) but with the remaining Mabs 
the size of the fluorescent particles varied with the state of 
vacuolation of the cells. If the cells were highly vacuolated (when 
viewed under normal light), a coarse pattern was produced and with 
less vacuolated cells, finer fluorescent granules were observed 
(Plate 2.8).
Internal diffuse: Mabs 22.8, 24.2, 24.4, 24.6 and 29.3 produced
internal diffuse fluorescence patterns. Experiments using Mab 24.6 
produced uniform diffuse fluorescent staining (Plate 2.9). With the 
other Mabs the patterns obtained varied with the state of vacuolation 
of the amoebae. Amoebae showing few vacuoles when observed under 
normal light were uniformly fluorescent while highly vacuolated 
amoebae showed discontinuous ("patchy") fluorescent patterns 
(Plate 2.10).
Perinuclear fluorescence: Mab 29.5 produced a unique fluorescent
staining pattern consisting of spots around the position of the 
nucleus which was stained dark red by the counterstain (Plate 2.11). 
The spots appeared as blebs on the surface of the amoebae but in live 
IFAT experiments no staining was observed (see below). In cells in 
the process of division, showing two nuclei, fluorescent blebs were 
observed around both nuclei. In certain cells, that seemed to 
contain no nuclei, the fluorescent blebs were more generally 
distributed over the entire cell.
2.3.3 IFAT experiments using live amoebae
All Mabs were tested for their activity against live E. histolytica. 
Only 22.1, 22.6 and 29.6 gave positive results. Bright uniform 
surface fluorescence, characterised by a bright ring at the periphery 
of the cells, was observed with all three Mabs when the amoebae were 
maintained at < 4 °C (Plate 2.12). If, after the experiment, the 
amoebae were allowed to warm to room temperature a surface 
redistribution or "capping" of fluorescent material was observed 
(Plate 2.13). The fluorescence was, over a period of approximately 
5 min, concentrated on one area of the cell surface and eventually 
shed in some cases, while in other amoebae the fluorescent material 
appeared to become internalised. As in experiments using fixed 
amoebae, Mab 22.1 appeared to produce almost 100% fluorescence while
22.6 and 29.6 stained only a lower percentage of cells, with 
non-fluorescent cells and occasional faintly fluorescent cells 
observed. Accurate counts of positive and negative cells were not 
performed.
2.3.4 IFAT experiments using methanol-fixed cloned amoebae
Methanol-fixed amoebae derived from two clones of strain 200:NIH were 
used in IFAT experiments with Mabs 22.6 and 29.6. In each case a 
heterogeneous staining pattern was observed. As with original 
200:NIH, some cells were brightly fluorescent (characteristic surface 
fluorescence), some were negative, while a small number showed an 
intermediate pattern. In experiments with 22.6 the majority of cells 
were fluorescent while with 29.6 the majority of cells were negative. 
The same was true for both clones. Too few cells were observed to 
enable accurate counting of positive and negative cells.
GUPM NO. SUBCLASS FLUORESCENT PATTERN IN IFA EXPERIMENTS USING:
METHANOL FIXED AMOEBAE LIVE AMOEBAE
22.1 G2b SURFACE (%) SURFACE (%)
22.3 G1 INTERNAL; GRANULAR -
22.4 G1 INTERNAL; GRANULAR -
22.5 G1 INTERNAL; VESICLES -
22.6 M SURFACE (%) SURFACE (%)
22.7 G1 INTERNAL / SOME INT. P.M. -
22.8 G1 INTERNAL; DIFFUSE -
24.1 G1 INTERNAL; GRANULAR -
24.2 G1 INTERNAL; DIFFUSE -
24.3 G1 INTERNAL; GRANULAR -
24.4 G1 INTERNAL; DIFFUSE -
24.5 G1 INTERNAL; GRANULAR -
24.6 G2a INTERNAL; DIFFUSE -
24.7 G1 INTERNAL; GRANULAR -
24.8 G1 INTERNAL; GRANULAR -
29.3 G1 INTERNAL; DIFFUSE -
29.5 M INTERNAL;PERINUCLEAR -
29.6 M SURFACE (%) SURFACE (%)
29.9 M INTERNAL; GRANULAR -
29.10 G1 INTERNAL; GRANULAR -
29.11 G1 INTERNAL; GRANULAR -
TABLE 2.1: IMMUNOGLOBULIN SUBCLASSES OF MONOCLONAL ANTIBODIES 
PRODUCED AND FLUORESCENT PATTERNS OBTAINED IN IFA EXPERIMENTS 
USING METHANOL-FIXED AND LIVE E. HISTOLYTICA (STRAIN 200:NIH)
ABBREVIATIONS: % = NOT ALL CELLS POSITIVE
INT. P.M. = INTERNAL PLASMA MEMBRANE
Green fluorescence was apparent for all positive results.
PLATE 2.1 Photomicrograph. E. histolytica, methanol-fixed (x 1000). 
Indirect fluorescent antibody test using GUPM 22.1.
Filopodia visible on cell on right.
PLATE 2.2 Photomicrograph. E. histolytica# methanol-fixed (x 1000).
IFAT using GUPM 22.6.

PLATE 2.3 Photomicrograph. E. histolytica, methanol-fixed (x 500).
IFAT using GUPM 22.6.
PLATE 2.4 Photomicrograph. E. histolytica, methanol-fixed (x 500).
Normal light, same field as Plate 2.3.

PLATE 2.5 Photomicrograph. E. histolytica, methanol-fixed (x 1000)
IFAT using GUPM 22.5.
PLATE 2.6 Photomicrograph. E. histolytica, methanol-fixed (x 1000) 
IFAT using GUPM 22.7.
Lower cell-negative, centre cell-marginal fluorescence.

PLATE 2.7 Photomicrograph. E. histolytica, methanol-fixed (x 1000)
IFAT using GUPM 24.7.
PLATE 2.8 Photomicrograph. E. histolytica, methanol-fixed (x 1000)
IFAT using GUPM 22.4.

PLATE 2.9 Photomicrograph. E. histolytica, methanol-fixed (x 1000).
IFAT using GUPM 24.6.
PLATE 2.10 Photomicrograph. E. histolytica, methanol-fixed (x 1000). 
IFAT using GUPM 24.2.
Lowest cell showing uniform fluorescence. Cell on left showing 
discontinuous ("patchy") fluorescence.
r- Q<u>
PLATE 2.11 Photomicrograph. E. histolytica/ methanol-fixed (x 1000). 
IFAT using GUPM 29.5.
Larger cell possessing two nuclei. Smaller cell possessing one 
nucleus.

PLATE 2.12 Photomicrograph. E. histolytica, live cell (x 1000) 
IFAT using GUPM 22.1.
Cells maintained at 4 °C.
PLATE 2.13 Photomicrograph. E. histolytica, live cell (x 1000) 
IFAT using GUPM 22.1.
Cells warmed to room temperature. Concentration of fluorescent 
material on right-hand side of amoeba.

2.4 DISCUSSION
Monoclonal antibodies produced by 21 mouse hybridomas were used to 
localise antigens of Entamoeba histolytica. The incidence of the 
various immunoglobulin classes and subclasses among the monoclonals 
approximately reflected the subclass composition of normal mouse 
serum immunoglobulin, as expected (Goding, 1986). The preponderance 
of IgG^ noted here was similar to that found by other authors 
preparing a series of monoclonal antibodies against whole protozoan 
cells screened by a similar indirect fluorescent antibody technique 
(IFAT) (Hall et al., 1983; Ravdin et al., 1986).
The three methods most commonly used for hybridoma supernatant 
screening are the Indirect Fluorescent Antibody Test (IFAT), primary 
binding Enzyme-linked Immunosorbent Assay (ELISA) and primary binding 
Radioimmunoassay (RIA). Of these, IFAT is generally considered most 
efficient since it does not select for Mabs directed only against 
antigens which are capable of non-covalently adsorbing to the 
polystyrene microhaemagglutination plates used in ELISA tests, 
although Voller et al. (1976) state that lysed sonicated E. 
histolytica material does adsorb satisfactorily. However, in one 
recent study involving E. histolytica where both IFAT and ELISA were 
used to screen hybridoma supernatants, 24 of the 35 positive 
supernatants- were positive by ELISA while 19 were positive by IFAT 
and 8 positive by both methods (Ravdin et al., 1986). In the work 
presented here IFAT was used for primary screening since the 
equipment was available and routinely used in this laboratory and 
because this method yielded immediate information on the localisation 
of the antigens concerned.
Since the monoclonal antibodies were raised against whole 
trophozoites they were expected to recognise a number of different 
antigens. Five groups of antibodies have been distinguished by the 
subcellular locations of their corresponding antigens determined by 
IFAT staining.
One group of three Mabs was directed against exposed surface antigens 
confirmed by fluorescence in IFAT experiments using live amoebae.
The cell surface of E. histolytica consists of, the surface coat and 
the plasma membrane, both of which contain antigenic material. The 
surface coat or glycocalyx of axenically-grown E. histolytica 
appears, in electron microscope studies using osmium tetroxide and 
ruthenium red fixation, to consist of short filaments, 6-10 nm in 
length (Martinez-Palomo, 1982) though the glycocalyx itself can be 
20-30 nm thick on bacteria-associated trophozoites isolated from 
intestinal lesions (Lushbaugh and Miller, 1974). The nature of the 
coat material is largely unknown but, based on ruthenium red and 
alcian blue staining, the presence of mucopolysaccharides has been 
claimed (Feria-Velasco et al., 1972; Lushbaugh and Miller, 1974).
The coat may contain exposed mannose or glucose residues since it 
binds the lectin concanavalin A (Con A) (Martinez-Palomo et al.,
1973).
Following interaction with specific molecules (both lectins and 
antibody), surface coat components redistribute and are accumulated 
at the uroid (Calderon et al., 1980) whence they are endocytosed or 
released into the medium. In indirect immunofluorescence experiments 
using patient sera and a fluorescein-conjugated anti-human antiserum 
Aust-Kettis et al. (1981) found that 34% of the material was 
internalised while 56% was released, most of that as antigen-antibody 
complexes. In contrast, using FITC-conjugated human patient sera in 
direct immunofluorescence experiments the amoebae tended to shed the 
material, without capping, over a longer period of 3-4 h. Since 
cross-linking and redistribution of a single layer of antibodies 
relies on the multivalency of the antigens (Aust-Kettis and 
Sundqvist, 1978) the authors concluded that because a double layer of 
antibodies was required for capping, the antigens possess only one 
determinant. This would seem unlikely since the serum used was 
polyspecific. However Calderon et al (1980) were able to induce 
capping with a single layer of antibodies using a polyspecific 
antiserum at higher concentration.
This same capping phenomenon was observed, in this work, using Mabs
22.1, 22.6 and 29.6 in live indirect immunofluorescence experiments. 
The Mabs were not used in direct immunofluorescence experiments (ie. 
directly conjugated to fluorescent compounds). However since 
monoclonal antibodies are by definition monospecific they would not 
be expected to induce capping in such experiments unless the antigen 
concerned contained repeating epitopes. Con A-induced capping mimics 
that achieved with a double layer of antibodies since the antigens 
concerned contain multiple ligand molecules (mannose or glucose) 
(Aust-Kettis and Sundqvist, 1978). The shedding or internalisation 
of surface antigen-antibody complexes and also the constant release 
of surface coat molecules into the extracellular environment (Pinto 
da Silva et al., 1975) have been proposed as possible methods of 
interfering with the effective mediation of humoral and cellular 
immune mechanisms against invading amoebae (Aust-Kettis and 
Sundqvist, 1978; Martinez-Palomo, 1982).
The plasma membrane, with which the surface coat molecules are
inextricably linked, is a highly dynamic structure. When grown in
vitro, the amoebae exhibit a high rate of pinocytosis (Reeves, 1984),
thought to be the main method of solute internalisation since
facilitated diffusion appears only to exist for glucose (Reeves,
1984) and pyrimidines (Booden et al., 1978). The rate has been
-1 -1reported to be between 6 and 9 plmin ml .(Serrano and Reeves, 1975) 
which Gitler and Mirelman (1986) extrapolate to suggest that the 
amoebae internalise their total surface membrane approximately every 
20 min, and that the plasma membrane is rapidly recirculated. The 
plasma membrane contains antigenic proteins (Aust-Kettis et al.,
1983; Parkhouse et al., 1978) as well as a highly immunogenic 
aminophosphoglycolipid (Gitler et al., 1984) and a chemically 
distinct lipophosphopeptidoglycan (Rivera et al., 1985) which 
nevertheless cross-reacts with purified antilipid antibodies (Gitler 
and Mirelman, 1986). Such antilipid antibodies were also shown to 
induce rapid capping in live amoebae (Gitler and Mirelman, 1986).
The plasma membrane proteins of axenically grown E.histolytica have 
recently been well characterised by Rosenberg and Gitler (1985) who 
recognised a total of 34 proteins separated by gel electrophoresis,
16 of which are exofacial as determined by labelling with 
lactoperoxidase (Hubbard and Cohn, 1975). Monoclonal antibodies
22.1, 22.6 and 29.6 may be directed either against antigens (protein 
or carbohydrate moieties) of the surface coat or against antigens 
(protein, carbohydrate or possibly even lipid moieties) of the plasma 
membrane. Further characterisation of these antigens will be 
considered in Chapter 5. It is also possible that the antigens 
against which these Mabs are directed are medium components which 
have adhered to the surface of the amoebae (Noya-Gonzalez et al., 
1980). This seems unlikely since Entamoeba invadens, a related 
species pathogenic in reptiles, grown in identical medium gave 
negative results in IFAT experiments (see Chapter 3) although it is 
possible that adherence mechanisms specific to E. histolytica exist.
Since this work was performed there have been several reports of 
monoclonal antibodies raised against E. histolytica, some of which 
describe their use in IFAT experiments. Previously, Lopez et al. 
(1982) had created 15 Mab-secreting stable mouse hybridomas, 
immunising with sonicated whole amoebae and screening by ELISA. No 
further characterisation was performed. Ximenez et al. (1985) used a 
membrane preparation (Aley et al., 1980) to immunise and produced 6 
hybridomas screened by ELISA. One of these was used in IFAT 
experiments giving characteristic surface fluorescence using live 
amoebae fixed, post-experiment, in formaldehyde. Torian et al. 
(1987), immunising with live amoebae, further characterised Mabs 
produced by 7 hybridomas selected from a total of 20 created cell 
lines. Using formalin-fixed amoebae all 7 produced patterns 
characterised by an even distribution of fluorescence over the entire 
body of the amoebae. Only 3 of the 7 produced similar fluorescent 
patterns using live amoebae. Ravdin et al. (1986a) produced 19 Mabs 
giving positive results in IFAT experiments using acetone-fixed cells 
but gave no details of fluorescence patterns observed. Most recently
Meza et al. (1987) immunising with a known amoeba surface protein 
produced Mabs which induced capping phenomena in IFAT experiments 
using live amoebae.
None of the above authors report the heterogeneity of fluorescence 
among amoebae that was observed in IFAT experiments using the 
surface-specific Mabs in this work. However this phenomenon has been 
reported by Aust-Kettis and Sundqvist (1978) using infected patient 
sera in direct and indirect immunofluorescence experiments. Antigen 
expression was found to vary with the cell cycle, being at a minimum 
during logarithmic growth and reaching a maximum during the 
stationary phase, suggesting that a metabolically active amoeba has 
low cell surface antigenicity (Aust-Kettis and Sundqvist, 1978). 
Another possible explanation, however, might be that prolonged 
culture of the amoeba (since 1949 for strain 200:NIH used both by 
these authors and in this work) had resulted in disappearance or 
alteration of certain antigens, as suggested by Bos (1978), such that 
antigens were presented during log phase that were not recognised by 
the patient serum. It may also be possible that during logarithmic 
phase there is increased adherence of serum components to the amoeba 
surface (Noya-Gonzalez et al., 1980). It is not known whether such 
variations in antigen expression occurs in vivo but, if so, they 
could contribute to evasion from immune attack by the parasite 
(Cohen, 1982).
The heterogeneity of surface antigen expression among cultured 
amoebae reported in this work did not seem to be a stable property of 
the cells concerned since cloned lines also exhibited heterogeneity. 
Time-sampling cultures were not performed to determine whether the 
heterogeneity had a cell cycle basis, but there was no obvious 
correlation between fluorescence and cell size which suggests that 
the phenomenon may have a different basis. Heterogeneity in single 
antigen expression within cultured isolates of Trichomonas vaginalis, 
using a monoclonal antibody, has been reported (Alderete et al., 
1986a). Using the Mab in IFAT and flow cytofluorometric experiments
it was found that some isolates showed no reaction and remained 
negative during extended culture while others were heterogeneous 
(Alderete et al. , 1986b). In a finding similar to that presented 
here for Entamoeba, these authors observed that clones of positive 
T. vaginalis cells (separated by Fluorescence Activated Cell Sorting 
- FACS) became negative or heterogeneous. This occurred over 
extended culture and the authors concluded that the perturbations 
were not coupled to single cell cycle events. It was also reported 
that Mab reactivity corresponded with patient serum reactivity, 
tested by antibody-dependent complement mediated lysis, suggesting 
that there is some coordination of antigen expression (Alderete et 
al., 1987) both in vitro and in experimental subcutaneous infections 
in mice. Interestingly, cells showing no Mab reactivity demonstrated 
an enhanced cytotoxic effect on cultured HeLa cells in vitro.
It would be interesting to determine whether such coordination in 
phenotypic variation is occurring in E. histolytica surface antigen 
expression. Relevant experiments would include detailed study of 
synchronised cloned cultures (Austin and Warren, 1983) using directly 
FITC- and TRITC-(tetramethylrhodamine isothiocyanate) conjugated Mabs 
to study, simultaneously, the expression of the antigens recognised 
by both 22.6 and 29.6 in individual cells. Preliminary efforts to 
prepare cells for use in FACS (results not shown) were hampered by 
the fragility of the cells. Correlation with cytopathogenicity could 
also be examined since an effective in vitro assay has been developed 
(Ravdin et al., 1980). Antigenic variation in vitro and :m vivo has 
also been reported in Giardia lamblia (Nash et al., 1988; Aggarwal 
and Nash, 1988). When clones of an isolate possessing a particular 
surface antigen were exposed to an antigen-specific cytotoxic 
monoclonal antibody, a small number of trophozoites expressing new 
surface antigens survived. Exposure of these trophozoites to a 
cytotoxic Mab against one of these, resulted in the survival of 
G. lamblia possessing another set of antigens. The antigenic 
variation described in these anaerobic protozoa (E. histolytica,
T. vaginalis and G. lamblia) is not as profound as the extensively
studied antigenic variation of the variant surface glycoproteins of 
the genus Trypanosoma (reviewed by Vickerman and Barry, 1982).
Unlike African trypanosomes which possess a surface coat composed of 
one antigen, the exposed surface of these anaerobes consists of a 
more complex mixture of antigens. Antigenic variation in 
trypanosomes and in bacteria of the genus Borrelia (Kehl et al.,
1986) is known to prolong infection by evading host immune 
mechanisms.
In order to investigate the functional significance of the surface 
antigens, against which the Mabs are directed, various further 
experiments could be performed:
(a) Use of the Mabs in in vitro assays to determine whether or not 
they can cause immobilisation (Zaman, 1960) or classical complement 
mediated lysis of trophozoites (Aust-Kettis and Utter, 1984).
(b) Use of the Mabs in in vitro cytotoxicity assays to determine 
whether or not they are capable of inhibiting the adherence of 
trophozoites to cultured cells or the cytotoxic effect of the 
trophozoites on these cells. Arroyo and Orozco (1987) and Meza et 
al. (1987) have independently produced Mabs, against two different 
lectin-like surface molecules, which partially inhibit amoebic 
adherence to cultured cells iui vitro. Ravdin et al. (1986a) have 
also produced such inhibitory Mabs which appear to be directed 
against an amoebic adherence lectin (Petri et al., 1987b).
Since surface-exposed antigens are those most likely to be shed and 
stimulate the immune system (Cox, 1968) and induce effector 
mechanisms possibly lethal to the parasite (Trissl, 1982) and since 
the cytopathogenic effect of the amoeba depends on surface contact, 
it is these antigens which have received most attention from 
investigators. However there is evidence to suggest that there are a 
larger number of more immunogenic antigens present in the cytoplasmic 
vesicle fractions than in plasma membrane fractions (Boonpucknavig et 
al., 1967). Later work has shown that a soluble cytoplasmic fraction 
contains more antigens recognised by human patient sera than either
of these membrane fractions (Mathews et al., 1986). Aside from their 
possible serodiagnostic value, the internal antigens of E. 
histolytica may be of interest due to their functional significance. 
Although the main cytotoxic event relies on target cell 
membrane/amoeba membrane adherence (Ravdin et al., 1980) the putative 
mediators of cytolysis and other processes in amoebic pathogenicity 
must have their origin within the parasite. Some of these factors 
may be in membrane-bound vacuoles such as proteinases (Lushbaugh et 
al., 1984), a collagenase (Munoz et al., 1982), lysodiacyl- 
phospholipids produced by amoebic phospholipase A action (Long-Krug 
et al., 1985) and an, as yet unidentified, lysosomal constituent 
(Ravdin et al., 1986b). Others may be in aggregated states within 
the cytoplasm as is proposed for a powerful ion-channel forming 
protein described by Lynch et al. (1982).
Eighteen of the twenty-one Mabs produced in this work were directed 
against internal antigens, confirmed by negative results in IFAT 
experiments using live amoebae. The cytoplasm of E. histolytica has 
a rather undifferentiated appearance at both the light and electron 
microscope levels and consequently little detail could be seen of the 
fluorescent patterns obtained which were divided into four more or 
less distinct groups; vacuolar, diffuse, granular and perinuclear 
fluorescence. Ultrastructural studies of E. histolytica 
(Martinez-Palomo, 1982; Miller et al., 1961) and E■ invadens (Deutsch 
and Zaman, 1959) show that the cytoplasm is devoid of many of the 
differentiated organelles found in most eukaryotic cells; 
mitochondria, golgi apparatus, centrioles, cytoplasmic microtubules 
or recognisable rough endoplasmic reticulum.
A large proportion of the cytoplasm is occupied by a heterogeneous 
population of membrane-bound vacuoles and vesicles, of variable size 
(0.5 pm - 9.0 pm) and shape though most ap»pear circular in profile in 
thin sections. Two of the Mabs, 22.5 and 22.7, appear to be directed 
against components of this system. Considering the continuous rapid 
rate of endocytosis of this parasite (Serrano and Reeves, 1975) there
can be little doubt that a significant proportion of the vacuoles is 
derived from internalised plasma membrane. Freeze-fracture studies 
(Martinez-Palomo et al., 1976) demonstrate the existence of two 
morphologically distinct populations of cytoplasmic vacuoles: the 
most numerous having a smooth contour, while the others appear 
crenated. The significance of such differences is not known. The 
exact sequence of vacuole processing after internalisation is 
likewise unclear, but internalised fluid-phase markers are rapidly 
released, demonstrating rapid membrane recycling (Aley et al., 1984). 
Whereas lysosomes in other eukaryotic cells contain soluble acid 
phosphatase within the vesicle, in Entamoeba the enzyme is 
membrane-associated (Aley et al. , 1980; Martinez-Palomo, 1982) 
although other enzymes, such as (3-D-glucosaminidase occur in both 
membrane-associated and soluble forms (Rosenberg and Gitler, 1985). 
Primary lysosomes (containing hydrolases that have not yet been 
active) have not been clearly differentiated from secondary lysosomes 
although Aley et al. (1984) described small highly acidic vesicles 
which may be relevant.
The vacuoles recognised by Mabs 22.5 and 22.7 were of variable size 
and did not appear to be recently internalised membrane, as 
demonstrated by IFAT experiments using erythrocyte-fed trophozoites. 
With hindsight the amoebae should have been sampled at various times 
after erythrocyte phagocytosis to determine whether or not the 
membranes surrounding the ingested erythrocyte became fluorescent 
after a longer period. Such a result would have suggested that the 
vacuoles concerned are indeed lysosomal. The peripheral fluorescent 
pattern observed in occasional cells with Mab 22.7 did not appear to 
involve surface-exposed antigens since no fluorescence was observed 
in live IFAT. However, the number of cells showing this peripheral 
fluorescence using fixed amoebae, was so small that such cells may 
not have been present in the smaller sample observed in live IFAT. 
These observations show that the antigen for which 22.7 is specific 
is probably associated with the membrane of certain vacuoles and, in 
some cells, becomes associated with the plasma membrane, though 
whether it is exposed on either face of the membrane is uncertain.
The presence of lysosomal membrane-associated enzymes associated with 
the plasma membrane has been reported (Aley et al., 1980; Rosenberg 
and Gitler, 1985) and is thought to be due to membrane recycling 
(Gitler and Mirelman, 1986). Alderete et al. (1986a) found that 
while many isolates of Trichomonas vaginalis expressed a certain 
membrane antigen on their surface (recognised by a Mab in IFAT), some 
isolates synthesised the protein but did not express it. A similar 
situation may be occurring within subpopulations of the cultured 
E. histolytica used here. The fluorescent pattern obtained with 22.5 
was always restricted to vacuoles within the cytoplasm. Since no 
plasma membrane fluorescence was observed, it is possible that the 
antigen concerned is located within the lumen of the vacuoles and is 
extruded from the cell as a vesicle/plasma membrane fusion occurs 
(Gitler and Mirelman, 1986). Alternatively these vacuoles might 
represent a population not involved in the lysosomal system, though 
considering their size and number this seems unlikely.
Two groups of Mabs were directed against cytoplasmic antigens 
apparently not associated with the vacuolar system. Indeed the 
presence of large numbers of vacuoles in some trophozoites used in 
IFAT experiments caused the cytoplasmic fluorescence to become 
locally more concentrated causing a coarser pattern in the case of 
Mabs producing granular fluorescence, and a less uniform pattern with 
those producing diffuse fluorescence.
Although the lack of observable detail in the cytoplasm makes it 
difficult to speculate on the nature of the antigens concerned, there 
are several more obvious features which are possible candidates; the 
tubular system, the cytoskeleton and ribosomal arrays.
A lattice of smooth tubules and vesicles, of approximately 20 nm in 
diameter is occasionally found in the cytoplasm of E. histolytica in 
thin sections and by freeze-fracture electron microscopy 
(Martinez-Palomo, 1982). The vesicles themselves are a more common 
occurence and have a membrane thickness of 6 nm compared with that of
the vacuolar and plasma membranes of 10 nm. It is possible that the 
granular patterns observed with some Mabs may be due to their 
recognising components of this system. It is thought that the system 
may be involved with synthesis, packaging and processing of 
extracellular amoebic products but there is no evidence to support 
this (Martinez-Palomo, 1982).
In spite of the detailed ultrastructural studies that have been 
performed, very little is known about the structural organisation of 
the cytoskeleton of E. histolytica. Actin filaments are the only 
filaments to have been identified in the cytoplasm with certainty, by 
electron microscopy (Martinez-Palomo et al., 1974) and using 
immunocytochemistry by Aust-Kettis et al. (1987) who, using an 
anti-human actin antiserum, produced a "star-like" IFAT pattern with 
brightest fluorescence at the centre of the cell or more occasionally 
patterns consisting of fluorescent "bunches or whirls". Such a 
pattern was not obtained with any of the Mabs produced in this work.
In ultrastructural studies most ribosomes of E. histolytica are not 
observed free in the cytoplasm or membrane-associated but appear in 
ordered helical arrays approximately 300 nm in length and 40 nm in 
diameter. The helices themselves are frequently found in association 
with membrane systems within the cytoplasm (Rosenbaum and Wittner, 
1970). Antibodies against protein constituents of these 
ribonucleoprotein bodies might be expected to produce granular 
fluorescence patterns in IFAT experiments.
Mab 29.5 produced a unique pattern of apparent surface blebs in IFAT 
experiments using fixed amoebae but gave no fluorescence using live 
cells, indicating that the antigen concerned may be located on the 
internal face of the plasma membrane. Where a nucleus was present, 
such blebs were consistently associated with the nuclear region while 
in the absence of a nucleus they had a more random distribution 
throughout the cell. This makes it tempting to speculate that the 
antigen concerned might be related to cytoskeletal specialisations on
the internal surface of the plasma membrane involved in anchoring the 
nucleus to the rest of the cytoskeleton. Little is known of the 
method of nuclear division in E. histolytica but that it occurs 
without dissolution of the nuclear membrane (Cervantes and 
Martinez-Palomo, 1980). Presumably such a process requires 
substantial interaction with the cytoskeletal system. No structures 
resembling these blebs have been reported in ultrastructural studies 
of Entamoebae.
More accurate localisation of antigens using these monoclonal 
antibodies could be performed using colloidal gold in double or 
direct labelling immunoelectronmicroscopy of frozen sections of 
E. histolytica (Geuze et al., 1981; de May, 1983). This technique 
has been successfully used in the study of antigen expression in 
other parasites such as variant surface glycoprotein in Trypanosoma 
brucei (Tetley et al., 1987).
The 21 monoclonal antibodies produced here were used throughout the 
subsequent investigations.
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3.1 INTRODUCTION
Individuals undergoing immunodiagnostic tests for infection with 
Entamoeba histolytica, whether for clinical or epidemiological 
purposes, are frequently host to a number of other protozoan 
gastro-intestinal parasites. This is particularly true of groups 
experiencing a greater than average degree of faecal-oral route 
contact, such as homosexual men (McMillan, 1988) and the mentally 
retarded (Thacker et al. , 1979). Of the various protozoa capable 
of inhabiting the human intestine, listed in Table 3.1, only seven 
are definitely known to cause disease; E. histolytica, Giardia 
lamblia, Balantidium coli, Isospora belli, Sarcocystis hominis, 
Sarcocystis suihominis and Cryptosporidium spp.
Since it was intended that the monoclonal antibodies produced in 
this work should be tested for their usefulness as immunodiagnostic 
reagents (see Chapter 6) it was decided to test their specificity 
for E. histolytica by checking for cross-reactivity with other 
protozoan parasites and other cultured cell types available.
Members of the genus Entamoeba Casagrandi and Barbagallo, 1895, 
occur as parasites of the digestive tract in a wide range of 
vertebrates although one species is found in invertebrates. In 
addition, one species, E. moshkovskii Tshalaia, 1914, appears to be 
free-living in sewage. The classification of the species within 
this genus is based on the number of nuclei in their mature cysts, 
either eight, four, or one (Neal, 1966). Examples of these groups 
are listed in Table 3.2. The division into four- or eight-nucleate 
cyst groups is also associated with a difference in nuclear 
morphology (in the position of the endosome and distribution of 
peripheral "chromatin") (Neal, 1966), though the one-nucleate cyst 
species are not distinguishable by nuclear structure alone.
TABLE 3.1: THE MORE COMMON INTESTINAL PROTOZOAN PARASITES OF MAN.
* denotes infection can cause disease symptoms
Amoebae
Entamoeba coli
Entamoeba hartmanni
Endolimax nana
Iodamoeba biitschlii
Flagellates
Ciliates
Coccidia
Chilomastix mesnili 
Enteromonas hominis 
Retortamonas intestinalis 
Giardia lamblia* 
Dientamoeba fraqilis 
Pentatrichomonas hominis
Balantidium coli*
Isospora belli* 
Sarcocystis hominis* 
Sarcocystis suihominis*
Cryptosporidium spp,
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Within the quadrinucleate-cyst amoebae there is a group of species 
which, at the light microscope level, are morphologically very 
similar: E. invadens Rodhain, 1934, E. histolytica, E. hartmanni 
von Prowazek, 1912, E. moshkovskii and E. histolytica-like amoebae. 
These last, also known as Laredo-type amoebae, include strains 
isolated from humans that substantially differ from most E. 
histolytica in several physiological attributes but have not been 
granted separate species status (reviewed by Martinez-Palomo,
1982).
These species/types can be distinguished by various features apart 
from host/habitat and pathogenicity; E. hartmanni cysts are 
consistently smaller than E. histolytica cysts and have distinct 
nuclear morphology (Burrows, 1964). E. invadens, E. moshkovskii 
and "E. histolytica-like" amoebae are characterised by their 
ability to grow well at 27 °C (Richards et al., 1966; Neal, 1966) 
and their tolerance of a hypotonic medium (Richards et al., 1966; 
Goldman, 1969). Studies comparing E. histolytica with the other 
amoebae of the mophologically similar group have revealed specific 
differences in isoenzyme patterns (Reeves and Bischoff, 1968; 
Sargeaunt et al., 1980b) and in antigenic composition (Goldman, 
1969; Krupp, 1966).
The Mabs were tested for their ability to recognise antigens in 
various members of the genus Entamoeba in IFAT tests. It was hoped 
that such experiments would yield information on the antigenic 
relatedness of these species to E. histolytica, which might be 
extrapolated to examine phylogenetic relationships within the 
genus.
No. of Nuclei in Cyst Species Host/Habitat
4
1
No cyst formation
E. coli 
E. gallinarum
E. muris 
E. baretti
E. histolytica*
E. histolytica-1ike 
E. hartmanni 
E. moshkovskii 
E. invadens*
E. terrapinae 
E. knowlesi 
E. pyrrhogaster 
E. ranarum 
E. philippinensis
E. aulostomi
E. bovis 
E. polecki 
E. suis 
E. ovis
E. gingivalis 
E. canibuccalis 
E. eguibuccalis
man
domestic 
fowl 
rats, mice 
turtles
human 
human 
human 
in sewage 
reptiles 
turtles 
tortoises 
salamanders 
amphibians 
roach, (Panesthia 
javanica) 
leeches 
(and other 
invertebrates)
cattle 
pigs, man 
pigs 
sheep
man, oral cavity 
dog, oral cavity 
horse, oral cavity
TABLE 3.2 Species of Entamoeba, showing host/habitat and number of 
nuclei in mature cyst. For octonucleate, uninucleate and non-cyst- 
forming groups not all known species are shown.
* denotes pathogenic
3.2 MATERIALS AND METHODS
3.2.1. Cells
E. invadens: Isolate GU had been maintained in this Department for
several years although the original source of the isolate is not 
known. Isolates TRM, ZM, TR1 and TR2 were obtained from Dr D.C. 
Barker, Molteno Institute, University of Cambridge. TRM, TR1 and 
TR2 were isolated in Madagascar in 1963 from different individuals 
of Testudo radiata. ZM was also isolated in Madagascar in 1963 
from Charanodon madagascarensis. These isolates were all 
maintained at 25 °C in Jones' Horse Serum and Marmite (JHSM) medium 
containing 5% heat inactivated horse serum (Gibco, Paisley) and 
supplemented with rice starch (Jones, 1946). Isolate LSH was 
obtained from Dr Ann Chayen, Department of Medical Protozoology, 
London School of Hygiene and Tropical Medicine (LSHTM), London, 
although the original source is not known. This isolate was 
maintained in axenic culture in TYI-S-33 medium at 25 °C.
E. moshkovskii: An isolate of E. moshkovskii (SAW 698) was
provided by P.G. Sargeaunt, Department of Medical Protozoology, 
LSHTM. It was isolated from sewage in Mexico City in 1979 and had 
been maintained in Robinson's Medium at 37 °C (Robinson, 1968).
E. coli Grassi, 1879, and E. hartmanni were obtained from P.G. 
Sargeaunt, LSHTM, both as constituents of isolate MH 661, isolated 
from a male homosexual patient at the Middlesex Hospital, London in 
1986. This isolate was maintained in Robinson's Medium.
E. muris Grassi, 1879, was obtained fresh from the intestine of a 
naturally infected Balb/c mouse. The mouse was killed by gentle 
cervical dislocation and the abdomen opened. The contents of the 
colon and caecum were removed, mixed with an equal volume of PBS 
(pH 7.4) and sieved through an Endecott filter (mesh size 250 pm) 
to remove large particles. The filtrate was centrifuged at 200 £ 
for 3 min (RT) and the pellet resuspended and washed again in PBS.
The final pellet was resuspended in a small volume of PBS 
containing 10% horse serum.
Pentatrichomonas hominis Davaine, 1860, was provided by Dr A Yule, 
Department of Medical Protozoology, LSHTM, and grown in modified 
Diamond's medium (Diamond, 1957).
Trichomonas vaginalis Donne, 1836, was provided by Dr G H Coombs 
of this Department, and grown in modified Diamond's medium.
Giardia lamblia Stiles, 1915, was provided by Dr H V Smith, 
Department of Bacteriology, Stobhill General Hospital, Glasgow and 
was grown in TYI-S-33 medium.
Trypanosoma (Trypanozoon) brucei rhodesiense: Bloodstream forms
were provided by Dr A J Scott of this Department. The cells were 
obtained from infected mouse blood following Diethylaminoethyl 
(DEAE)-cellulose ion-exchange chromatography (Lanham and Godfrey, 
1970). Procyclic forms of the same species were provided by Cathy 
Cameron, of this Department, and grown in Minimal Essential Medium 
(MEM) with 10% Foetal calf serum.
Trypanosoma (Nannomonas) congolense Broden, 1904, bloodstream 
forms were provided by Frances Devaney, of this Department, and 
prepared from mouse blood as for T. brucei rhodesiense above. 
Procyclic forms of T. congolense were provided by Dr Kay A K 
Hendry, of this Department and were grown in MEM, as above.
Acanthamoeba castellani and Naegleria gruberi were provided by 
Cathy Cameron. A. castellani was grown axenically in Neff's medium 
(Neff, 1957) while N. gruberi was grown on non-nutrient agar with 
Klebsiella aerogenes as a food source.
Chinese Hamster ovary (CHO) cells were obtained from Flow Labs, 
Irvine and grown in Hams' F-12 medium with 10% FCS.
3.2.2 Indirect fluorescent antibody test
Cells grown in Robinsons' medium (E. hartmanni, E. coli and 
E. moshkovskii) were prepared for IFAT by removing a small quantity 
of liquid from the bottom of the agar slope by pipette, and gently 
mixing to form a suspension.
All other cell types apart from E. muris as previously described, 
were washed in PBS (pH 7.4), centrifuged at 200 g for 3 min and 
resuspended in a small volume of PBS containing 10% horse serum.
Drops of all cell suspensions were placed in wells of multispot 
slides (Hendley, Essex) and allowed to air-dry. Following fixation 
in methanol (5 min) the slides could be used immediately or stored 
desiccated at -22 °C.
Ascitic fluids containing Mabs were used diluted in PBS at two 
dilutions above their endpoint obtained in IFAT titration 
experiments using E. histolytica strain 200:NIH as antigen.
Slides of antigen were warmed to room temperature and 5 pi 
quantities of diluted ascitic fluids were placed in each well and 
the slides processed as previously described in Section 2.2.2.7. 
Control wells received 5 pi of a 1/100 dilution of normal mouse 
serum.
3.2.3. IFAT experiments using live E. invadens
IFAT experiments using live E. invadens isolate ZM were performed 
using Mabs 29.5 and 22.6 as previously stated for E. histolytica.
3.3 RESULTS
All 21 Mabs were used in IFAT experiments using methanol-fixed 
cells of all species and cell lines described in Section 3.2.1.
The fluorescent patterns observed were recorded and are summarised 
in Table 3.3. The results of experiments involving N. gruberi,
A. castellani, species of trypanosomes and CHO cells are not shown
in the table. The results of IFAT experiments involving isolates
of E. invadens are summarised in Table 3.4.
Two Mabs, 29.5 and 29.9, gave positive results with all cell types
tested. Mab 29.5 produced perinuclear fluorescent patterns in most 
cells except N. gruberi and CHO cells where the fluorescence 
appeared to be localised beneath the plasma membrane. Only in 
other members of the genus Entamoeba was the perinuclear 
fluorescence similar to that observed in E. histolytica, consisting 
of apparent membrane "blebs". No fluorescent cells were observed 
in IFAT experiments using live E. invadens (strain ZM). Mab 29.9 
produced internal granular fluorescent patterns in all amoebae 
tested (including N. gruberi and A. castellani) but more diffuse 
patterns in all flagellates and CHO cells.
Eight Mabs (22.1, 22.3, 22.5, 22.7, 22.8, 29.6, 29.10 and 29.11) 
gave negative results with all cell types tested.
Mab 22.4 reacted with all members of the genus Entamoeba, apart 
from E. hartmanni, and also reacted with P. hominis. In each case 
a granular internal fluorescence pattern was produced. Mab 22.6 
gave positive results with four out of the six isolates of 
E. invadens tested (ZM, TRM, TR1 and TR2) but with no other cell 
type. In each case only a percentage of cells were fluorescent. 
Most positive cells showed specks of fluorescence on their surface 
while a minority showed typical membrane fluorescence as seen with
E. histolytica (Section 2.3.2). The external surface location of 
the antigen concerned was confirmed by positive results in IFAT 
experiments using live E. invadens (strain ZM). Mab 24.1 reacted 
with only one isolate of E. invadens (GU) giving internal granular 
fluorescence. It also reacted with T. brucei rhodesiense, both 
bloodstream and procyclic forms, with the flagellum being the only 
fluorescent part of the cell. Mab 24.1 did not react with 
T. congolense or any other flagellate tested. Mabs 24.2 and 24.4 
reacted with only the GU isolate of E. invadens and with the 
isolate of E. moshkovskii used, giving a diffuse internal 
fluorescence pattern.
Mab 24.3 reacted with E. moshkovskii, E. muris and E. coli 
producing an internal granular fluorescence pattern. Mabs 24.5, 
24.7 and 24.8 reacted with all six isolates of E. invadens tested 
but with no other cell type. All three Mabs produced internal 
granular fluorescence patterns.
Mab 24.6 reacted only with E. moshkovskii producing an internal 
diffuse fluorescence pattern.
Mab 29.3 reacted with all six isolates of E. invadens and with 
E. moshkovskii and produced a diffuse fluorescence pattern in each 
case.
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TABLE 3.3: IFA EXPERIMENTS USING METHANOL-FIXED PROTOZOA;
ENTAMOEBA INVADENS
ENTAMOEBA MOSHKOVSKII (E. MOSK.)
ENTAMOEBA MURIS 
ENTAMOEBA COLI 
ENTAMOEBA HARTMANNI 
PENTATRICHOMONAS HOMINIS 
TRICHOMONAS VAGINALIS 
GIARPIA LAMBLIA
FLUORESCENT PATTERNS OBSERVED:
I = INTERNAL
S = SURFACE
- = NEGATIVE RESULT
S/- = SURFACE IN CERTAIN ISOLATES, NEGATIVE IN OTHERS
I/- = INTERNAL IN CERTAIN ISOLATES, NEGATIVE IN OTHERS
(SEE TEXT FOR DETAILS)
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GUPM NO. ISOLATES OF ENTAMOEBA INVADENS
GU LSHTM TRM ZM TR1 TR2
22.1(S)
22.3 _ _ _ _ _ _
22.4 I I I  I I I
22.5
22.6(S) - S% S % S% S%
22.7 - - -
22.8 _ _ _ _ _ _
24.1 I -
24.2 I -
24.3 _ _ _ _ _ _
24.4 I - - - -
24.5 I I I I I I
24.6 - - - - -
24.7 I I I I I I
24.8 I I I ' l l  I
29.3 I I I I I I
29.6(S) _ _ _ _ _ _
29.10 -
29.11 _ _ _ _ _ _
TABLE 3.4 : FLUORESCENT PATTERNS OBTAINED IN IFA EXPERIMENTS USING 
ISOLATES OF ENTAMOEBA INVADENS.
I = INTERNAL
S% = SURFACE, NOT ALL CELLS POSITIVE. (CONFIRMED BY IFA USING LIVE 
AMOEBAE)
- = NEGATIVE RESULT
SEE TEXT FOR DETAILS OF STRAINS
3.4 DISCUSSION
The specificity of the 21 monoclonal antibodies for E. histolytica/ 
was determined by testing for cross-reactivity with a range of 
other cell types in IFAT experiments. These cells included members 
of the genus Entamoeba, other parasitic and free-living protozoa 
and one mammalian cell line. Such tests comprised part of the 
initial assessment of the suitability of these Mabs for use in an 
antigen-capture assay in immunodiagnosis. However it must be 
emphasised that the Mabs were used here in immunofluorescence tests 
with methanol-fixed whole-cell antigen, whereas antigen-capture 
assays in which they may be useful, such as ELISA (Chapter 6), 
employ native, often soluble, antigen. Therefore the absence of 
cross-reaction in these experiments does not necessarily exclude 
cross-reaction with the same cells under different conditions. 
Additionally, these Mabs may cross-react with other, non-protozoan 
antigens that may be present in samples tested in a diagnostic 
assay, for example serum proteins in body fluids and various 
commensal and pathogenic intestinal bacteria present in faeces.
Eight of the Mabs (22.1, 22.3, 22.5, 22.7, 22.8, 29.6, 29.10 and 
29.11) failed to cross-react with any of the cell types used.
A further nine (22.6, 24.1, 24.2, 24.4, 24.5, 24.6, 24.7, 24.8 and 
29.3) cross-reacted with E. invadens or E. moshkovskii or both of 
these. Since E. invadens seems only to infect certain reptiles 
(Ratcliffe and Gieman, 1938) and since attempts to infect man 
(Rogova, 1958) and other mammals (de Carneri, 1958) with 
E. moshkovskii have been unsuccessful, these Mabs may yet be of use 
in E. histolytica antigen detection in human-derived samples, as 
these two species of amoebae would not be present to create 
confusion.
Most other work involving Mabs raised against E. histolytica has 
reported only those that fail to cross-react with other protozoan 
species. However Lopez et al. (1982) reported that one out of six 
Mabs described, cross-reacted in ELISA with E. moshkovskii
(although no other cell types were tested) and Ximenez et al.
(1985) found that five out of six Mabs produced, cross-reacted with 
E. invadens, E. moshkovskii and the "E. histolytica-like1 Laredo 
strain.
Cross-reactions with monoclonal antibodies cannot always be taken 
to suggest a functional or evolutionary relationship between the 
antigens involved, since identical or closely similar epitopes may 
occasionally occur on otherwise unrelated antigens, as has been 
suggested by Nigg et al. (1982) for the cross-reaction between 
viral src-c-peptide and (3-tubulin. This is particularly true if 
the epitopes concerned are carbohydrate moieties but cross-reaction 
may also occur with protein epitopes. If, however, cross-reactions 
occur between apparently related species then there is a higher 
probability that such cross-reactions do reflect an evolutionary 
relationship, where a larger number of shared epitopes are to be 
expected. There are two distinct explanations for the physical 
basis of the more capricious Mab cross-reactions (Lane and 
Koprowski, 1982). One interpretation involves two antigens which 
share a small and precise detail of their surface topology. Such 
an epitope might not be detectable using conventional antisera in 
which most of the antibodies would be directed against determinants 
specific to one or other of the antigens. In the second 
interpretation the two epitopes have dissimilar structures but 
interact with the same antibody molecule since antibody binding 
sites are known to be polyfunctional (Richards et al., 1975). 
Obviously a mid-way situation may exist where an epitope on one 
antigen may be partly homologous to an epitope on another.
The antigens recognised by Mabs 29.5 and 29.9 are likely to be 
conserved antigens since the cross-reactions occurred throughout a 
wide range of species. The suggestion that Mab 29.5 recognises an 
element of the cytoskeleton (Section 2.4) is strengthened here by 
the observation that a perinuclear fluorescence pattern was 
observed in most cell types. The cross-reaction observed with Mab
24.1 and T. brucei rhodesiense is more likely to represent the
u •
fortuitous presence of a similar epitope since it occurred only in 
one species of unrelated (except by Phylum!) protozoan. It is 
interesting to note that Mab 24.1 recognised the flagellum of the 
trypanosome, since Dulbecco et al. (1981), who found a 
cross-reaction between an anti-Thy 1 Mab and intermediate 
filaments, suggested that the large concentrations of cytoskeletal 
proteins in the cell may be a factor in the detection of such 
cross-reactions by IFAT.
Phylogenetic relationships between species have been determined 
using conventional antisera (Ibrahimi et al., 1979; Prager et al., 
1979) to detect cross-reactive and non cross-reactive epitopes and 
while a single Mab against a single epitope is not an effective 
tool for this kind of investigation it was felt that a larger panel 
of Mabs against a wider range of antigens might be useful in 
drawing at least preliminary conclusions. A negative result in 
these species cross-reaction experiments may signify an absence or 
change in the epitope for which the Mab is specific or absence of 
the antigen altogether. The cross-reactions observed with Mab 29.5 
and 29.9 have been mentioned and will not be discussed further.
None of the Mabs (other than 29.5 and 29.9) cross-reacted with 
Naegleria gruberi and Acanthamoeba castellani. This finding 
supports that of Sen et al. (1961b) who found that anti-E. 
histolytica antiserum failed to react with N. gruberi antigen in 
precipitin tests. Adam (1964), using the immobilisation test, 
(which by nature, examines surface-exposed antigens), showed that 
antisera prepared against E. histolytica, E. invadens and 
E. moshkovskii failed to have an immobilising effect on four 
strains of A. castellani. Such antigenic difference is not 
suprising given these free-living amoebae are morphologically and 
biochemically very distinct from members of the genus Entamoeba 
(Bowers and Korn, 1968; Gutteridge and Coombs, 1977).
E. coli and E. muris both showed cross-reactions with the same two 
Mabs, 22.4 and 24.3. This unique pattern of cross-reactivity is
interesting since both species belong to the octonucleate cyst 
group and are morphologically indistinguishable from each other 
(Neal, 1950) differing only in their host-restrictions. It would 
be interesting to discover if this pattern of reactivity occurred 
with other members of the group eg. E. gallinarum and E. barretti. 
Immunological cross-reactivity between E. coli and E. histolytica 
has been reported by Goldman (1954) using antisera to both species 
in IFAT experiments. However the heterologous fluorescence was 
removed after absorption with the appropriate species.
The cross-reactivities observed with members of the quadrinucleate 
cyst group were more complex. E. hartmanni failed to cross-react 
with any of the Mabs, except 29.5 and 29.9. This is in contrast to 
the findings of Goldman et al. (1960) who, using anti-E.histolytica 
antiserum in IFAT experiments, reported that cross-reaction with 
E. hartmanni occurred to the same extent as cross-reaction with 
E. invadens and E. coli. There are various possible explanations 
for this anomaly. Since the Mabs used in this work are merely a 
random sample of the total mouse response to E. histolytica, it is 
possible that, by chance, those hybridomas involving plasma cells 
producing antibodies that do cross-react with E. hartmanni, were 
not selected during screening. Another possibility is that 
significant antigenic heterogeneity might exist between isolates of 
E. hartmanni, although antigens cross-reacting with other members 
of the genus would most likely be conserved (as observed in E. coli 
and E. muris). Finally it is possible that the small amoeba 
present in isolate MH 661 was not E. hartmanni, although its 
nuclear morphology (similar to E. histolytica) and small size, 
suggested that it was. It is interesting to note that Mab 22.4 
showed a cross-reaction with the flagellate Pentatrichomonas 
hominis, and yet none with E. hartmanni, nor with the other 
trichomonad tested, Trichomonas vaginalis.. The significance of 
this finding is not known.
The large number of Mabs cross-reacting with E. invadens and 
E. moshkovskii suggest that these two species are antigenically 
closely related to E. histolytica. However the two species do 
differ in terms of the individual Mabs that recognise them.
Apart from 29.5 and 29.9, six other Mabs cross-reacted with 
E. moshkovskii; 22.4 and 24.3 (as with E. muris and E. coli), 24.2, 
24.4, 24.6 and 29.3. Interestingly, E. moshkovskii was the only 
cell type other than E. histolytica which was recognised by 24.6.
A certain amount of heterogeneity of cross-reactions was observed 
among the six isolates of E. invadens tested. Five Mabs reacted 
with all six of the isolates; 24.5, 24.7 and 24.8 (cross-reacting 
only with E. invadens), 22.4 (which also recognised other species 
of Entamoeba except E. hartmanni) and 29.3 which also cross-reacted 
with E. moshkovskii. Isolate GU also cross-reacted with 24.2 and
24.4 in common with E. moshkovskii and uniquely with 24.1. All 
four Madagascar isolates of E. invadens (TRM, ZM, TR1, TR2) gave 
surface fluorescence with Mab 22.6, of a pattern similar to that 
observed in E. histolytica. No isolate of E. invadens gave a 
positive reaction with Mab 24.3 which cross-reacted with 
E. moshkovskii, E. muris and E. coli. These results demonstrate 
antigenic heterogeneity among isolates of E. invadens and the 
importance of testing more than one isolate of a certain species 
when attempting to determine antigenic relatedness. Unfortunately 
this was not accomplished with any of the species other than 
E. invadens.
Several other workers have examined cross-reactions between the 
antigenic structures of E. histolytica and other members of the 
quadrinucleate cyst groups, although only in some of these were 
E. moshkovskii and E. invadens examined simultaneously. Using 
antisera against E. histolytica in IFAT, Goldman et al. (1960) 
found there was much stronger cross-reaction with E. invadens than 
with E. moshkovskii. Zaman (1960) showed that anti-E. histolytica 
antiserum was capable of immobilising E. invadens but not 
E. moshkovskii trophozoites, an observation supported by the
finding of cross-reacting surface antigens in E. histolytica and 
E. invadens in the work presented here. In contrast, Ali Khan and 
Meerovitch (1968), using a variety of techniques, (indirect 
haemagglutination, gel precipitation and iirununoelectrophoresis) 
demonstrated that anti-E. histolytica antiserum cross-reacted more 
strongly with E. moshkovskii than with E. invadens. Conflicting 
results have also been reported in experiments using 
anti-E.invadens antiserum. Siddiqui and Balamuth (1966) in IFAT 
experiments showed a stronger cross-reaction with E. moshkovskii 
than with E. histolytica, while Ali Khan and Meerovitch (1968) in 
indirect haemagglutination tests showed the converse. It is 
agreed, however, that both E. invadens and E. moshkovskii are more 
closely related antigenically to E. histolytica-like strains such 
as the Laredo and Huff strains (E. moshkovskii in particular) than 
they are to normal E. histolytica (Siddiqui and Balamuth, 1966; 
Krupp, 1966; Goldman and Cannon, 1968) reflecting their 
relationship in terms of ijn vitro culture characteristics.
It would be interesting to test E. histolytica-like strains with 
the panel of Mabs produced here to shed further light on the 
antigenic relatedness of the members of the quadrinucleate cyst 
group. In particular, such experiments may help to investigate a 
theory (de Carneri, 1968) that E. moshkovskii and Laredo-type 
strains originated from a common quadrinucleate cyst ancestor 
living in decaying organic matter and that E. invadens and 
E. histolytica evolved from this Laredo-type strain.
In summary, experiments with these Mabs have, demonstrated 
differences between octonucleate and quadrinucleate cyst groups of 
Entamoebae and within the latter have demonstrated a certain number 
of common antigens although results obtained with one isolate of 
E. hartmanni seem to contradict previous work.
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CHAPTER 4
ISOLATE SPECIFICITY OF MONOCLONAL ANTIBODIES
4.1 INTRODUCTION
The immunodiagnosis of a particular infectious disease normally relies 
on the successful detection of either antigen(s) or a host response to 
antigen(s) common to all isolates of the causative species. In some 
cases, where isolates of the organism are known to differ in their 
pathogenic capability, a more useful approach might involve antigens 
specific to those members of the species causing disease. Such a 
situation may occur in amoebiasis (see below).
Sargeaunt and his colleagues, by analysis of the isoenzyme profiles of 
trophozoites from thousands of asymptomatic and symptomatic cases 
around the world, have characterised at least 20 distinct zymodemes 
(Sargeaunt and Williams, 1978, 1979; Sargeaunt et al., 1982, 1987). 
Based on the serology and clinical status of the isolate source, these 
zymodemes have been grouped into two categories: pathogenic and 
non-pathogenic. Isolates belonging to non-pathogenic zymodemes are 
derived from asymptomatic carriers with negative serology, while the 
pathogenic zymodemes are usually found in patients with positive 
serology and a history of clinical symptoms. Sargeaunt has never 
reported the occurrence of a non-pathogenic zymodeme in conjunction 
with a pathogenic one in the same host (Sargeaunt, 1985). In 
longitudinal culture studies in the presence of bacteria from 
pathogenic or non-pathogenic zymodemes, no evidence of zymodemic 
alteration from pathogenic to non-pathogenic, or vice versa, could be 
demonstrated (Sargeaunt, 1985, 1987). Thus it has been proposed that 
isoenzymes are stable biochemical markers that distinguish two 
different E. histolytica subspecies and that patients harbouring 
^  non-pathogenic zymodemes require no drug treatment ( Lancet * 1985; 
Sargeaunt, 1987). A non-treatment policy is already in practice in
populations where the occurrence of infection with pathogenic 
zymodemes is rare, for example in male homosexuals in London 
(Allason-Jones et al., 1986; Goldmeier et al., 1986). This policy, 
and the "stable zymodeme" hypothesis underlying it, has been called 
into question by the findings of Mirelman et al. (1986) who detected 
virulence and zymodeme changes of cloned cultures during axenization. 
This phenomenon has been observed in other laboratories (B. Andrews, 
personal communication) and suggests that although harsh changes, such 
as those experienced by the amoebae during the axenization process, 
probably do not occur in vivo, the possibility for transformation 
within the host does exist. However the bulk of the epidemiological 
evidence does favour the "stable zymodeme/virulence" hypothesis and an 
immunodiagnostic test detecting such virulent amoebae would be an 
improvement over the need for isolation, culture and zymodeme 
analysis.
Thus comparison of the antigenic composition of different isolates of 
E. histolytica has been attempted by various workers in order to 
detect (a) antigens common to all isolates and (b) antigens specific 
for pathogenic isolates. Early work by Krupp (1966) using 10 
pathogenic isolates and 3 antisera in immunoelectrophoresis (IEP) 
produced 4 precipitin arcs common to all isolates. Later work (Krupp, 
1977) using 2 axenic isolates with 148 patient antisera in IEP, showed 
a common repertoire of 14 antigens recognised by patient sera (but not 
all sera) from a world-wide range of geographical locations.
Subsequent work by Chang et al. (1979) using 2-dimensional-IEP and 
Mathews et al. (1986) using EITB showed a large number of shared 
antigens between axenically-grown pathogenic strains. It should be 
noted that much of the reported work on the study of virulence and 
virulence-markers in E. histolytica has been performed comparing 
virulent axenic strains with so-called "avirulent" axenic strains 
which are, in fact, only less virulent members of pathogenic zymodemes
and were originally isolated from symptomatic patients (Trissl et al. 
1978; Mattern et al., 1978; Orozco et al. , 1980).
In this study, 19 monoclonal antibodies raised against axenically- 
grown E. histolytica strain 200:NIH, were used in IFAT experiments 
against a variety of both long-term and recent isolates of various 
zymodemes and differing geographical origin, in order to identify 
common and perhaps pathogen-specific antigens.
4.2 MATERIALS AND METHODS
4.2.1 Cells
Details of the isolates of E. histolytica used, including date of 
isolation, country of origin, patient status and isoenzyme 
characteristics are presented in Table 4.1. Characterisation of 
isoenzymes (Glucose phosphate isomerase - E.C.5.3.1.9, 
Phosphoglucomutase - E.C.2.7.5.1, L-Malate:NADP+ Oxidoreductase - 
E.C.l.1.1.40 and Hexokinase - E.C.2.7.1.2) and zymodeme classification 
was performed by P.G. Sargeaunt, Department of Medical Parasitology, 
London School of Hygiene and Tropical Medicine (Sargeaunt and 
Williams, 1979; Sargeaunt et al., 1982; Sargeaunt, 1987). In two 
cases where full isoenzyme characterisation was not performed, 
hexokinase mobility alone was analysed in agarose mini-gels (Strachan 
et al., 1988). Pathogenicity (ie., whether pathogenic or 
non-pathogenic) was determined according to the isoenzyme mobility 
pattern and clinical presentation of the patient (Sargeaunt, 1988).
Isolates 200:NIH (ATCC 30458), HK9 (ATCC 30015) and HM1:IMSS are all 
widely grown laboratory strains and were originally obtained from Dr 
L.S. Diamond, National Institutes for Health, Bethesda, Md.
The Loon Lake isolate of E. histolytica was provided by Dr Eileen 
Proctor, Department of Medical Microbiology, University of British 
Columbia, Vancouver, B.C. All four of these isolates were grown 
axenically in TYI-S-33 medium in this laboratory as described in 
Section 2.2.1.
The remaining isolates were grown with bacteria in Robinson's medium 
on agar slopes with rice starch (Robinson, 1968).
Six isolates with the prefix SAW were provided by P.G. Sargeaunt and 
originally isolated by Sargeaunt and J.E. Williams at the London 
School of Hygiene and Tropical Medicine.
Isolates MH651 and MH716 were isolated by P.G. Sargeaunt from stool 
samples obtained from male homosexual outpatients at the Middlesex 
Hospital, London.
Isolates SGH:1 and SGH:2 were provided by Dr H.V. Smith, Department of 
Bacteriology, Stobhill General Hospital, Glasgow. They were isolated 
from E. histolytica cyst-positive stools sent to the hospital for 
parasitological examination. Information on patient history and 
possible sources of infection was not available.
Isolate PRC:1 was provided by Professor W. Hu and Dr T. Zhang,
Division of Infectious Diseases, Department of Medicine, 2nd Hospital 
of Tianjin Medical College, Tianjin, Peoples' Republic of China. The 
cells were sent as methanol-fixed smears on microscope slides, stored 
with desiccant. Information on patient status and isolate 
pathogenicity was not available.
Isolates C29 and MP:1 were provided by Dr J.P. Ackers, Department of 
Medical Parasitology, London School of Hygiene and Tropical Medicine.
4.2.2 IFAT experiments
Axenically-grown isolates were prepared for IFAT as described in 
Section 2.2.2.7. Isolate PRC:1 was prepared as stated. All other 
isolates grown in Robinson's medium were prepared at source. Samples 
were withdrawn from the bottom of the agar slope by pipette and gently 
mixed to suspend amoebae. Drops of this suspension were then placed 
in wells of multispot slides and left to air dry. After fixation in 
Methanol (5 min) the slides were stored desiccated at -22 °C.
For isolates 200:NIH, HK9, HM1 and Loon Lake full titrations of the 
Mabs were performed using lo<Jg dilutions from 1 to 12 (ie. 1/3 to 
1/531441). For all other isolates, ascitic fluids containing Mabs 
were used at two log^ dilutions above endpoint dilution determined 
using strain 200:NIH as antigen.
After warming the slides to room temperature, 5 pi quantities of 
ascitic fluid dilution were added to wells and the slides processed as 
described in Section 2.2.2.7. Negative controls used were (a) Mouse 
monoclonal GUPM 18.2 raised against Trypanosoma brucei rhodesiense 
variant surface glycoprotein used at 1/50, followed by FITC conjugate, 
and (b) FITC conjugate alone. Esqperiments were repeated at least 
once.
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4.3 RESULTS
IFAT experiments with 19 Mabs were performed using 17 different 
isolates of E. histolytica. Mabs 29.5 and 29.9, previously found to 
recognise antigens in a variety of unrelated cell types (Chapter 3), 
were not used in these experiments. No amoebae were fluorescent with 
either of the negative controls although in some isolates, fluorescent 
bacteria were observed with both controls. The results of these 
experiments are summarised in Table 4.2. Where a negative result was 
obtained, the Mabs were tested at a series of lower dilutions to 
confirm. This was not possible with isolates SAW 142 and SAW 1719 due 
to the small number of slides available and the low number of amoebae 
on each slide.
Thirteen of the Mabs (22.4, 22.7, 22.8, 24.1, 24.2, 24.4, 24.5, 24.6, 
24.7, 24.8, 29.3, 29.10 and 29.11) gave positive results with all 
isolates tested. In all cases the fluorescent patterns observed were 
identical to those obtained with strain 200:NIH (Section 2.3.2) 
although the presence of large food vacuoles in polyxenically-grown 
amoebae occasionally interfered with the pattern. Mab 22.7 continued 
to stain only around 90% of cells and the pattern observed was one of 
internal vacuolar fluorescence. No plasma membrane fluorescence was 
observed.
Mab 22.1 gave positive results in all isolates except SGHrl where, in 
repeated experiments, no fluorescent cells were seen. In most cases 
plasma membrane fluorescence was observed, similar to that seen in 
strain 200:NIH (Section 2.3.2), but in isolates MP:1 and C29 some of 
the cells showed a general internal fluorescence, similar to the 
internal diffuse pattern obtained using Mab 24.6 for example.
Mab 22.6 failed to label cells in isolates MP:1 and SAW 142. In the 
remainder of the isolates, plasma membrane fluorescence was observed
although in isolates SAW 1760 and SAW 1774, cells showing internal 
fluorescence without membrane fluroescence were observed.
Mab 29.6 failed to label cells in isolates SAW 1719, SAW 142 and 
SGH:1. Plasma membrane fluroescence was observed in most of the 
remaining isolates, although in isolates MP:1 and SAW 1766 internal 
fluorescence was observed in some of the cells. In isolate C29 no 
plasma membrane fluorescence was observed and all positive cells 
showed only diffuse internal fluorescence. IFAT experiments using 
live amoebae to confirm the surface localisation of the antigens 
concerned were not performed using these isolates of E. histolytica.
With all three of these Mabs (22.1, 22.6 and 29.6) only a percentage
of cells were positive, whether showing surface or internal 
fluorescence. This was true of all isolates tested where positive 
cells were observed. The actual percentage of cells stained varied
considerably between isolates. Unfortunately, accurate determination
of these values was not possible in isolates SAW 1766, SAW 1719 and 
SAW 142 due to the very low numbers of cells present on the microscope 
slides. Among the polyxenically-grown isolates: Mab 22.1 staining 
ranged from 96% in MH 716 to 36% in SAW 1760 and indeed even lower in 
SAW 142. Mab 22.6 staining ranged from 37% in SAW 1760 to < 0.1% in
SAW 408. Mab 29.6 staining ranged from 69% in SAW 1774 to 3% in
SAW 408. Among the axenically-grown isolates the percentages of 
positive cells were generally higher: Mab 22.1 stained just below 100% 
of cells in all four isolates. Mab 22.6 staining ranged from 98% in 
one sample of 200:NIH to 48% in HK9. Mab 29.6 staining ranged between
74% in HK9 to 17% in 200:NIH.
Mabs 22.3, 22.5 and 24.3 were the only antibodies recognising purely 
internal antigens that failed to stain all isolates tested. Mab 24.3 
gave positive results with all isolates except SGH:2. Mab 22.3 failed 
to recognise C29, MH 651, MH 716, PRC:1 and SGH:1. Mab 22.5 failed to
100
recognise these five isolates and in addition failed to recognise 
SAW 1719 and SAW 142.
End point Mab titres were obtained using isolates HK9, HM1:IM55 and 
Loon Lake (data not shown) and were found to be within one log^ 
dilution of these obtained using 200:NIH.
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TABLE 4.1
Information on isolates used in experiments.
Assigned Pathogenicity Status inferred by Zymodeme/Hexokinase Mobility. 
AbbreviationsrNIH - National Institutes of Health, Bethesda, Ma., USA.
LSHTM - London School of Hygiene and Tropical Medicine, 
Keppel St., London.
SGH - Stobhill General Hospital, Glasgow.
TMS - Tianjin Medical School, Tianjin, Peoples 
Republic of China.
UBC - Dept, of Medical Microbiology, University of 
British Columbia, Canada.
HK - Hexokinase 
P - Pathogenic 
NP - Non-Pathogenic
N.A.- Information not available 
N.D.- Not Done
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4.4 DISCUSSION
The detection and study of differences between isolates from 
asymptomatic and symptomatic hosts of E. histolytica from different 
geographical regions, is important in increasing our understanding of 
the pathogenesis and epidemiology of amoebiasis (Guerrant, 1986). 
Monoclonal antibodies represent specific tools for use in such a study 
and may subsequently be useful as a basis for an immunodiagnostic 
test.
In a large study of E. histolytica antigens Krupp (1977) used 148 
patient sera from Africa, Asia, Central America and Canada in IEP with 
axenic amoebae as antigen. One particular precipitin arc was produced 
using all sera while up to thirteen other arcs occurred less 
regularly. From this work, it is difficult to draw conslusions on the 
antigenic composition of the amoebae originally stimulating the 
response in the patient since, as the author states, individual 
response to infection must vary with length of exposure to infection, 
repeated amoebic infections, concurrent infections and nutritional and 
genetic factors. In her earlier study, Krupp (1966) had demonstrated 
antigenic differences between pathogenic E. histolytica isolates and 
the non-pathogenic E. histolytica-like Huff and Laredo strains but non 
pathogenic E. histolytica isolates from asymptomatic patients were not 
tested.
In this study 19 monoclonal antibodies raised against axenically-grown 
strain 200:NIH (in culture since 1949) were used in IFAT experiments 
against 3 other long-term cultured axenic isolates and 13 more recent 
isolates grown with mixed intestinal flora. The amoebae were isolated 
in S.E. Asia, N.E. Asia, India, Australia, Central America, Canada and 
the U.K., although the exact origin of 5 of the U.K. infections is not 
known since at least 3 of the source patients were known to have 
travelled widely. However, the isolates obtained from male 
homosexuals in London are thought to be indigenous infections. The 
unavailability of African isolates for testing was unfortunate, since
approximately 17% of the world's infections occur in this continent 
(Walsh, 1986). Nine of the isolates were designated as pathogenic and 
six as non-pathogenic based on the clinical status of the patient from 
which they were obtained, and their isoenzyme profile. Full isoenzyme 
characterisation of isolate SGH:1 was not performed but the advanced 
bands of hexokinase (fast HK) obtained in agarose mini-gels were 
concluded to indicate its pathogenic nature (Mirelman et al., 1986).
In general, there was little variation in Mab reactivity between 
strains, with 13 out of the 19 Mabs reacting with all isolates. 
Unfortunately end point titre values for each Mab with each isolate 
were not obtained due to the scarcity of antigen slides of many of the 
isolates. This was particularly true for isolates SAW 142, SAW 1719 
and SAW 1766 where only a few poorly-fixed amoebae were present in 
each well, since the cultures from which these samples were taken were 
old (late stationary phase). End point titre values would have 
provided more detailed information on isolate differences but would 
have been difficult to interpret since titre variation can be caused 
by both differences in the epitope structure and differences in 
antigen concentration. It is possible, that by developing Mabs using 
200:NIH as immunising antigen, antibodies against antigens common to 
all isolates were being selected for. Prolonged culture of E. 
histolytica is thought to result in the disappearance or masking of 
certain antigens (Bos, 1978) and it is interesting to note that the 
three axenically-grown isolates had Mab endpoint titres in IFAT 
experiments similar to 200:NIH. These four isolates, and 
polyxenically-grown SAW 408, show an identical pattern of reactivity 
with the panel of Mabs and are all members of zymodeme II. Though 
this result may be significant, no other correlation between Mab 
reactivity and zymodeme was noticed. There is also evidence to 
suggest that the zymodeme to which an amoeba belongs is not a stable 
characteristic. Aside from the non-pathogenic to pathogenic 
transformation reported by Mirelman et al. (1986) under severe 
artificial conditions, Gathiram and Jackson (1987) suggest that the 
zymodeme changes (within the pathogenic group) observed in
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longitudinal studies of asymptomatic patients were due to a change in 
amoebic isoenzyme expression occurring in vivo (and probably not due 
to mixed infection or re-infection).
Variation in isolate reactivity was observed with the surface-specific 
Mabs, with 22.1 failing to react with one isolate, 22.6 failing to 
react with two isolates and 29.6 failing to react with three isolates. 
However all these Mabs stained only a percentage of cells in each
experiment (as previously discussed in Chapter 2). Thus, failure to
react may be due to failure to detect a low percentage of cells 
expressing antigen; for example with SAW 408, only 2 fluorescent cells 
were counted out of at least 3000 observed. Therefore the results of 
such experiments must be interpreted with caution especially with 
isolates SAW 142, SAW 1719 and SAW 1766 where a total of under 50 
cells were observed in experiments using each Mab. A similar 
explanation may account for the failure to detect cells stained with 
Mab 22.7 demonstrating plasma membrane fluroescence as observed with 
very small numbers of 200:NIH cells in Chapter 2.
No correlation was observed between percentage of cells stained and
pathogenicity, with different pathogenic isolates showing both low and 
high percentage staining with all surface-specific Mabs. Indeed the 
large variation in percentage staining between isolates further 
supports the theory that the variations in expression observed in 
Chapter 2 are not due to single cell cycle events but perhaps due to 
cell sub-populations in the cultures as occurs in Trichomonas 
vaginalis (Alderete et al., 1987) and in Giardia lamblia (Nash, 1988).
The internal (non-membrane) fluorescence observed in some cells in 
certain isolates in experiments with 22.1, 22.6 and 29.6 suggests that 
in some cases the antigen is present, but not expressed on the plasma 
membrane. This phenomenon has been reported in T. vaginalis by 
Alderete et al. (1986a) where a sub-population of cells, negative in 
live fluorescence experiments, were found to contain the protein 
detected in lysates using a Mab in EITB experiments. Amoebae showing
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surface fluorescence would also be expected to contain the antigen 
internally, either in the cytoplasm or in elements of the vesicular 
system, since it must be synthesised within the cell. However such 
internal staining would be masked by the surface fluorescence. 
Immunogold experiments, as suggested in Section 2.4, would perhaps 
provide more detailed information on surface antigen localisation and 
synthesis.
The failure of Mab 24.3 to recognise isolate SGH:2 is suprising since 
this monoclonal gave positive results with all other E. histolytica 
isolates and with E. coli, E. muris and E. moshkovskii (Chapter 3).
Of the other Mabs recognising internal antigens, only 22.3 and 22.5 
failed to react with some of the isolates. Failure of both 22.3 and 
22.5 to react coincided in 5 isolates while only 22.5 failed to react 
with SAW 142 and SAW 1719. Interestingly, 6 of these 7 isolates have 
been designated as non-pathogenic by virtue of their isoenzyme 
characteristics and, except in the case of SGH:1, the clinical status 
of the source-patient. Mabs 22.3 and 22.5 both reacted with all 
pathogenic isolates used. It seems therefore, that 22.5 staining 
correlates perfectly with pathogenicity for all isolates where 
pathogenic/non-pathogenic status has been determined. Based on this, 
it could be suggested that isolate PRC:1 might belong to 
non-pathogenic zymodeme, although this information was not available. 
The correlation of 22.3 staining and pathogenicity is not perfect 
since this Mab recognises two non-pathogenic isolates. However the 
correlation of 22.3 and 22.5 IFAT results in thirteen out of fifteen 
isolates suggests that further investigation is required. Subsequent 
work using both 22.3 and 22.5 is presented in this thesis in 
Chapter 7.
The reactivity of E. histolytica-specific Mabs with various isolates 
of the species has not been extensively reported by other workers. 
Ortiz-Ortiz et al. (1986) found Mab MC 004 reacted with four 
axenically-grown strains of E. histolytica but not with the E. 
histolytica-like Laredo strain. Torian et al. (1989), using a Mab
1 *. in
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against a 96 KD surface membrane antigen, were able to purify the 
antigen from 4 axenically-grown isolates and could detect it in 
several polyxenically-grown pathogenic and non-pathogenic clinical 
isolates.
A panel of nine Mabs raised against Trichomonas vaginalis have been 
used in IFAT experiments to examine antigenic heterogeneity in a total 
of 88 isolates from four cities in the United States (Krieger et al., 
1985). The individual antibodies reacted with between 22% and 76% of 
the isolates although some antibodies recognised none out of 15 
isolates from one particular location indicating substantial 
geographical variation in antigenic composition. In contrast, the 
work reported here with E. histolytica shows quite a high degree of 
antigenic similarity and relatively little geographical variation.
From this work it is clear that the surface-specific Mabs, 22.1, 22.6 
and 29.6, are not suitable individually for use in an immunodiagnostic 
test, since expression of the corresponding antigens is so variable. 
Apart from Mab 22.4 which recognises commensal species of Entamoeba 
(Chapter 3), the other 12 of the 13 Mabs reacting with all isolates 
tested may be suitable for use in an assay detecting both pathogenic 
and non-pathogenic types of E. histolytica.
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CHAPTER 5 IMMUNOCHEMICAL ANALYSIS OF ANTIGENS
5.1 INTRODUCTION
Until the advent of techniques for the axenic cultivation of 
E. histolytica (Diamond, 1961; Diamond, 1968; Diamond et al., 1978) 
attempts to characterise the antigenic composition of the amoeba gave 
unsatisfactory results because trophozoites were grown in association 
with intestinal bacteria or other protozoa (Sen et al., 1961b).
Early work using immunoelectrophoresis (IEP) revealed 6-8 distinct 
precipitin bands with rabbit antiserum (Lunde and Diamond, 1969). 
Later, Krupp (1977) detected a basic pattern of 14 antigens reacting 
with sera from patients from different geographical locations. The 
use of 2-dimensional immunoelectrophoresis by Chang et al (1979) 
provided an increase in resolution and detected up to 32 precipitin 
peaks using immune rabbit antisera.
Homogenates of axenic trophozoites have also been subjected to column 
chromatographic fractionation, with the main serological activity, as 
detected by immunodiffusion and indirect haemagglutination, being 
present in the high molecular weight fractions (Sawhney et al., 1980). 
Protection against infection in hamsters and guinea-pigs (by 
intrahepatic inoculation) can be induced most effectively by these 
fractions (Ghadirian et al., 1980; Sawhney et al., 1980).
Polyacrylamide gel electrophoresis in the presence of sodium dodecyl 
sulphate (SDS-PAGE) is perhaps the most widely used single method of 
protein analysis. Introduced by Shapiro et al. in 1967 and modified 
by Laemmli in 1970, it has since been used in numerous studies 
involving the characterisation of many proteins, including the 
antigens of E. histolytica. When proteins are heated to 100 °C for 
2-5 min in the presence of SDS and reducing agents they unfold and 
bind approximately 1.4 g SDS per gram of protein. The unfolding is 
probably not complete and a considerable degree of secondary structure
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is likely to be retained. The native charge of the protein is however 
masked by the strong negative charge so that the mass:charge ratio 
becomes constant for virtually all proteins and the electrophoretic 
mobility in acrylamide is inversely proportional to the logarithm of 
the molecular weight (Weber and Osborne, 1969).
SDS-PAGE of E. histolytica homogenates (Aust-Kettis et al., 1983;
Mathews et al., 1986) and detergent lysates (Joyce and Ravdin, 1988)
stained for total protein have revealed up to 60 recognisable bands
(Aust-Kettis et al., 1983) all within a 10-200 kD apparent molecular
weight range. In a detailed study of plasma membrane proteins
Rosenberg and Gitler (1984) identified 34 proteins, ranging from 13 to
205 kD, of which 16 were externally exposed (ie. could be labelled 
125using I-lactoperoxidase).
Attempts have been made to identify the clinically relevant antigenic 
components of E. histolytica by various methods. Parkhouse et al. 
(1978) used patient sera to immunoprecipitate membrane glycoproteins, 
identifying 1 major and 3 minor bands on SDS-PAGE. Using 
immunoadsorption (involving purified patient IgG covalently bound to 
CNBr-Sepharose) Aust-Kettis et al. (1983) identified 7 antigens in 
trophozoite homogenates. Most other studies have used electroimmuno- 
transfer (or "Western") blotting in which proteins are probed with 
antibody after electrophoretic separation. ' The heterogeneous mixture 
of proteins is separated by SDS-PAGE and the proteins eluted electro- 
phoretically by a transverse electric field onto a membrane which 
binds protein tightly, most commonly nitrocellulose (Towbin et al., 
1979). The membrane is then probed with either labelled antibody, or 
antibody followed by a labelled second antibody. Aust-Kettis et al. 
(1983) detected 11 antigens recognised by rabbit immune serum and 8 
using human patient serum of which 7 were surface membrane antigens. 
Mathews et al. (1986) probing with human serum, detected at least 20 
distinct bands in a soluble (cytosol) fraction alone and a lower 
number of more reactive bands in internal and plasma membrane 
fractions.
In this work antigens of E. histolytica were analysed by SDS-PAGE and 
electroimmunotransfer blotting (EITB) using the 21 monoclonal 
antibodies described in Chapter 2.
5.2 MATERIALS AND METHODS
5.2.1 Cells
E. histolytica: Strain 200:NIH and the Loon Lake isolate were used in
these experiments. Both were grown in TYI-S-33 medium at 35.5 °C in 
Lux plastic tissue culture tubes (Flow, Irvine).
E. invadens: The LSH isolate, described in Section 3.2, was used in
these experiments. Cells were grown axenically, in TYI-S-33 medium at 
25 °C in plastic tissue culture tubes.
5.2.2 Preparation of Lysates
This method was used for both E. histolytica and E. invadens. Tubes
containing amoebae in late log phase growth were cooled for 5 min in
ice water then gently inverted several times to dislodge adherent
cells. Following centrifugation at 200 g for 5 min the amoebae were
washed twice in PBS (pH 7.45) (see Section 2.2.3) and finally
6resuspended in ice cold PBS at a concentration of 4 x 10 /ml.
A solution of 1% (w/v) Nonidet P40 (BDH, Poole) in PBS containing 1 mM 
ethylenediamine tetra-acetic acid (EDTA) and 1 mM iodoacetic acid 
(IAA) was cooled on ice. Immediately prior to use, 1 pi of a 0.1 M 
solution of phenylmethylsulphonyl fluoride (PMSF) in acetone was added 
per 0.5 ml of detergent solution. Equal volumes of cell suspension 
and detergent solution were gently mixed in a glass centrifuge tube by 
pipette and incubated on ice for 15 min. The mixture was then 
centrifuged at 200 g for 5 min at 4 °C and the supernatant removed and 
centrifuged in an ultracentrifuge at 11800 g for 5 min at 4 °C. The 
supernatant was stored at -22 °C.
5.2.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE)
SDS-PAGE was performed essentially as described by Laemmli (1970) 
using 7.5%, 10% and 5-15% - gradient separating gels and 5% stacking 
gels. Gels were run under both reducing and non-reducing conditions.
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Sample Buffer - Reducing:
62 mM Tris-HCl (pH 6.8)
2% (w/v) SDS
7.5% (w/v) Glycerol
5% (v/v) 2-Mercaptoethanol
0.02% (w/v) Bromophenol Blue
Sample Buffer - Non-Reducing:
62 mM Tris-HCl (pH 6.8)
2% SDS
7.5% Glycerol
10 mM Iodoacetamide
0.02% Bromophenol Blue
NP40 lysate samples (and samples of TYI-S-33) medium were diluted 1 in 
4 in appropriate sample buffer and boiled for 10 min prior to 
electrophoresis. If both non-reduced and reduced (ie. molecular 
weight markers) samples were electrophoresed in the same gel a 1/10 
volume of 1.5 M iodoacetamide was added to the reduced samples after 
boiling to destroy excess reducing agent. Samples were 
electrophoresed at approximately 10-15 V/cm length of gel (30 mA) 
until the dye front had reached the bottom of the gel.
Molecular weight markers used in these experiments were obtained from 
Sigma (Poole).
Myosin 205 kD
(3-Galactosidase 116 kD
Phosphorylase B 97.4 kD
Bovine Albumin 66 kD
Egg Albumin 45 kD
Carbonic Anhydrase 29 kD
Trypsinogen 24 kD
(3-Lactoglobulin 18.4 kD
Lysozyme 14.3 kD
1 i 4
Gradient gels (5-15%) were fixed and stained for total protein with 
Coomassie Brilliant blue 0.25% (w/v) in 45% (v/v) methanol, 10% (v/v) 
glacial acetic acid overnight at RT. Gels were destained in 25% (v/v) 
methanol, 7.5% (v/v) glacial acetic acid until a clear background was 
obtained. Gels were dried in a vacuum gel drier.
5.2.4 Electro-imniinotransfer blotting (EITB)
Following SDS-PAGE, the separate proteins were electrophoretically 
transferred onto nitrocellulose paper (Biorad) according to the method 
of Towbin et al. (1979). The transfer was performed at 60 V, 0.21 A 
for 5 hr in a Tris/ Glycine/Methanol buffer:
Tris 9.09 g
Glycine 43.2 g
Methanol 600 ml
distilled water 2.4 1 (pH 8.2)
Following transfer the nitrocellulose sheet was incubated overnight at
4 °C in 0.1 M Tris-HCl (pH 7.6) containing 13% (w/v) glycine to block 
spare protein-binding sites on the paper. The sheet was then cut into
5 mm-wide strips. Strips bearing transferred molecular weight markers 
and one strip of transferred lysate proteins were stained for total 
protein in 0.5% (w/v) amido black prepared in 5% (v/v) acetic acid 50% 
(v/v) methanol for 5 min. Following 1 min'washing in water the strips 
were destained in 5% (v/v) acetic acid 50% (v/v) methanol until a 
clear background was obtained. The remainder of strips, bearing 
transferred lysate proteins, were incubated in 1/100 dilutions of 
Ascitic fluids in 0.1 M Tris-HCl (pH 7.6) containing 2% (w/v) glycine 
(diluting buffer) for 30 min at RT with gentle agitation. Following 
washing for 30 min in 3 x 50 ml of 0.1 M Tris-HCl (pH 7.6) containing 
0.1% (v/v) Triton-X 100 (Sigma, Poole) (wash buffer) the strips were 
incubated in diluting buffer containing 1/250 horseradish 
peroxidase-conjugated goat anti-mouse antibody (HRP-GAM) (SAPU, Law 
Hospital, Lanark) for 30 min at RT. Following 30 min washing in wash
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buffer, antibody binding was visualised by treating the strips with a 
solution of peroxide containing 4-chloro-l-napthol (0.018% (w/v) 
4-chloro-l-napthol in 6% methanol in wash buffer plus 0.025 ml 40%
H202 per 100 ml). The reaction was stopped by rinsing the strips in 
several changes of dH20. HRP-GAM-treated strips and amido 
black-stained strips were photographed using Ilford FP4 125 ASA plate 
film. Controls included a) strips incubated in a 1/100 dilution of a 
Mab raised against Plasmodium chabaudi followed by conjugate b) strips 
incubated in conjugate alone and c) strips subjected to chloronapthol 
colour development only.
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5.3 RESULTS
5.3.1 SDS-PAGE
Proteins in NP-40 lysates of E. histolytica (strain 200:NIH) and 
E. invadens (isolate LSH) were separated by polyacrylamide gel 
electrophoresis under reducing conditions on 5-15% gradient gels. The 
approximate molecular weights of visible bands were calculated, using 
the known molecular weights of marker proteins, and are presented in 
Table 5.1. The protein profiles of the two species showed several 
bands of similar intensities at similar or identical molecular 
weights. In both species the bulk of proteins detectable by this 
method had molecular weights in the range 20-130 kD. The most 
prominent protein bands within the lysates of E. histolytica had 
approximate apparent molecular weights of 130 kD, 102 kD, 53 kD,
49 kD, 42 kD and 20 kD.
5.3.2 Electroiimniinotransfer Blotting (EITB)
5.3.2.1 EITB using E. histolytica antigens
All 21 Mabs were used to probe nitrocellulose blots of 200.-NIH whole 
cell NP40 lysates previously electrophoresed on 7.5% and 10% polyacryl­
amide gels. The apparent molecular weights obtained under reducing 
(i.e. with mercaptoethanol) conditions are presented in Table 5.2. 
Fourteen of the Mabs recognised antigens in' these experiments (Plates
5.1 and 5.4). The antigens detected ranged in apparent molecular 
weight from 12 to 190 kD with the majority around 100 kD. Of the Mabs 
recognising surface antigens in intact amoebae, only 22.1 detected 
bands of protein on these blots. This Mab detected one band at 
approximately 58 kD (the most intense band), one at 95 kD and several 
high molecular weight bands greater than 300 kD (Plates 5.1 and 5.2). 
This Mab also consistently produced a smear of stain on blots between 
the high molecular weight bands and the 58 kD band. Mab 29.11 
similarly detected multiple bands at 12 kD, 16 kD and 45 kD (Plates
5.2 and 5.4). The remaining twelve Mabs detected single bands of
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E. histolytica E. invadens
230 ...................................  230
1 3 0 ................................. 125
1 0 2  102
74
72
6 0  60
5 3 ................................ 52
4 9 ................................ 48
4 2 ................................ 41
39.5   39.5
3 5 ................................ 36
3 3 ................................ 33
29
28.5
25
24
23
22
21
20 20
18.5
17
16
15 . , 
14
15
TABLE 5.1: Approximate apparent molecular weights (kD) of major
proteins of E. histolytica and E. invadens NP40 lysates, detectable by 
Coomassie Blue staining of SDS-Polyacrylamide 5-15% gradient gels run 
under reducing conditions. The weights of the most prominent bands 
are underlined. Bands, apparently related in terms of staining 
intensity and similar molecular weights are shown joined by dotted 
lines.
1
protein. Mabs 22.8, 24.2 and 24.4 all detected bands of 100 kD. The 
intensity of the staining and thickness of the band was identical 
using Mabs 24.2 and 24.4 but different with 22.8 which recognised a 
thinner band (Plate 5.2). Mabs 24.5, 24.7 and 24.8 all recognised 
bands of 97 kD that were identical in thickness and intensity of 
staining (Plates 5.2 and 5.3). Mabs 22.4, 22.7, 24.3, 29.3 and 29.9 
recognised single bands at 115 kD, 190 kD, 130 kD, 120 kD and 125 kD 
respectively. A photograph of the protein band recognised by Mab 29.9 
is not shown.
When the SDS-PAGE was performed under non-reducing conditions only 
4 Mabs recognised bands on the corresponding blots (Plate 5.5).
However in the two experiments performed under these conditions the 
resolution of protein bands was not good (Total protein Eh track in 
Plate 5.5). Mab 22.4 recognised a protein of 230 kD. Mabs 24.2 and
24.4 both recognised a band at 100 kD and Mab 29.3 recognised a band 
at 120 kD.
5.3.2.2 EITB using E. invadens antigen
All 21 Mabs were used to probe nitrocellulose blots of LSH whole cell 
NP40 lysates previously electrophoresed on 7.5% polyacrylamide gels 
under reducing conditions. Only one Mab gave a positive result:
Mab 29.3 recognised a band at 120 kD (Plate 5.6).
1 I 0
GUPM NO. (and subclass) MOLECULAR WEIGHT (kD)
22.1 (G2b) 58
22.3 (Gl) -
22.4 (Gl) 115
22.5 (Gl) -
22.6 (M) -
22.7 (Gl) 190
22.8 (Gl) 100
24.1 (Gl) -
24.2 (Gl) 100
24.3 (Gl) 130
24.4 (Gl) 100
24.5 (Gl) 97
24.6 (G2a) -
24.7 (Gl) 97
24.8 (Gl) 97
29.3 (Gl) 120
29.5 (M) -
29.6 (M) -
29.9 (M) 125
29.10 (Gl) -
29.11 (Gl) 12
95 ( + 3 HMW bands >300 )
16 45
TABLE 5.Z : APPROXIMATE APPARENT MOLECULAR WEIGHTS 
(KILODALTONS) OF ANTIGENS OF ENTAMOEBA HISTOLYTICA 
(STRAIN 200:NIH) DETECTED USING MONOCLONAL ANTIBODIES 
ON NITROCELLULOSE BLOTS OF WHOLE CELL LYSATES FOLLOWING 
SDS-PAGE (REDUCING CONDITIONS).
PLATE 5.1
ELECTROIMMUNOTRANSFER BLOT (EITB) following SODIUM DODECYL SULPHATE 
POLYACRYLAMIDE GEL ELECTROPHORESIS (sds-PAGE) (10% gel-reducing 
conditions) of E. histolytica strain 200:NIH lysate.
Eh - Nitrocellulose strip stained for total protein with amido 
black (0.5%w/v).
22.4 - Strip probed with GUPM 22.4
22.8 - Strip probed with GUPM 22.8
22.1 - Strip probed with GUPM 22.1
Approximate molecular weight values in kilodaltons.
Eh 22.4 2 2.8 2 2.1
205 -
116-
97.4-
66-
4 5 -
29 -
24-
- 2 0 5
-1 1 6
- 97.4
-66
- 4 5
- 2 9
- 2 4
PLATE 5.2
EITB following SDS-PAGE (7.5% gel-reducing conditions) of 
E. histolytica strain 200:NIH lysate.
Eh - Strip stained for total protein with amido black (0.5%w/v)
22.1 - Strip probed with GUPM 22.1
22.8 - Strip probed with GUPM 22.8
24.2 - Strip probed with GUPM 24.2
24.3 - Strip probed with GUPM 24.3
24.4 - Strip probed with GUPM 24.4
24.5 - Strip probed with GUPM 24.5
24.7 - Strip probed with GUPM 24.7
24.8 - Strip probed with GUPM 24.8
29.3 - Strip probed with GUPM 29.3
29.11 - Strip probed with GUPM 29.11
Approximate molecular weight values in kilodaltons.
n1 «>-iL h>
PLATE 5.3
EITB following SDS-PAGE (10% gel-reducing conditions) of 
E. histolytica strain 200:NIH lysate.
Eh - Strip stained for total protein with amido black (0.5% w/v)
22.4 - Strip probed with GUPM 22.4
22.7 - Strip probed with GUPM 22.7
22.8 - Strip probed with GUPM 22.8
24.5 - Strip probed with GUPM 24.5
24.7 - Strip probed with GUPM 24.7
24.8 - Strip probed with GUPM 24.8
Approximate molecular weight values in kilodaltons.
Eh
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116-
97.4-
66-
22.4 22.7 22.8 24.5 24.7 24.8
- 2 0 5
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PLATE 5.4
EITB following SDS-PAGE (10% gel-reducing conditions) of 
E. histolytica strain 200:NIH lysate.
Eh - Strip stained for total protein with amido black (0.5% w/v)
29.3 - Strip probed with GUPM 29.3
29.11 - Strip probed with GUPM 29.11
Approximate molecular weight values in kilodaltons.

PLATE 5.5
EITB following SDS-PAGE (7.5% gel - non-reducing conditions) of 
E. histolytica strain 200:NIH lysate.
Eh - Strip stained for total protein with amido black (0.5% w/v)
22.4 - Strip probed with GUPM 22.4
24.2 - Strip probed with GUPM 24.2
24.4 - Strip probed with GUPM 24.4
29.3 - Strip probed with GUPM 29.3
Approximate molecular weight values in kilodaltons
Eh 22.4 24.2 24.4 29.3
2 0 5 - - 2 0 5
1 1 6 -
9 7 .4 -
-1 1 6
-9 7 .4
66- -66
PLATE 5.6
EITB following SDS-PAGE (7.5% gel-reducing conditions) of 
E. invadens, LSH strain, lysate.
Ei - Strip stained for total protein with amido black (0.5% w/v)
29.3 - Strip probed with GUPM 29.3
Approximate molecular weight values in kilodaltons

5.4 DISCUSSION
The electrophoretic patterns of proteins from detergent lysates of 
axenically grown E. histolytica and E. invadens were analysed by 
SDS-PAGE and certain individual antigens recognised by Mabs in EITB 
("Western-blotting"). It must be stressed at this point that the 
molecular weights described here are "apparent molecular weights" and 
since inaccuracies in estimations occur, especially in the case of 
glycosylated proteins (Goding, 1986), comparisons between antigens 
detected here and those reported by other workers are made only 
tentatively.
Gradient polyacrylamide gels stained with Coomassie Blue for total 
protein revealed 22 distinct bands for E. histolytica and 15 bands for 
E. invadens all in the range 14-230 kD apparent molecular weight.
There were twelve protein bands, in both species, that appeared to 
correspond in terms of similar apparent molecular weight and intensity 
of staining; this further supports the existence of substantial 
interspecific antigenic cross-reaction discussed in Chapter 3.
A number of the more prominent bands observed here with E. histolytica 
do seem to have possible counterparts in other reports. Both Aley et 
al. (1980) and Aust-Kettis et al. (1983) detect major bands at 130 kD, 
100 kD, and several between 43-48 kD similar to those described 
here.
Using the 21 Mabs in EITB, it was found that 14 of these recognised 
antigens on nitrocellulose immune replicas of E. histolytica lysates 
following SDS-PAGE under reducing conditions. There are various 
reasons why 7 Mabs failed to react in these experiments. Firstly, the 
relevant antigens may not have been present in the detergent lysates 
produced. Although Nonidet-P40 is thought to solubilize most proteins 
(Goding, 1986; Johnstone and Thorpe, 1982) there are certainly some 
antigens of E. histolytica that would not be present in these lysates. 
Additionally some antigens may be glycolipids, such as the aminoglyco- 
phospholipid isolated by Calef and Gitler (1984), which would probably
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be absent from detergent lysates. It is possible that the antigens 
against which Mabs 22.6 and 29.6 are directed are lipid-based 
molecules, such as those located within the plasma membrane.
Secondly, the relevant antigen may be present on the nitrocellulose 
but in a denatured form such that the conformational determinant is 
not recognised by the monoclonal antibody. This inability to detect 
SDS-denatured antigen has been reported by several authors (Turner, 
1983; Conelly et al., 1985). It is thought that during EITB as the 
protein binds to the nitrocellulose, much of the denaturing SDS 
continues to the anode allowing the protein to regain more of its 
native configuration (Goding, 1986), but removal of all SDS would be 
unlikely. It is to be expected that a certain proportion of Mabs 
raised against native antigens will not recognise SDS-denatured 
antigen in EITB, but since the screening method utilised here required 
that the Mabs be capable of recognising antigen fixed in methanol, 
this perhaps lowered that proportion (Goldstein et al., 1982). Three 
out of the four IgMs among the Mabs did not give results in EITB, 
reflecting perhaps the lower affinity binding of this subclass failing 
to recognise partially denatured antigen.
Mab 22.1 detected several bands on blots as well as a smear of 
staining between the bands. Multiple bands in EITB have been reported 
by other workers (Ortiz-Ortiz et al., 1986) and a number of underlying 
explanations are possible: (a) The Mab may be recognising common 
determinants (especially if carbohydrate) 'on a series of related cell 
proteins or on subunits (separated under the reducing conditions) of 
one protein. (b) The Mab may be recognising the products of 
degradative proteolysis of a protein by the amoeba's own proteinases 
during production of the lysate. This phenomenon has been reported by 
Reichlin (1975) with human serum albumin. (c) The Mab may be 
recognising precursors of a protein during biosynthesis and processing 
in the cell as reported by Holder and Freeman (1982) for an antigen of 
Plasmodium falciparum. Since Mab 22.1 recognises an antigen expressed 
on the surface of the amoeba and also internally in some cells 
(Chapter 4), it is possible that these bands may represent stages, 
from synthesis within the cytoplasm to expression at the plasma
membrane. Analysis of purified plasma membrane and other subcellular 
fractions by EITB may yield further information relating to this 
phenomenon. The significance of the smear obtained in blots is not 
known but its restriction to the area between discrete bands suggests 
that it may be due to the protein being heavily glycosylated because 
of irregular binding of SDS and a consequently variable charge:mass 
ratio (Goding, 1986).
Rosenberg and Gitler (1985) identified a major plasma membrane glyco­
protein of 57 kD and one of 100 kD among a total of 34. More recently 
Torian et al. (1987) described 5 Mabs recognising a protein of 96 kD 
present on the surface membrane of E. histolytica. This antigen is 
believed to be a glycoprotein since binding of the Mabs is sensitive 
to oxidation by periodate although periodate treatment may also affect 
the polypeptide structure of the protein (Cecil, 1963; Bergamini et 
al., 1983). Calderon and Avila (1986) isolated rabbit antibody- 
induced caps of E. histolytica and identified a 98 kD surface protein 
enriched in the cap. It is possible that these reported surface 
proteins of approximately 98 kD apparent molecular weight represent 
the same molecule and that Mab 22.1 is also recognising it. The Mabs 
produced by Torian et al. (1987) however, did not recognise any
labelled antigens of other molecular weights in immunoprecipitation
125experiments. Other workers using the same I-lactoperoxidase 
labelling method (Krupp et al., 1983; Joyce and Ravdin, 1988) failed 
to detect surface proteins of either 57 kD or 98 kD. However 
Joyce and Ravdin (1988) did detect an internal 59 kD glycoprotein 
antigen recognised in EITB experiments using all 11 of the human 
patient sera tested. This further demonstrates the difficulty of 
comparing immunochemical analyses from independent sources.
Recently, three independent groups of workers have detected specific 
surface proteins of functional significance. Petri et al. (1987b) 
have detected and isolated the galactosamine/N-acetyl-D-galactosamine- 
inhibitable lectin found to consist of 170 kD and 35 kD subunits which 
migrate as a single band of 260 kD under non-reducing conditions 
(Petri et al., 1989). Rosales-Encina et al (1987) isolated a 220 kD
lectin whose effect is inhibitable by the trimer or tetramer of 
N-acetyl-D-glucosamine. Arroyo and Orozco (1987) have identified a 
112 kD protein, Mabs against which were capable of partially 
inhibiting amoebic adherence to erythrocytes and the cytopathogenic 
effect on cultured cell monolayers. All three of these antigens are 
recognised by antibodies present in human immune sera. No details of 
surface-related antigens of molecular weight greater than 300 kD, such 
as those detected here by Mab 22.1, have so far been reported in the 
literature.
The multiple bands of low molecular weight detected by Mab 29.11 may 
have a similar basis to the phenomenon observed with 22.1 discussed 
above. The antigens detected by 29.11 however, are internal and not 
expressed on the surface of the amoeba. A major internal antigen of 
43 kD, recognised by 8 out of 11 sera from cured liver abscess 
patients, has been reported by Joyce and Ravdin (1988).
Mab 22.7, which in IFAT experiments recognised internal vacuolar 
structures and occasionally the inner surface of the plasma membrane 
(Chapter 2), detected a protein band with an apparent molecular weight 
of 190 kD. Although Rosenberg and Gitler (1985) report a 195 kD 
glycoprotein present in the membrane but apparently not exposed on the 
external surface it is not known whether it also occurs in internal 
membranes. Mathews et al. (1986) detected antigens of approximately 
230 kD, 175 kD and 145 kD using human immune sera in EITB analysis of 
both internal and plasma membrane fractions of amoebae demonstrating 
the antigenic similarity of the two membrane systems.
Mabs 22.8, 24.2 and 24.4 all recognised antigens of approximately 
100 kD in EITB under non-reducing conditions. Under reducing 
conditions, 24.2 and 24.4 detected an antigen of 100 kD while 22.8 
failed to detect any bands of protein. Considering this result, the 
identical EITB band pattern obtained with 24.2 and 24.4 (different 
from 22.8), and taking into account the identical behaviour of these 
two Mabs in IFAT experiments using E. histolytica and E. invadens 
(Chapters 2 and 3), it is not unreasonable to suggest that they both
recognise the same single chain polypeptide of approximately 100 kD 
molecular weight. They may be directed against different epitopes of 
the same antigen but the possibility exists that they arose from the 
same clone due to cross-contamination of cultures during early 
hybridoma growth although every precaution was taken against this.
Mab 22.8 appears to recognise a different 100 kD polypeptide.
A similar situation occurred with Mabs 24.5, 24.7 and 24.8, which 
produced identical patterns on blots, recognising an antigen of 
approximately 97 kD. The same possibility that these Mabs might be 
identical due to cross-contamination of cell lines, also exists. This 
question could be answered by testing the ability of the Mabs to 
recognise the same fragments in EITB experiments using affinity- 
purified antigen that has been exposed to limited proteolytic 
digestion (eg. using trypsin). The sensitivity of the Mabs1 antigen 
binding capacity to antigen that has received prior Proteinase K or 
periodate treatment (see below) would also yield information on 
whether or not the epitopes recognised are different or identical.
Mab 29.3 recognised an antigen with an apparent molecular weight of 
120 kD under both reducing and non-reducing conditions, indicating 
that the molecule within the cell is a single polypeptide. Interest­
ingly, a protein of identical molecular weight was detected by this 
Mab in EITB experiments using an E. invadens lysate under reducing 
conditions supporting the cross-reaction noted with this species in 
IFAT experiments (Chapter 3).
Mab 22.4 detected an antigen of 115 kD under reducing conditions that 
migrated as a band of 230 kD under non-reducing conditions suggesting 
that the in vivo protein might possibly be a dimer consisting of two 
identical 115 kD subunits.
Finally, Mab 24.3 detected a protein of 130 kD which might possibly 
correspond to the prominent band of the same molecular weight noticed 
in gradient SDS-polyacrylamide gels and EITB strips stained for total 
protein (Plate 5.2).
1 f' -2 X  O' -i-
With the limited experimental evidence presented here it is difficult 
to draw conclusions on the significance of these antigens, detected by 
the Mabs, in terms of their function or their role in stimulating an
immune response in infected individuals. The latter might be
investigated by using affinity purified antigen (using the Mabs) in 
EITB experiments and probing blots with human immune serum. Further 
immunochemical analysis would involve investigation of the biochemical 
nature of the antigens. Protein antigens are likely to be sensitive 
to proteases, such as proteinase K or trypsin, destroyed by heat 
(100 °C) and to survive treatment by periodate. The converse is true 
for carbohydrate antigens although none of these tests is absolutely 
diagnostic. For example, some proteins are extremely resistant to 
proteolysis (Hardman et al., 1981) while certain amino-acids such as 
tyrosine and tryptophan are oxidised by periodate (Geoghegan et al., 
1980). In spite of this, abrogation Mab binding following some of 
these antigen treatments may give a prelimary suggestion of the nature 
of the epitope involved and thus the antigen.
Attempts could also be made to characterise antigens where the Mabs
failed to produce results in EITB experiments. These would involve
(a) immuno-precipitation of metabolically-labelled or iodinated (in 
surface antigens) antigen followed by SDS-PAGE and autoradiography or
(b) Affinity chromatography or immunoadsorption experiments using Mab 
covalently linked to solid phase gel.
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6.1 INTRODUCTION
The definitive diagnostic test for amoebiasis is generally regarded 
to be detection of the organism in faeces or tissues (Healy, 1978).
In asymptomatic cases this involves the detection of cysts in the 
faeces, while diagnosis of symptomatic intestinal amoebiasis relies 
on the identification of trophozoites containing ingested 
erythrocytes (Elsdon-Dew, 1969). Numerous fixatives, stains and 
concentration techniques are available for use in the direct 
identification of amoebic cysts and trophozoites. There are, 
however, certain problems associated with microscopic examination:
(i) the method is time-consuming and requires trained personnel (ii) 
the excretion of parasites is not continuous and their distribution 
in the faecal specimen may be uneven (Despommier, 1981). For this 
reason, it is recommended that at least three separate stool 
specimens be examined. (iii) Successful detection relies on the 
morphological integrity of the trophozoites or cysts. (iv) A number 
of "interfering" substances are capable of causing reduction, or 
temporary elimination, of numbers of amoebae in the stool (Juniper, 
1969). Such substances include broad-spectrum antibiotics, antacids, 
sulphonamides and various antidiarrhoeal preparations.
The diagnosis of hepatic amoebiasis by direct observation is 
complicated by the fact that: (i) liver abscesses frequently occur
after or in the absence of intestinal symptoms (Adams and MacLeod, 
1977b) and (ii) attempts to aspirate amoebic liver abscesses are not 
always successful and amoebae are not always detected in the sample 
(Healy, 1986). In the light of these and the problems associated 
with stool sample examination, the use of immunological techniques 
for the diagnosis of amoebiasis has become widespread in the last 
25 years. These techniques have been of great value both for the 
diagnosis of invasive disease in individual patients, and for 
assessing the extent of invasive amoebiasis in populations by 
seroepidemiological survey. Immunodiagnostic tests can be of two 
basic types: (a) Those involving the detection of specific
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anti-E. histolytica antibodies in sera, and (b) those involving the 
detection of E. histolytica antigen in patient samples (usually 
stools or sera).
There are about eleven different types of immunodiagnostic test for 
the presence of specific circulating antibody currently in use in 
various parts of the world (Healy, 1986). However, those in most 
widespread use are: cellulose acetate membrane precipitation (CAP),
Ouchterlony immunodiffusion (ID), indirect fluorescent antibody test 
(IFAT), indirect haemagglutination (IHA) and enzyme-linked 
immunosorbent assay (ELISA). The ELISA (or enzyme immunoassay-EIA) 
method has received particular attention over recent years and has 
resulted in the production of a number of commercially available 
kits. A problem common to these serodiagnostic tests is the 
persistence of circulating antibody in patients long after therapy 
and presumed cure (Healy et al., 1974) and the consequent inability 
to distinguish between current infection and past disease.
The detection of amoebic antigen in patient samples implies current 
infection with E. histolytica. Several authors have reported the
successful detection of circulating immune complexes in the serum of
patients. Pillai and Mohimen (1983) using radioimmunassay found 
immune complexes in the sera of all 21 patients with amoebiasis and 
none in the sera of 22 uninfected control patients or 6 drug-cured 
dysenteric cases. This procedure involved the polyethylene glycol 
(PEG) precipitation of the immune complexes and took approximately 
24 hours. More recently, Vinayak et al. (1986) reported the use of a 
more rapid (11 hours) ELISA that detected immune complexes in the
sera of 14 out of 15 confirmed amoebic liver abscess patients and 4
out of 7 suspected cases. None of 9 sera from cases of non-amoebic 
hepatitis or 10 sera from controls, contained detectable complexes. 
These results show promise for the development of a simple, rapid, 
non-radioactive procedure for routine laboratory diagnosis of 
amoebiasis. Although reasonable success has been reported in the 
detection of amoebic antigen in liver abscess aspirates using counter 
immunoelectrophoresis (Mahajan and Granguly, 1980) and ELISA 
techniques (Bhave et al., 1985), the need for successful aspiration 
remains a disadvantage.
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Root et al. (1978) described an ELISA method for the detection of 
amoebic antigen in faeces. The IgG fraction of rabbit anti-E. 
histolytica antisera was adsorbed onto 3 discs (positive and negative 
controls and sample) of a patented material mounted on a polystyrene 
slide. A suspension of faeces in buffer solution was applied to one 
of the discs and the slide agitated for 12-16 hours. After washing, 
peroxidase-conjugated antiamoebic IgG was added to each disc and the 
slide incubated for 2 hours at 20 °C. After further washing, colour 
development using 3-amino-5-ethylcarbazole was performed together 
with the inclusion of discs not treated with conjugated IgG, to test 
for endogenous peroxidase activity of the sample. Problems 
associated with the test included the requirement that faeces had to 
be fresh or at most, stored at 4 °C for only a few hours, and the 
presence of peroxidase in the faecal sample. This method formed the 
basis of a commercial kit (Immunozyme E. histolytica Reagent Kit, 
Millipore Corporation). The first extensive trial of this ELISA was 
reported by Palacios et al. (1978), in which doubts about the 
specificity of the system were raised. Although 155 of 159 samples 
containing cysts or trophozoites of E. histolytica were ELISA- 
positive, only 307 out of 562 microscopy-negative samples were 
ELISA-negative. Although these results may have been due to false 
positives, it is possible that the numbers of organisms present in 
the stools were below the level of microscopic detection. Randall et 
al. (1984) using the same kit in a study in male homosexuals, 
reported no ELISA-positive/ microscopy-negative results, but found 
that only 5 out of 12 microscopy-positive samples were ELISA- 
positive. In contrast, these results show a high specificity but a 
lower sensitivity, which, the authors suggested, may be due to a 
lower reactivity of cysts (present in the stools of these patients) 
as compared with trophozoites, against which the rabbit antiserum 
used in the test, was raised.
Grundy (1982) described the use of plastic microtitre plates in an 
ELISA test, again using rabbit anti-E. histolytica antiserum as a 
capturing antibody. Of the five samples tested that were positive 
for E. histolytica by microscopic examination, the three containing
trophozoites were ELISA-positive, while the two containing cysts were 
negative. This evidence supports the above suggestion by Randall et 
al. (1984), since here again, axenically-grown trophozoites were used 
as immunising antigen for production of the rabbit antiserum.
The use of a monoclonal antibody antibody in an ELISA test for E. 
histolytica in faecal samples was described by Ungar et al. (1985). 
Polystyrene microtitre plates were coated with a commercially 
produced monoclonal antibody raised against the HK9 axenically-grown 
strain. After incubation with diluted faecal sample and appropriate 
washes, rabbit antiserum against HK9 was added, followed by an 
alkaline phosphatase-conjugated goat anti-rabbit antiserum. Out of 
22 specimens containing E. histolytica trophozoites and/or cysts, 18 
were positive by ELISA; the 4 ELISA-negative stools had been stored 
frozen for up to 3 months, a finding similar to the loss of 
antigenicity following freezing described by Root et al. (1978).
Only three of 186 microscopy-negative stools were ELISA-positive and 
all stools containing other species of amoebae were ELISA-negative. 
The test described was comparatively rapid (approximately 5 h), 
specific and sensitive and, in contrast to the previously mentioned 
test, showed good reactivity with the cyst stage of the parasite.
Some of the monoclonal antibodies described in earlier chapters were 
tested as "antigen capture" antibodies in an ELISA similar in 
procedure to that described by Ungar et al. (1985).
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6.2 MATERIALS AND METHODS
6.2.1 Preparation of E. histolytica antigen
0
Culture tubes containing approximately 10 amoebae (strain 200:NIH) 
in late log phase growth were cooled in ice water for 5 min, inverted 
several times to remove adherent cells and centrifuged at 200 g for 5 
min at RT. The pellet was washed twice in PBS (pH 7.4) and the cells 
resuspended in 1 ml of PBS in a 1.8 ml microcentrifuge tube. This 
suspension was subjected to three freeze-thaw cycles in liquid 
nitrogen. Following centrifugation at 11,800 q for 10 min at 4 °C, 
the supernatant was assayed for protein content using the method of 
Lowry et al. (1951) and stored at -22 °C.
6.2.2 Preparation of rabbit anti-E. histolytica antiserum
One New Zealand White rabbit was immunised intramuscularly with 2 x 
0
10 washed E. histolytica (strain 200:NIH) in Freund's complete 
adjuvant and boosted on days 14 and 28 with the same dose in Freund's 
incomplete adjuvant. Blood was collected on day 35 and serum 
prepared.
This serum was subjected to affinity chromatography to remove any 
cross-reactivity with mouse immunoglobulin. A column of mouse 
monoclonal antibody against Trypanosoma brucei rhodesiense (GUPM 7.1) 
coupled to cyanogen bromide activiated Sepharose 4B (Pharmacia) was 
prepared according to the manufacturer's instructions using 10 mg 
protein per ml of gel. A 5 ml aliquot of immune rabbit serum was 
applied to an equal volume of coupled gel and the column washed with 
20 ml of PBS (pH 7.4). The eluate was collected and concentrated by 
osmotic pressure dialysis using polyethylene glycol, 40000 D 
molecular mass (Sigma, Poole).
6.2.3 Enzyme-linked immunosorbent assay (ELISA)
A double antibody ELISA was used, involving anti-E.histolytica 
monoclonal antibody adsorbed to the solid phase (microtitre plate). 
After the addition of test material, the presence of antigen was 
detected using Rabbit anti-E.histolytica antiserum followed by 
alkaline phosphatase-conjugated goat anti-rabbit antiserum. Optimal 
concentrations of these reagents were determined by titration.
The standard protocol was as follows: Microtitre plate (Immuno II,
Nunc) wells were coated with 50 |il of Mab-containing ascitic fluid, 
diluted 1/1000 in 0.05 M sodium carbonate/bicarbonate buffer pH 9.8, 
overnight at 4 °C. The plate was washed three times with PBS 
containing 0.05% Tween-20 (Sigma, Poole) (PBS-Tween) before use.
E. histolytica lysate was diluted in PBS-Tween containing 0.25% w/v 
BSA (diluting buffer), and 50 pi aliquots added to duplicate wells at 
the following concentrations of total protein: 50 pg/ml, 10 pg/ml,
1 pg/ml 0.1 pg/ml and 0.01 pg/ml. Control wells received 50 pi of 
diluting buffer. After incubation for 30 min at 37 °C, the plate was 
washed three times with PBS-Tween and 50 pi aliquots of Rabbit 
anti-E.histolytica antiserum, diluted 1/200 in diluting buffer, were 
added to each well. After a further incubation for 30 min at 37 °C, 
followed by three washes, 50 pi of alkaline phosphatase-conjugated 
goat anti-Rabbit antiserum (Sigma, Poole), diluted 1/500 in diluting 
buffer, was added to each well. Following incubation for 30 min 
(37 °C) and three washes, colour was developed by the addition of 
50 pi p-nitrophenyl phosphate substrate solution (Sigma, Poole)
(1 mg/ml in 10% Diethanolamine, pH 9.8) to each well. After 
incubation for 30 min at 37 °C the reaction was stopped by the 
addition of 50 pi 3 M NaOH to each well, and the optical density at 
405 nm was measured using a Titertec Multiscan Colourimeter (Flow, 
Irvine).
Protocol B contained the following alterations to the standard 
protocol: (i) The E. histolytica antigen was diluted in PBS-Tween
containing 5% w/v Marvel (Cadbury’s) instead of normal diluting 
buffer. (ii) Incubation steps involving E. histolytica antigen,
* Dried skimmed milk
Rabbit antiserum and anti-Rabbit conjugate were performed for 30 min 
at room temperature with the plate on a rotary shaker (240 cycles per 
min).
Protocol C contained the following alteration: A separate incubation
step was added between Mab coating and antigen incubation. This 
involved the addition of 75 |il of PBS-Tween containing 5% Marvel to 
each well and incubation for 30 min at 37 °C, followed by washing 
three times in PBS-Tween. All other steps performed as standard 
protocol.
6.2.4 Preparation of faecal extract
Samples of parasitologically-negative human faeces were thoroughly 
mixed in an equal volume of PBS (pH 7.4). The mixture was passed 
through an Endecott filter, 250 pm mesh size, to remove large 
particles, followed by passage through Whatman No.l filter paper.
This filtrate was filter sterilised through 0.22 pm Millex filters 
(Millipore) and stored as 3 ml aliquots at -22 °C.
6.2.5 Preincubation of E. histolytica antigen in human faecal 
extract
Amoebic lysate was incubated in human faecal extract at a 
concentration of 50 [iq/ml for 7 days at 4 °C. This antigen was used 
in ELISA experiments, protocol C in place of antigen in diluting 
buffer. Control wells received 50 |il of faecal extract in place of 
diluting buffer in the antigen incubation step.
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6 . 3 RESULTS
Seventeen Mabs (22.1, 22.3, 22.5, 22.6, 22.7, 22.8, 24.1, 24.2, 24.4,
24.5, 24.6, 24.7, 24.8, 29.3, 29.6, 29.10, 29.11) were tested as 
"antigen-capture" reagents in a double layer indirect ELISA for 
soluble E. histolytica antigen, using the standard protocol 
described. Antigen was used at five different concentrations and the 
tests carried out in duplicate wells. The mean of the two optical 
density values was calculated and the results are presented in Figure 
6.1. A dilution of antigen was considered positive if it yielded an 
optical density value greater than twice that of diluting buffer 
alone (control wells).
Mabs 24.7 and 29.3 were able to detect amoebic antigen at a level of 
0.1 pg/ml while eight other Mabs (22.3, 22.6, 22.8, 24.2, 24.4, 24.5,
24.6 and 24.8) were able to detect antigen down to a level of 
1 pg/ml. V^/ing the dilutions of the Mab in coating solutions from 
1/100 to 1/4000 produced very little difference in both maximum and 
minimum optical density values obtained (results not shown).
Nine Mabs (22.8, 24.2, 24.4, 24.5, 24.6, 24.7, 24.8, 29.3 and 29.10) 
were used in experiments in which the standard ELISA protocol 
(protocol A) was altered. Protocol B involved shaking during 
incubation steps, while protocol C involved a separate blocking step 
after coating and prior to sample addition. The results of these 
experiments are presented in Figure 6.2. The alterations to the 
standard protocol (A) employed in protocol B had little or no effect 
on the sensitivity of the antigen detection. The addition of a 
separate blocking step in protocol C caused, in general, a reduction 
of background signals (diluting buffer controls) and an increase in 
the sensitivity of antigen detection, although no statistical 
analyses were performed. Consequently seven Mabs (22.8, 24.2, 24.4,
24.5, 24.6, 24.7 and 29.3) were able to detect amoebic antigen down 
to a level of 0.1 pg total protein per ml.
Nine Mabs (22.8, 24.2, 24.4, 24.5, 24.6, 24.7, 24.8, 29.3 and 29.10) 
were used in ELISA experiments, protocol C, to detect ameobic antigen 
that had been previously incubated in human faecal extract for 
7 days. Five Mabs (22.8, 24.2, 24.5, 24.8 and 29.3) were able to 
detect antigen down to a level of 0.1 (ig/ml total protein, while 
Mab 24.7 detected antigen to a level of 0.01 \iq/ml. The results of 
these experiments have not been presented graphically.
FIGURE 6.1
Titration curves of Optical Density at 405 run (OD^^) versus 
E. histolytica lysate protein concentration using Mabs in double 
sandwich ELISA under optimum conditions.
Mabs 22.1, 22.3, 22.5, 22.6, 22.7, 22.8, 24.1, 24.2, 24.4, 24.5, 24.6, 
24.7, 24.8, 29.3, 29.6, 29.10 and 29.11 used to coat microtitre plates 
at 1/1000 dilution.
E. histolytica lysate antigen diluted in PBS-Tween with 0.25% BSA
Dotted line = OD,,-- obtained with diluted buffer in place of 405
E. histolytica antigen.
See Section 6.2 for details of method.
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FIGURE 6.2
Titration curves of Optical Density 405 nm (OD^^.) versus 
E. histolytica lysate protein concentration using Mabs in double 
sandwich ELISA under three sets of conditions.
Mabs 22.8, 24.2, 24.4, 24.5, 24.6, 24.7, 24.8, 29.3 and 29.10 used to 
coat microtitre plates at 1/1000 dilution.
Protocol A - Standard protocol
Protocol B - Incubations performed on rotary shaker 
Protocol C - Separate pre-antigen blocking step (5% Marvel)
Dotted line = OD^- obtained with diluting buffer in place of 405
E. histolytica antigen.
See Section 6.2 for details of methods.
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6.4 DISCUSSION
Previous attempts to develop ELISA tests for the detection of E. 
histolytica antigen in patient samples have, with the exception of 
one, used polyclonal antisera. These assays have been lengthy to 
perform and, in the case of one widely used assay for ameobic antigen 
in faeces (Root et al. , 1978; Palacios et al. , 1978), shown 
inadequate specificity. Ungar et al. (1985), using the specificity 
of a monoclonal antibody in combination with an animal derived 
antiserum, developed an apparently successful ELISA with a 
considerably shorter assay duration. In the work described in this 
Chapter, Mabs raised against axenically-grown E. histolytica (strain 
200:NIH) that were shown not to cross-react with other human 
protozoan parasites in IFAT experiments (Chapter 3), were used as 
"antigen capture" antibodies in a rapid (3 hour) double sandwich 
indirect ELISA for laboratory prepared 200:NIH antigen.
Two of the Mabs (24.7 and 29.3), when used in the assay, were able to 
detect antigen down to a level of 0.1 ng total amoebic protein per ml 
of sample. When a separate 30 min blocking step was added before 
antigen incubation, a further five Mabs were capable of this level of 
detection. These results compare very favourably with the results 
reported by previous workers; Root et al. (1978) showed that their 
method had a sensitivity of 0.23 ng/ml while the assay described by 
Grundy (1982) had a higher sensitivity of 0.15 \iq/ml. Ungar et al. 
(1985) gave no precise figures for amoebic protein detection.
If, however, an approximation of 10 organisms being equivalent to 
1 mg of protein is used, their highest reported sensitivity of 40 
organisms per ml would correspond to detection of 0.04 |ig/ml.
The poor performance of several of the Mabs in this assay has several 
possible causes: (a) the antigens for which they are specific may be
present only in small amounts in the lysate or may have been 
denatured during the lysate preparation. (b) The antigens bound by 
the Mabs may be recognised by antibodies present only in very small
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If, however, an approximation of 10 organisms being equivalent to 
1 mg of protein is used, their highest reported sensitivity of 40 
organisms per ml would correspond to detection of 0.04 |ig/ml.
The poor performance of several of the Mabs in this assay has several 
possible causes: (a) the antigens for which they are specific may be
present only in small amounts in the lysate or may have been 
denatured during the lysate preparation. (b) The antigens bound by 
the Mabs may be recognised by antibodies present only in very small
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amounts in the rabbit antiserum. (c) The Mabs may be of low 
affinity, so that antigen is only weakly bound or is easily displaced 
from the antigen binding site during washing stages. This last, is 
probably the most likely explanation, since low optical densities 
were obtained even in conditions of antigen excess (Steward and Lew, 
1985). While the addition of a separate blocking step, designed to 
reduce non-specific binding of antigen to the plate, seemed to 
increase the sensitivity of the assay, attempts to maximise antigen 
monoclonal and antibody-antibody interactions by mixing on a rotary 
shaker did not seem to have any effect.
Results obtained with antigen previously incubated in human faecal 
extract for 7 days were encouraging. Faecal components do not seem 
to cross-react or interfere with at least six of the Mabs, and the 
antigens for which these Mabs are specific do not seem sensitive to 
any protease activities in the extract, which can be a problem in 
faecal antigen detection (Green, 1986).
Most of the Mabs produced in this work, the exceptions being 22.3 and
22.5, have not been tested for their reactivity with cysts of 
E. histolytica (the only reliable source being asymptomatic carrier 
faeces). Since they were raised against trophozoites of the 
parasite, it is possible that, like 22.3 and 22.5, they do not 
recognise cyst antigens. E. histolytica trophozoite antigens have, 
however, been shown to cross-react with Entamoeba invadens cyst 
antigens (Yap et al., 1970) and the Mab utilised by Ungar et al.
(1985) was certainly capable of recognising E. histolytica cysts. 
These Mabs may therefore have more use in the detection of 
circulating immune complexes which would involve trophozoite-derived 
antigens. Such a test would, by nature, be specific for current 
invasive disease; whereas faecal antigen detection, unless 
pathogen-specific Mabs were utilised (Chapter 7), would detect both 
asymptomatic and symptomatic (invasive) amoebiasis. Unfortunately 
the Mabs specific for pathogenic amoebae (22.3 and 22.5) did not 
perform well in the ELISA procedure described here.
In summary, several of the Mabs appear promising as reagents in an 
ELISA specific for amoebic antigen, although the type of assay in 
which they might be suitable (faeces or serum detection of antigen), 
can only be determined by the extensive testing of patient samples.
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CHAPTER 7
IMMUNOLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC 
ISOLATES OF ENTAMOEBA HISTOLYTICA.
7.1 INTRODUCTION
7.2 MATERIALS AND METHODS
7.3 RESULTS
7.4 DISCUSSION
This work was performed in the Department of Medical Protozoology, 
London School of Hygiene and Tropical Medicine, London. Financial 
support for this work was provided by the Wellcome Trust and the 
World Health Organisation.
This work has been previously published as: Strachan, W.D., Spice,
W.M., Chiodini, P.L., Moody, A.H. and Ackers, J.P. (1988). 
Immunological differentiation of pathogenic and non-pathogenic 
isolates of Entamoeba histolytica.
Lancet, i: 561-563.
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7.1 INTRODUCTION
While there are up to 500 million human infections with Entamoeba 
histolytica worldwide (Walsh, 1986b), in the vast majority of cases 
the parasite lives as a harmless commensal confined to the lumen of 
the large intestine. However, in a small but very variable 
proportion, invasion and dissemination occurs, causing symptomatic 
amoebiasis - classically and most frequently invasive intestinal 
disease or amoebic liver abscess. There has been much debate over 
the years between those who believe that all amoebae are potentially 
capable of invasion and are restrained by some host-mediated defence 
mechanisms (Faust et al., 1970), and those who feel that two kinds 
(or even two species) of Entamoeba are involved, one of which is 
always (potentially) invasive and the other incapable of causing 
disease (Brumpt, 1949). (This argument should not be confused with 
the similar-sounding disagreement over the pathogenic potential of 
the "small race" of E. histolytica, now universally accepted as a 
different and non-pathogenic species, E. hartmanni (WHO, 1969)). The 
argument for all E. histolytica being potential pathogens restrained 
by the host's immune system, was supported by exacerbations which 
seemed to occur during pregnancy (Abioye, 1973) and following 
treatment with corticosteroids (Kanani and Knight, 1969) and was 
widely accepted. However, in 1982 some of the first evidence of a 
fundamental difference between E. histolytica isolates obtained from 
symptomatic patients and asymptomatic cyst-passers was presented by 
Martinez-Palomo et al. (1973), who demonstrated differences in 
agglutinability by the lectin Concanavalin A. Since then other 
differences have been found which seem to be inherent in the 
organism, the best validated of which are the isoenzyme results of 
Sargeaunt and Williams (Sargeaunt et al., 1978; Sargeaunt and 
Williams, 1979). These authors have shown that particular band 
patterns obtained after starch-gel electrophoresis with the enzymes 
hexokinase (HK) and phosphoglucomutase (PGM) correlate very closely 
with the clinical findings in the patients from whom the organisms 
were isolated. In particular, E. histolytica isolates from patients
*, r '' X  «u* *'■>
with invasive disease possess two advanced HK bands ("fast") while in 
isolates from asymptomatic cyst-passers the two bands are less 
advanced ("slow"). The same results have been obtained by other 
groups using different electrophoretic media: agarose (Mirelman et 
al., 1983), polyacrylamide (Mathews et al., 1983), and cellulose 
acetate (Moss and Mathews, 1987).
These results, and in particular their practical application, have 
been discussed in two recent Lancet editorials (Editorial, 1985; 
Editorial, 1986), with particular reference to the question of 
whether it is necessary or desirable to treat patients shedding cysts 
of a non-invasive zymodeme. In some populations where the carriage 
of invasive zymodemes appears to be extremely rare (for example male 
homosexuals in London (Goldmeier et al., 1986)) a non-treatment 
policy is already practised (Allason-Jones et al., 1986). This 
policy has recently been questioned by Mirelman and his co-workers, 
following their discovery that it is possible, by certain (admittedly 
very artificial) manipulations of the bacterial flora which accompany 
most cultures of E. histolytica, to change not just the isoenzyne 
pattern, but also the in vitro and in vivo virulence of non-invasive 
isolates of the parasite (Mirelman et al., 1986a,b). The 
significance or otherwise of these experiments is currently the 
subject of vigorous debate (Mirelman, 1987; Sargeaunt, 1987).
However, the epidemiological results presented over the years by 
Sargeaunt and his co-workers leave little doubt that, in the majority 
of cases, the outcome of an infection with E. histolytica does 
correlate with the zymodeme of the infecting organism. This 
correlation clearly does have important clinical implications, as 
well as opening up new approaches for research. If, however, 
determination of the invasive potential is ever to be applied to 
routine samples, a method which is simpler, quicker and cheaper than 
culture (for up to seven days to obtain sufficient organisms) 
followed by isoenzyme electrophoresis, will need to be developed.
A method is presented here, based on immunofluorescence using 
monoclonal antibodies, which may partially meet this need.
7.2 MATERIALS AND METHODS
The monoclonal antibodies (Mabs) 22.3 and 22.5 were members of a 
large group prepared by standard procedures from BALB/c mice 
immunised with axenically-grown trophozoites of the 
laboratory-adapted strain of E. histolytica 200:NIH, and utilised in 
the form of ascitic fluids obtained from pristane-primed mice.
200:NIH (ATCC 30458) was first isolated from sigmoidoscopic material 
in 1949 (Tobie, 1949) and has since been adapted to axenic 
(Bacteria-free) culture but retains a pathogenic zymodeme (Z II) 
(Sargeaunt et al., 1980b). It had already been established that some 
of the monoclonal antibodies (including 22.3 and 22.5) were specific 
for E. histolytica (Chapter 3), and since it was suspected that these 
two Mabs were specific for invasive isolates (Chapter 4), the trial 
described here was set up.
All faecal samples, found by routine examination at the Hospital for
Tropical Diseases (St Pancreas, London), to contain cysts of
E. histolytica, were stored at 4 °C for not more than six days,
before being inoculated into Robinson's medium (Robinson, 1968) (but
using 50% less starch than in the original formula) and cultivated at
37 °C. After the initial overlay change, sub-cultures were made as
necessary until sufficient growth was obtained for isoenzyme
examination (usually within seven days). Several older isolates of
known invasiveness, which had been cryopreserved for up to four
years, were re-established in the same medium. When enough organisms 
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(about 10 ) were present, the amoebae from a single 5 ml bottle (plus 
starch and bacteria) were harvested by centrifugation, washed, 
resuspended in 20 fil of lysis buffer (20 mM Tris, 150 mM NaCl,
1 mM phenylmethylsulphonyl fluoride, 1 mM iodoacetate and 10 ng/ml 
N-p-Tosyl-L-lysine chloromethyl ketone, pH 8.0) and lysed by freezing 
(in liquid nitrogen) and thawing three times. Centrifugation 
(12,000 g for 1 min) yielded the supernatant which was used for 
isoenzyme assay. Only HK was examined, and lysates were run in 
agarose mini-gels submerged in 0.1 M borate buffer pH 8.0 (Mirelman 
et al., 1986a) at 50 V for 90 minutes. Enzyme bands were visualised
by the method used by Sargeaunt and Williams (1979), except that no 
overlay was used, and development was performed in a tank. Two 
strains of known invasiveness and zymodeme, TE (invasive, zymodeme 
II) and C29, (non-invasive, zymodeme I), were included as controls. 
Under these conditions the distinction between fast bands, indicating 
invasiveness, and slow bands was clear.
Reaction of the amoeba with the Mabs was assessed by indirect 
fluorescent antibody test. Samples of the bottom starch layer of 
2-day Robinson's medium cultures were removed and gently mixed.
Drops of suspension were added to the wells of the multispot 
PTFE-coated slides (Henley) and air dried. Slides were fixed in 
methanol (5 min) and stored with desiccant at -22 °C. Tripling 
dilutions of ascitic fluid were applied to wells and the slides 
incubated in a humidified atmosphere at room temperature for 30 min. 
Following two washes in phosphate-buffered saline (PBS) pH 7.2, 
fluorescein isothiocyanate-conjugated (FITC) rabbit anti-mouse 
immunoglobulin (Amersham) was applied, diluted 1:50 in PBS with 
1/10,000 Evans Blue, and the slides incubated for a further 30 min. 
Finally the slides were washed twice with PBS and mounted in 50% 
glycerol (Citifluor) in PBS. Wells were examined using a Leitz 
microscope with incident-light fluorescence, using a HB50 high 
pressure mercury vapour lamp, a TK 510 dichroic mirror, a 2 x KP 490 
(exciting) and a K 515 (suppressing) filter. End-point dilutions 
were recorded as the highest producing recognisable specific 
fluorescence. All cultures were confirmed as E. histolytica by 
morphology and staining with the species-specific Mab 22.8. 
Immunofluorescence results were read before the HK gels were run; 
subsequently clinical details and the results of amoebic serology 
(where available) were supplied by Dr P L Chiodini, Consultant 
Parasitologist, Hospital for Tropical Diseases.
7.3 RESULTS
Fifty two faecal samples containing cysts of E. histolytica were 
obtained, from which 25 successful cultures (48%) were established 
although one (G) grew insufficiently to enable isoenzyme analysis. 
Results from these isolates, together with those for six 
cryopreserved isolates and four invasive, laboratory-adapted, axenic 
strains, are shown in Table 7.1. The pattern of staining produced by 
the two Mabs was not entirely similar; 22.3 produced a granular 
internal fluorescence, while 22.5 produced an internal vacuolar 
staining pattern (Section 2.3.2).
The two Mabs, 22.3 and 22.5 appear to bind exclusively to isolates of 
E. histolytica possessing fast mobility HK bands. All five of the 
isolates obtained from patients showing positive serology were 
recognised. Results from IFAT experiments using isolates possessing 
slow mobility HK bands were all negative at a Mab dilution of 1/9 
(log3 titre =2), while fast mobility HK isolates were positive to 
log3 titres 7-12.
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LEGEND TABLE 7.1
COMPARISON OF CLINICAL FINDINGS, HEXOKINASE MOBILITY AND IFAT 
STAINING WITH THE TWO MONOCLONAL ANTIBODIES 22.3 AND 22.5 FOR VARIOUS 
ISOLATES OF ENTAMOEBA HISTOLYTICA.
The first four strains are long-established invasive isolates which 
have been adapted to grow without bacteria in axenic medium; the next 
six are cryopreserved clinical isolates recultured in Robinson's 
medium, and the remaining strains, fresh clinical isolates.
All clinical samples contained E. histolytica (cysts unless otherwise 
stated), and in addition: E.h + rbc = haematophagous trophozoites;
G.1 = Giardia lamblia (G. intestinalis); E.c = Entamoeba coli; I.b 
= Iodamoeba buetschlii; E. hart = Entamoeba hartmanni; E. nana = 
Endolimax nana; Z = zymodeme.
Ocas.diar.: occasional diarrhoea
E.h antibody: IFAT = Reciprocal slide immunofluorescence titres
using fixed 200:NIH organisms as antigen; CAP = Precipitin reaction 
on cellulose acetate membrane (+ = Positive result; - = Negative 
result).
Mab IFAT titres are log^ dilutions 
NA: Information not available
ND: Not done
IG: Insufficient growth for isoenzyme analysis
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7.4 DISCUSSION
It is clear from Table 7.1 that Mabs 22.3 and 22.5, when used in IFAT 
experiments, recognise only those isolates belonging to pathogenic 
zymodemes. Although full zymodeme characterisation of many of these 
isolates has not been performed (involving the isoenzymes Glucose 
phosphate isomerase, Phosphoglucomutase, L-malate: NADP+ 
Oxidoreductase as well as Hexokinase), all isolates possessing fast 
mobility HK bands are considered to belong to pathogenic zymodemes 
(Sargeaunt, 1987). Isolates belonging to the rare zymodeme XIII do 
show "slow" (non-pathogenic) HK bands but in conjunction with 
phosphoglucomutase bands characteristic of pathogenic status 
(Sargeaunt, 1987). However, this zymodeme has not yet been isolated 
from symptomatic cases of amoebiasis, or cases showing positive 
serology, and cannot yet be classified as pathogenic or 
non-pathogenic (Jackson et al., 1985). Thus it is likely that all 
isolates used here that showed slow HK bands, and failed to react 
with the Mabs, belonged to non-pathogenic zymodemes. The 
disease-causing potential of the Mab-positive/"fast" HK isolates is 
confirmed by patient clinical symptoms and antiamoebic antibody 
titres, when available (amoebic serology is not normally requested 
for asymptomatic patients).
The nature of the antigens for which these Mabs are specific are not 
known; neither Mab was able to detect antigen on electroimmuno- 
transfer blots of E. histolytica lysates after SDS-PAGE (Chapter 5). 
It is unlikely that both are directed against the same antigen 
however, since the patterns obtained with each Mab in IFAT 
experiments were markedly different. The antigens may be directly 
related to virulence or, as is likely with isoenzyme virulence 
markers, be indirectly linked in some way. Whether the 
non-pathogenic isolates fail to express these antigens or express 
them in altered forms unrecognisable to the Mabs remains to be 
answered.
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The practical utility of these findings will largely depend on the 
resolution of current controversies over the treatment of 
asymptomatic cyst-passers; but clearly they have the potential to 
provide the basis for a relatively cheap and rapid method for 
determining the invasive potential of a clinical isolate of 
E. histolytica. The Mabs do not appear to react directly with 
E. histolytica cysts, so that preliminary culture is still required, 
but sufficient organsisms for the production of IFAT slides can often 
be obtained within two days, rather than the seven days often needed 
for preparing the lysate for isoenzyme analysis. Unfortunately, the
22.3 cell line has ceased producing antibody; but now that it is 
clear that antigenic differences between invasive and non-invasive 
organisms do exist, attempts to produce further Mabs with the same 
specificity are in progress.
CHAPTER 8 GENERAL DISCUSSION
CHAPTER 8 GENERAL DISCUSSION
Twenty one monoclonal antibody-secreting hybridoma cell lines were 
produced from fusions between mouse myeloma cells and spleen cells 
from mice immunised with axenically-cultured E. histolytica 
trophozoites. These Mabs were used as probes to study the amoebic 
antigens against which they were directed. With hindsight, a 
slightly more rational approach to the characterisation of amoebic 
antigens might have yielded more useful information. This would have 
involved the identification of immunologically relevant antigens 
recognised by human patient serum, and their subsequent isolation.
The antigens studied in this work represent a more or less random 
selection of the total antigenic composition of E. histolytica.
The indirect fluorescent antibody test (IFAT) provided a rapid and 
effective technique to determine the subcellular locations of the 
antigens and was utilised extensively in this study. When IFAT 
experiments were performed using a variety of other protozoan, (and 
one mammalian) cell types, it was found that two of the Mabs, 29.5 
and 29.9, reacted with all cells tested, suggesting that they were 
recognising conserved antigens. The remaining 19 Mabs produced a 
variety of staining patterns in E. histolytica trophozoites in IFAT 
experiments. Although preliminary attempts at immunochemical 
analysis of the antigens recognised by the Mabs was performed, the 
functional significance of these antigens was not investigated in 
this study.
Three of the Mabs recognised antigens exposed on the surface of the 
amoeba; results confirmed by the fluorescence of live trophozoites 
used in IFAT experiments. These antigens may either be components of 
the surface plasma membrane of the amoeba, or part of the glycocalyx 
external to it. When reduced SDS-denatured lysates of E. histolytica
were electrophoresed and subjected to electroimmunotransfer blotting 
(EITB), one of these Mabs, 22.1, detected a series of antigen bands 
with a variety of approximate molecular weights. Surface antigens 
with approximate molecular weights corresponding to two of these 
bands (58 kD and 95 kD) have been detected by other authors 
(Rosenberg and Gitler, 1985; Calderon and Avila, 1986; Torian et al., 
1987). A smearing of stain between the bands suggests that the 
antigen may be a glycoprotein (Goding, 1986). Though other possible 
explanations exist, it is attractive to suggest that these multiple 
bands might correspond to precursors of a surface located antigen 
during intracellular processing, as reported for an antigen of 
Plasmodium falciparum (Holder and Freeman, 1982). Although the 
detection of such internal precursors would probably be obscured by 
surface membrane fluorescence in IFAT experiments using fixed 
amoebae, it was noted, that in certain isolates of E. histolytica 
tested, amoeba showing only internal fluorescence did occur. The 
purely internal location of antigens more frequently located on the 
surface of the amoebae was also detected using Mabs 22.6 and 29.6 in 
a number of isolates (though never occurring with all three Mabs in 
the same isolate). This phenomenon has been reported in Trichomonas 
vaginalis (Alderete et al., 1986a), in which it is due to a 
subpopulation within the culture failing to express the antigen on 
the cell surface.
A heterogeneity of surface antigen expression among cultures and 
cloned lines of amoebae was detected using all three of these Mabs. 
Although such variation in expression might be coordinated with cell 
cycle events, reported in E. histolytica by Aust-Kettis and Sundqvist 
(1978), it seemed to have features more in common with the antigenic 
heterogeneity described in T. vaginalis by Alderete et al. (1986a,b). 
Variation in the numbers of cells expressing surface antigen occurred 
over extended culture and these authors concluded that the changes 
were not coupled to single cell cycle events. It is not known
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whether this type of variation in antigen expression occurs in vivo 
in E. histolytica, as it does in T. vaginalis (Alderete et al.,
1987).
Mabs 22.1, 22.6 and 29.6 recognised surface-located antigens in most 
isolates of E. histolytica tested; although negative results may have 
been due to undetectably low proportions of cells expressing the 
particular antigen. Two of these antigens, recognised by 22.1 and
29.6, were specific to E. histolytica, while the antigen recognised 
by 22.6 was also detected in Entamoeba invadens among a range of 
related and unrelated gut protozoa tested.
Two Mabs, 22.5 and 22.7 appeared to recognise antigenic components of 
the vacuolar system specific to E. histolytica. Mab 22.7, which 
recognised an antigen of approximately 190 kD molecular weight in 
EITB, also produced plasma membrane staining in a very small 
proportion of observed amoebae. Whether or not this antigen is 
exposed on the surface of live amoebae, is not certain. A 195 kD 
plasma membrane protein, apparently not exposed on the surface, has 
been identified by Rosenberg and Gitler (1985). Mab 22.5 recognised 
an antigen of unknown molecular weight, detectable only in pathogenic 
isolates of E. histolytica (see below).
The remaining fourteen Mabs recognised cytoplasmic components of the 
amoeba. Only four of these detected antigens specific to 
E. histolytica, while the other ten detected antigens shared mainly 
by other members of the genus Entamoeba. One of the E. histolytica- 
specific antigens, recognised by Mab 22.3, was detected in all 
pathogenic isolates tested in a detailed study (Chapter 7) though 
some conflicting results involving non-pathogenic isolates had been 
obtained in earlier work (Chapter 4). The other E. histolytica- 
specific antigens included a 100 kD antigen detected by 22.8, a 
series of antigens of approximately 12 kD, 16 kD and 45 kD molecular 
weights (on EITB after SDS-PAGE under reducing conditions) detected 
by 29.11.
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Mab 22.4 recognised an antigen of 230 kD, detectable in several other 
species of Entamoeba (and Pentatrichomonas hominis), which is 
possibly a dimer composed of two 115 kD subunits (from EITB after 
SDS-PAGE under reducing and non-reducing conditions). Mab 24.3 
recognised a 130 kD monomeric antigen, undetectable in one isolate of 
E. histolytica, that was shared also by Entamoeba moshkovskii, while
29.3 detected a 120 kD monomeric antigen also detected in both 
E. moshkovskii and all tested isolates of E. invadens. One pair of 
Mabs, 24.2 and 24.4, appeared to recognise the same antigen, 
producing identical IFAT staining patterns, EITB results (100 kD) and 
species cross-reactions (E. moshkovskii and E. invadens). This 
result, as discussed, may have arisen due to contamination of cell 
lines during hybridoma culture. A similar phenomenon was observed 
using Mabs 24.5, 24.7 and 24.8. These Mabs recognised a 97 kD 
E. histolytica antigen also detected in E. invadens. Mabs 24.1 and
24.6 detected internal antigens of unknown molecular weight also 
detected in one isolate of E. invadens, in the case of 24.1, and 
E. moshkovskii in the case of 24.6. Except in the case of Mab 29.3, 
where a 120 kD antigen was detected in EITB experiments using both 
E. histolytica and E. invadens lysates, it is not known whether Mabs 
detecting antigens in other protozoan species were recognising 
antigens of the same approximate molecular weight as those in 
E. histolytica.
Studies with other protozoan species (Chapter 3) showed that these 
Mabs recognised antigens restricted mainly to the genus Entamoeba; 
except 29.5 and 29.9 which recognised every cell type tested, only 
two Mabs reacted with species other than the Entamoebae. The 
cross-reaction of Mab 24.1 with the flagellum of only Trypanosoma 
brucei rhodesiense, among several flagellate species tested, is not 
likely to represent the existence of an evolutionarily-conserved 
antigen but rather the fortuitous possession of cross-reacting 
epitopes. While only eight of the Mabs were specific for 
E. histolytica, a further eight recognised only E. invadens or 
E. moshkovskii or both, out of the range of cells tested. Since 
E. invadens seems restricted to reptilian hosts (Ratcliffe and
Gieman, 1938), and E. moshkovskii seems non-infective to man (Rogova, 
1958), the potential of these eight Mabs for use in a diagnostic test 
for human amoebiasis cannot be excluded. The cross-reaction of these 
eight Mabs with E. invadens and E. moshkovskii demonstrated the close 
relationship, in terns of antigenic composition, between these 
morphologically similar members of the quadrinucleate-cyst group of 
Entamoeba. However, one member of this group, Entamoeba hartmanni, 
showed no cross-reactions (except with 29.5 and 29.9); in contrast to 
the findings of Goldman et al. (1960) who reported that anti- 
E. histolytica antiserum cross-reacted with E. hartmanni to the same 
extent as it did with E. invadens. The identical patterns of Mab 
cross-reactivity obtained with Entamoeba coli (a commensal species in 
man) and Entamoeba muris (a commensal in mice) reflected the 
morphological indistinguishability of these two members of the 
octonucleate-cyst group of Entamoeba (Neal, 1950).
The heterogeneity of Mab cross-reactions observed among the various 
isolates of E. invadens tested, demonstrates the importance of 
testing for cross reactions in more than one isolate of a certain 
species. Very little heterogeneity in antigenic composition was 
observed among the fifteen isolates of histolytica tested. Apart 
from two Mabs (22.3 and 22.5) which detected antigens only in 
pathogenic isolates (Chapter 7), only the three surface-staining Mabs 
(as previously discussed) and Mab 24.3 failed to react with all the 
isolates. The failure of 24.3 to react with one particular isolate 
is surprising since it recognised E. moshkovskii, E. coli and 
E. muris.
Since Mab 22.4 was capable of recognising the human commensal amoeba, 
E. coli, it was concluded that twelve of these thirteen Mabs that 
detected all tested isolates of E. histolytica, were potentially 
useful antigen capture agents in an immunodiagnostic assay for 
detecting both pathogenic and non-pathogenic E. histolytica in human 
samples. Current W.H.O. directives (T. Vesikari, pers. comm.) favour 
the development of an assay able to detect the presence of only
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pathogenic amoebae in human samples, both as an epidemiological tool 
and as a possible aid to targeting treatment towards asymptomatic 
patients at risk from invasive disease. Mabs 22.3 and 22.5 might be 
useful as the basis for such a test. Unfortunately the pathogen- 
specificity of these Mabs had not been determined when preliminary 
investigation of the Mabs' diagnostic potential was carried out.
Seventeen Mabs were tested as antigen capture reagents in a double 
sandwich enzyme-linked immunosorbent assay for amoebic antigen.
Seven of these were capable of detecting antigen down to a level of 
100 ng/ml total amoebic protein. The sensitivity of this assay was 
improved by the addition of a separate blocking step immediately 
after coating of the assay plates with Mab, before sample incubation. 
Incubation of amoebic lysate in human faecal extract for 7 days 
caused no apparent loss of reactivity of at least six of the antigens 
concerned.
In extensive studies examining the correlation of isolate isoenzyme 
profile with the clinical and serological status of the source- 
patient, Sargeaunt and his colleagues have grouped isolates of 
E. histolytica into two distinct categories: pathogenic and non-
pathogenic (Sargeaunt and Williams, 1978, 1979; Sargeaunt et al., 
1984; Sargeaunt, 1987). Amoebae belonging to non-pathogenic 
zymodemes are isolated only from asymptomatic patients with negative 
serology, while amoebae belonging to pathogenic zymodemes are 
isolated mainly from symptomatic patients, although asymptomatic 
carriers of these zymodemes occur in endemic areas (Sargeaunt, 1987). 
Although other markers for pathogenicity apparently exist (Section 
1.5), isoenzyme electrophoretic mobility analysis was, until 
recently, the only method widely tested in clinical isolates of 
E. histolytica. The work discussed here (Chapter 7) and in Strachan 
et al. (1988), represents the first published report of antigenic 
differences between pathogenic and non-pathogenic isolates. More
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recently, differences at the DNA level have been discovered. Using 
two sets of DNA probes derived from tandemly repeated sequences 
present in extrachromosomal circular elements from both pathogenic 
and non-pathogenic isolates, the two groups of amoebae could be 
differentiated in hybridization experiments (Garfinkel et al., 1989; 
Huber et al., 1989).
There are two opposing hypotheses to explain the basis of 
pathogenicity in E. histolytica. One hypothesis proposes that 
pathogenic and non-pathogenic isolates represent distinct subspecies 
of this parasite (Sargeaunt, 1987). Long-term studies of 
asymptomatic carriers of non-pathogenic amoebae (Allason-Jones et 
al., 1986) and in vitro studies in which the bacterial flora of 
polyxenically-cultured non-pathogenic amoebae was altered, showed no 
evidence of changes from non-pathogenic to pathogenic zymodemes 
(Sargeaunt, 1987). This evidence of zymodeme stability has been used 
to propose a non-treatment policy of patients harbouring amoebae 
belonging to non-pathogenic zymodemes (Allason-Jones et al., 1986). 
The second hypothesis, that zymodemes and pathogenicity are not such 
stable characteristics, is based on the recent work of Mirelman and 
his colleagues (Mirelman et al., 1986a,b). These authors found that 
during the attempted axenization of a cloned non-pathogenic isolate, 
the isoenzyme mobility pattern changed from a non-pathogenic one to a 
pathogenic one. This change was accompanied by a concomitant 
increase in in vitro and in vivo virulence. Furthermore 
reassociation of this converted strain with its original flora 
resulted in a return to a non-pathogenic isoenzyme pattern and a 
decrease in virulence, while association with bacterial flora from a 
polyxenically-cultivated pathogenic isolate resulted in no such 
reversion. Whether such changes could actually occur in vivo is not 
known, but the possibility does exist.
Garfinkel et al. (1989) have shown that, in these converted strains, 
the hybridisation patterns obtained with the pathogen-specific and 
non-pathogen-specific DNA probes correlated prefectly with isoenzyme
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pattern. Recent unpublished results using Mabs 22.3 and 22.5 in IFAT 
experiments with these strains and others prepared by the same 
technique in a different laboratory, have shown a similar 
correlation. During the axenization process, Mab recognition occurs 
at the same time as the isoenzyme pattern changes from one 
characteristic of a non-pathogenic zymodeme to one characteristic of 
a pathogenic zymodeme. Although the molecular mechanisms occurring 
during conversion and change in zymodeme are not known, these results 
suggest a coordination of processes within the amoeba. Studies on 
the hexokinase enzymes of pathogenic and non-pathogenic strains of 
E. histolytica have suggested that electrophoretic differences might 
be due to post-translational modifications of the proteins (Bracha et 
al., 1987). Since these enzymes are unlikely to be virulence factors 
in themselves it is possible that such changes are the consequences 
of a more general activation of metabolic processes within the 
amoeba. Further work involving the characterisation of the antigens 
for which Mabs 22.3 and 22.5 are specific, is being continued.
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